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Abstract 
Haemonchus contortus and Dictyocaulus viviparus are parasitic nematodes which infect 
small ruminants and cattle, respectively worldwide causing huge economic losses. The 
current major control method is the usage of anthelmintic drugs. However, increasingly this 
strategy is failing due to an increase in parasite drug resistance. New control methods are 
therefore urgently needed and an attractive potential choice would be vaccination. However, 
all the attempts to create recombinant vaccines to date have failed therefore a potentially 
novel approach would be the development of carbohydrate-based vaccines. One of the major 
bottlenecks in this approach is the lack of structurally characterized parasitic nematode 
glycans.  
In this thesis mass-spectrometry-based structural glycomic characterization of protein linked 
N- and O-glycans from Haemonchus contortus and Dictyocaulus viviparus adult and L3 stage 
parasites has been performed. The adult Haemonchus contortus glycomic analysis revealed 
previously unseen Gal-Fuc structures present in both N- and O-glycans. None of these 
structures were detected in L3 stage N- and O-glycan analysis. In comparison phosphorylated 
Galβ1-3(Galβ1-6)-GalNAc Core O-glycans were observed. The O-glycan analysis of L3 
stage Dictyocaulus viviparus revealed the presence of Galβ1-3(Galβ1-6)-GalNAc Core 
glycans which can be further modified with fucose and α/β-galactoses. In contrast to L3 
stage, the adult O-glycan analysis reveals mainly Core-2 based structures with the highest 
molecular weight structure forming the Lewisx antenna which is also abundantly observed in 
adult N-glycans. 
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AC                                                  Alternating current 
AMBIC                                          Ammonium bicarbonate     
APC                                                Antigen-presenting cell 
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Da                                                   Dalton 
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DMSO                                            Dimethyl sulfoxide 
DTT                                                Dithiothreitol 
DV                                                  Dictyocaulus viviparus 
ECM                                               Extracellular matrix 
EDTA                                             Ethylenediaminetetraacetic acid 
EI                                                    Electron ionization 
ER                                                  Endoplasmic reticulum 
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ESI                                                  Electrospray ionisation 
FAB-                                               Fast atom bombardment 
Fuc                                                  Fucose            
Gal                                                  Galactose 
GalNAc                                           N-acetylgalactosamine 
GC-MS                                            Gas chromatography coupled to mass spectrometry 
Glc                                                   Glucose 
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GPCR                                              G-protein-coupled receptor 
GPI                                                  Glycophosphatidylinositol 
HA                                                   Haemagglutinin 
HC                                                   Haemonchus contortus 
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Hib                                                   Haemophilus influenza b type 
Hex  Hexose 
HexNAc                                          N-acetylhexosamine 
HF                                                   Hydrofluoric acid 
HPLC                                              High pressure liquid chromatography 
IAA                                                 Iodoacetic acid 
IgA                                                  Immunoglobulin A 
IL                                                     Interleukine 
IRIV                                                Immune-potentiating reconstituted influenza virosome 
KOH                                                Potassium hydroxide 
KBH4                                                       Potassium borohydride 
KLH                                                Keyhole limpet haemocyanin 
LDN                                                GalNAcß1-4GlcNAc 
LDNF                                              GalNAcß1-4(Fucα1-3)GlcNAc  
Lewisx                                             Fucα1-3(Galß1-4)GlcNAc 
Lewisy                                             Fucα1-3(Fucα1-2Galß1-4)GlcNAc 
LGC                                                Ligand-gated channel 
LN or LacNAc                                Galß1-4GlcNAc 
LPG                                                 Lipophosphoglycan 
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Man                                                 Mannose 
MGL                                               Macrophage galactose type C-type lectin 
MHC                                               Major histocompatibility complex 
MR                                                  Mannose receptor 
MALDI-                                          Matrix assisted laser desorption ionization  
MS  Mass spectrometry 
MSn                                                                   Mass spectrometry to the power of ‘n’ 
MS/MS  Tandem mass spectrometry 
m/z                                                   Mass-to-charge ratio 
NaCl                                                 Sodium chloride 
NH4OH                                             Ammonium hydroxide 
NMR                                                 Nuclear magnetic resonance 
OST                                                  Oligosaccharyltransferase 
OVA                                                 Ovalbumin  
PC                                                     Phosphorylcholine 
PCR                                                  Polymerase chain reaction 
PEtN                                                 Phosphoethanolamine 
PGC                                                  Porous graphitized carbon 
PMMA                                              Partially methylated alditol acetates 
QIT                                                   Quadrupole ion trap 
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Q-TOF                                              Quadrupole time-of-flight 
RF                                                     Radio frequency 
SEA                                                  Schistosome egg antigen 
Schisto Core                                      Galβ1-3(Galβ1-6)GalNAc 
TACA                                               Tumour-associated carbohydrate antigens 
TCR                                                  T-cell receptor 
Th1/Th2                                            T-helper 1/T-helper 2 
TIC                                                    Total ion count 
TLR                                                   Toll-like receptor 
TOF   Time of flight 
TRIS                                                  Tris(hydroxymethyl)aminomethane 
TF                                                      Transcription factor 
TT                                                      Tetanus toxoid 
UDP                                                   Uridine diphosphate 
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1.1 Nematodes and their control methods 
1.1.1 Introduction to nematodes 
Nematodes or roundworms are extremely diverse multicellular invertebrate organisms 
belonging to the phylum Nematoda (see Figure 1). About 80 percent of all multicellular 
terrestrial animals are nematodes which establish them as the most abundant multicellular 
organisms on Earth (Platt, 1994). Their habitats include terrestrial, fresh water and marine 
environments and in the latter they comprise 90% of all multicellular organisms (Danovaro et 
al., 2008). In 2011 the nematode species Halicephalobus mephisto was reported to be found 
in mines in South Africa at depths of 1.3 km. The authors speculated that this finding ‘has 
important implications for the search for subsurface life on other planets in our Solar System’ 
(Borgonie et al., 2011). 
Although species like Placentonema gigantissimum infecting sperm whales can be up to a 
meter long, the majority of nematodes are less than 1 mm in length. They feed on different 
sources of food with most of them being harmless to humans and higher order organisms. For 
example, free-living Caenorhabditis elegans is usually found in compost heaps where it feeds 
on bacteria and small eukaryotes (Felix and Braendle, 2010). This organism has also attracted 
a lot of scientific attention. Sydney Brenner, John Sulston and Robert Horvitz won the Nobel 
Prize in 2002 using Caenorhabditis elegans as a model organism for their research on organ 
development and apoptosis. Some nematodes are parasites infecting humans, animals and 
plants. For example, Oncocercha gibsoni infects cattle whereas the closely related species 
Oncocercha volvulus infects humans. Trichinella spiralis is found in a wider range of hosts, 
namely rodents, pigs, horses, humans. Closely related species Toxocara canis and Toxocara 
cati are known parasites of dogs and cats, respectively. Other species such as Haemonchus 
contortus and Dictyocaulus viviparus infect small ruminants and cattle and these two 
parasites are the nematodes of my research interest. 
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Figure 1 The phylogenetic tree of Nematode species.                                                            
The figure has been taken from (Liu et al., 2013) and modified. The nematode species 
mentioned later in the thesis are circled in black. The close relationship of Dictyocaulus 
viviparus parasite to Trichostrongloidea, Strongyloidea and Ancylostomatoidea families is 
based on (Gasser et al., 2012). Another parasite not shown but mentioned in my thesis, 
Ostertagia ostertagi is close to Ancylostoma and Necator species as based on (Abubucker et 
al., 2009). 
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1.1.2 Introduction to Haemonchus contortus and its life cycle 
Haemonchus contortus is an economically important gastrointestinal parasite infecting small 
ruminants such as goats and sheep. By residing inside the animal and feeding on its blood, the 
parasite causes anaemia, weight loss, reduction of milk production and occasional death of 
the host thus causing huge economic losses worldwide. H. contortus is usually found in 
warmer countries such as Australia, New Zealand, South Africa and Southern U.S.A, 
however likely due to global climate change the incidence of haemonchosis in the UK is 
becoming more common. A study conducted in 2012 (Burgess et al., 2012) found H. 
contortus on about fifty percent of farms across the UK confirming its widespread presence 
in this country.  
As originally described in 1915 by Dr Frank Veglia (Veglia, 1916), during its three week life 
cycle H. contortus undergoes different morphological stages (see Figure 2) and recent 
genomic and transcriptomic analyses provided additional molecular details of the changes 
happening at each developmental stage (Laing et al., 2013; Schwarz et al., 2013) (see Figure 
2). When eggs within the faeces are excreted from the animal, the eggs are exposed to the 
harsh environment outside the animal. This is consistent with big changes of the 
transcriptome of H. contortus during egg to L1 stage transition (Laing et al., 2013; Schwarz 
et al., 2013). A total of 1621 genes are up-regulated in the L1 stage. Of those 641 code for 
various channels such as ligand-gated channels and G-protein-coupled receptors, 43 code for 
transcription factors, 100 code for kinases and 35 for phosphatases most likely reflecting the 
adaptation to changes in chemo-sensation, mechano-sensation, osmo-sensation and 
proprioception (Laing et al., 2013; Schwarz et al., 2013). 
Upon larval transition from L1 to L2 and consequently to the L3 developmental stage, the 
down-regulation of earlier up-regulated genes is observed (Laing et al., 2013; Schwarz et al., 
2013). 50 and 85 percent down-regulations of gene expression are observed upon L1 to L2 
and L2 to L3 stages respectively (Schwarz et al., 2013) with many down- regulated genes 
related to motor activity and metabolic processes (Laing et al., 2013; Schwarz et al., 2013). 
These observations are consistent with ensheathment of L3 stage larva which are no longer 
able to feed and survive on accumulated resources at lower metabolic rates (Veglia, 1916). 
On the other hand genes involved in oxygen transport and haem binding as well as various 
oxidoreductases are up-regulated (Laing et al., 2013). The latter results are consistent with 
earlier findings of up-regulated levels of cytochrome P450 activity in larval, but not adult, 
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stages of H. contortus (Kotze, 1997). The increased activity of cytochrome P450 is most 
likely related to degradation of endogenous waste accumulated during morphological changes 
in the oxygen-rich environment.  
Upon animal grazing on the grass, the infective stage L3 organism gets inside the animal and 
undergoes a new boost of gene up-regulation upon transition to the L4 stage (Laing et al., 
2013; Schwarz et al., 2013). Many of the up-regulated genes are related to motor activity and 
structural changes such as collagen- containing cuticle development (Laing et al., 2013; 
Schwarz et al., 2013). In addition more than 120 peptidases such as metalloproteases, aspartic 
and cysteine proteases are up-regulated in the L4 stage as well as the adult stage (Schwarz et 
al., 2013) which can be explained by the need to digest proteins for the blood-feeding L4 and 
adult stage parasites. Other transcriptional changes upon L4 stage larva transition to the adult 
parasite include a set of gender-specific genes resulting in male and female parasites (Laing 
et al., 2013; Schwarz et al., 2013). Transcriptional changes to deal with reactive oxygen 
species upon L4 to adult transition are observed such as up-regulation of glutathione-S-
transferase, Cu/Zn superoxide dismutase and catalase (Schwarz et al., 2013). However L4 to 
adult transition undergoes less transcriptional changes overall when compared to egg-L1 or 
L3-L4 transitions (Laing et al., 2013; Schwarz et al., 2013). 
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Figure 2 The lifecycle of Haemonchus contortus parasite                                                       
The key features of transcriptome changes upon transformation between different 
developmental stages have been shown as based on (Laing et al., 2013; Schwarz et al., 2013). 
LGC-ligand gated channel, GPCR-G-protein coupled receptor, TF-transcription factors. The 
original diagram was kindly provided by Dr Simon North and modified.  
 
1.1.3 Introduction to Dictyocaulus viviparus and its life cycle 
Dictyocaulus viviparus, commonly known as bovine lungworm, is an economically important 
parasitic nematode which infects cattle in temperate regions across the world. By infecting 
the lungs of the cattle D. viviparus causes parasitic bronchitis commonly known as ‘husk’ 
resulting in weight loss of the animal and occasional death thus bringing huge economic 
losses to the farming industry. It has a complex life cycle (see Figure 3) and analyses of the 
transcriptomes for some of the parasitic stages provided more insights into the molecular 
changes occurring throughout the life cycle (Cantacessi et al., 2011; Ranganathan et al., 
2007; Strube et al., 2012). 
The life cycle of D. viviparus begins when worms residing in the cattle lungs lay eggs into 
the bronchi. Eggs are coughed up by the animal and then swallowed into the gastrointestinal 
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tract where they develop into the L1 larval stage. The L1 stage together with faeces is 
excreted and undergoes transition into L2 and L3 stage larvae. The faeces where L1, L2 and 
L3 stage larvae reside support the growth of Pilobolus fungi. The L3 stage larvae infect these 
fungi and reside in the sporangium awaiting the maturation of spores. When fungal spores get 
dispersed the infective L3 larvae spread around. Cattle graze the grass and get infected with 
L3 stage larvae. Although no genomics/transcriptomics analyses are available for eggs, L1 
and L2 stages, transcriptomic analyses of the infective L3 stage, when compared to adults, 
revealed up-regulation of astacin metalloproteases (Cantacessi et al., 2011) which are 
possibly involved in the exsheathment and free-living to parasitic stage transition of this 
nematode (Cantacessi et al., 2011). Compared to the later L5 stage, up-regulation of the 
cleavage stimulating factor, cstf-64 was reported in the L3 stage (Strube et al., 2012). The 
cstf-64 protein forms part of the Poly-(A+) machinery needed for poly-adenylation and 3-end 
cleavage of mammalian pre-mRNA (Takagaki et al., 1990) and was also shown to be 
involved in C. elegans gene silencing (Kim et al., 2005). Other genes such as those coding for 
collagen and serine-threonine kinases were expressed in both L3 and adult stage parasites 
(Cantacessi et al., 2011). 
The ingested D. viviparus L3 stage penetrates the intestinal wall, reaches the lymph nodes 
and there matures into the L4 stage larvae. The L4 stage larvae use the bovine blood 
circulation system to reach the lungs where they mature into pre-adult L5 and eventually 
adult stage parasites. Unfortunately no genomics/transcriptomics data is available yet for L4 
stage parasite. Pre-adult L5 stage transcriptomic analysis, compared to L3 transcriptomics, 
revealed up-regulation of genes belonging to SCP/TAPS family (Strube et al., 2012) which 
have been suggested to play a role in host-pathogen interactions and defence mechanisms 
(Cantacessi and Gasser, 2012). In addition, compared to L3 larvae, cysteine proteases and H-
Gal-GP orthologs are also up-regulated in the L5 stage and their possible roles in nutrition, 
digestion, host-pathogen interactions have been proposed (Strube et al., 2012). The adult 
stage parasite transcriptome revealed the expression of common house-keeping genes such as 
ribosomal proteins, aldolases and kinases (Ranganathan et al., 2007). In addition the 
transcription of serine-, cysteine- and metallo-proteases has been demonstrated and their 
potential role in tissue migration and feeding has been proposed (Ranganathan et al., 2007). 
The expression of genes coding for protease inhibitors have been shown (Ranganathan et al., 
2007), which may protect the parasite from host proteases thus helping to establish infection 
in the lungs (Knox, 2007). 
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Figure 3 The life cycle of Dictyocaulus viviparus 
 
1.1.4 Anthelmintics as a major control of nematode infection  
Anthelmintics are small molecule-based chemicals which are the major choice in controlling 
nematode infections. Anthelmintics have a broad range of activity mechanisms and can be 
divided into the three major classes, namely benzimidazoles, imidothiazolates-
tetrahydropyrimidines and macrocyclic lactones. Benzimidazoles bind to the microtubule -
forming protein tubulin, and block the polymerization of one end of the microtubule whereas 
the other end of the microtubule gets depolymerized thus disrupting the cytoskeleton of 
nematode cells (Lacey, 1990). Imidothiazolates-tetrahydropyrimidines such as levamisole 
and pyrantel act as nicotinic acetylcholine receptor agonists and by stimulating these 
receptors they cause calcium ion influx inside muscle cells and resultant muscle spasms 
(Williamson et al., 2009). In addition levamisole has been shown to exert an 
immunomodulatory effect on the host immune system thus having an additional role as an 
adjuvant (Renoux, 1980). Macrocyclic lactones such as ivermectin disrupt the 
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neurotransmission of the parasite by acting on glutamate-gated chloride channels which are 
found only in invertebrate organisms (Cully et al., 1994). 
Although widely available and applicable to a wide range of parasitic nematodes and other 
species, the major concern with anthelmintics is the worldwide increase of parasite resistance 
to them (Kaplan, 2004; Taman and Azab, 2014), see Table 1. The benzimidazole drug 
thiabendazole was introduced into the market around 1961 (Kaplan, 2004). However a few 
years later the resistance of H. contortus was reported (Conway, 1964). The imidothiazolate-
tetrahydropyrimidines drug levamisole was introduced into the market around 1970 (Kaplan, 
2004) and in 1979 resistance to this and other classes of anthelminitcs was reported in the 
nematodes Trichostrongylus colubriformis and Ostertagia circumcincta (Sangster et al., 
1979). The avermectin-milbemycin drug ivermectin was introduced around 1981 and in 1988 
H. contortus strains were reported with multi-drug resistance against ivermectin, closantel, 
rafoxanide and benzimidazole anthelmintics (van Wyk and Malan, 1988). Recently new class 
of anthelmintics against sheep and cattle parasites, the aminoacetonitrile derivatives (AAD), 
has been introduced (Scott et al., 2013). By acting on nematode-specific acetylcholine 
receptor subunits, AADs showed the ability to affect parasitic nematodes displaying multi-
drug resistance (Kaminsky et al., 2008). However in 2013 resistance to this drug was also 
reported (Scott et al., 2013). 
 
Drug (class) Year introduced Year resistance reported 
Thiabendazole (Benzimidazole) 1961 (Kaplan, 2004)  1964 (Conway, 1964)  
Levamisole (Imidothiazolate-
tetrahydropyrimidine) 
1970 (Kaplan, 2004)  1979(Sangster et al., 1979)  
Ivermectin (macrocyclic lactone) 1981 (Kaplan, 2004)  1988 (van Wyk and Malan, 
1988)  
Monepantel (aminoacetonitrile 
derivatives) 
2009 (Kaminsky et al., 
2008)  
2013 (Scott et al., 2013)  
Table 1 Summary of anthelmintics                                                                                       
Table shows representatives from each class of anthelmintics, year the drug has been 
introduced and year the resistance against the drug has been reported for the first time. The 
introduction of the drug may vary slightly for different countries. 
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1.1.5 Currently available nematode vaccines 
In 1959 the vaccine against D. viviparus called Huskvac’ or ‘Dictol’ has been developed 
(Jarrett et al., 1959; Jarrett et al., 1960a, b) and for a very long time it was the only nematode 
vaccine commercially available. ‘Huskvac’ is based on attenuated D. viviparus larvae and is 
effective in reducing the parasite burden. However as most attenuated vaccines it has a range 
of drawbacks such as the need for the parasite donor, short shelf-life and batch-to-batch 
variations (Bain, 1999).  
In October 2014 the second nematode vaccine called ‘Barbervax’ was commercially 
launched against H.contortus parasite. The vaccine is based on ‘hidden’ native antigens 
purified from infected sheep. Similarly to attenuated larva-based vaccines although effective 
it has number of drawbacks such as the need for animal donors and potential batch-to-batch 
variations. In addition there is no boosted response after challenge infection and hence the 
need for repeated vaccinations. For these reasons cheap, effective and well-defined synthetic 
molecular based vaccines for H.contortus and D. viviparus would be preferable. 
 
1.1.6 Unsuccessful attempts to create recombinant vaccines against 
nematode infections  
Vaccination trials against H. contortus identified a range of parasite proteases as major 
vaccine targets (Bethony et al., 2006). One such candidate, H11 is a membrane-associated 
glycoprotein from adult stage intestinal microvilli (Munn et al., 1993) having microsomal 
aminopeptidase characteristics (Smith et al., 1997). Vaccination of lambs with H11 resulted 
in a substantial decrease of parasite load (Munn et al., 1993). Another major vaccine 
candidate, H-gal-HP is a multi-protein complex of at least 12 proteins, mainly proteases 
found in the microvillar membrane of the parasite intestine (Smith et al., 1999). Vaccination 
of lambs using different components of H-gal-HP multi-protein complex showed up to 72% 
and up to 93% reduction of worm and egg burdens, respectively, in sheep (Smith et al., 
2003). Recombinant Hc15/24 (Vervelde et al., 2002) and HCp26/23 proteins (Garcia-
Coiradas et al., 2010), cysteine proteases (Redmond and Knox, 2006) and galectins (Yanming 
et al., 2007) have been expressed in E. coli. However no successful immunization has been 
demonstrated. Alternative expression systems capable of protein glycosylation have been 
attempted with proteases from the G-Gal-GP complex being expressed in an insect cell line 
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(Cachat et al., 2010) and H11 protein being expressed both in insect cell line (Reszka et al., 
2007) and C. elegans expression systems (Roberts et al., 2013; Zhou et al., 2014). However, 
no significantprotection levels have been achieved.. Excretory-secretory (ES) proteins from 
D. viviparus showed promising results in inducing significant levels of protection in a guinea 
pig model (McKeand et al., 1994a, b). However vaccination of calves with native ES 
products and a single recombinant component, acetylcholinesterase showed no significant 
protection against parasites in vaccinated animals (Matthews et al., 2001). 
Amongst the potential reasons for the lack of success of recombinant protein-based vaccines 
is the requirement for minor unidentified components in native extracts as well as potential 
incorrect protein folding and post-translational modifications in recombinant material. The 
choice of adjuvant can also have a significant impact on the final worm burden reduction. 
Using the L3 stage-purified HcsL3 antigen together with pertussis (Jacobs et al., 1999) or 
Freund’s adjuvants (Turnbull et al., 1992) vaccination of sheep resulted in significant boost 
of antibody responses without significant protection. On the other hand, aluminium and 
DEAE-dextran adjuvants for the same HcsL3 antigen resulted in reduced cumulative faecal 
egg count and worm burden with the latter adjuvant being almost twice as effective as 
aluminium (Piedrafita et al., 2013). Interestingly the addition of Quil A adjuvant resulted in 
abrogation of protection in lambs (Piedrafita et al., 2013). Different outcomes of vaccination 
using the same antigen but different adjuvant could be partially explained by the fact that the 
QuilA adjuvant is known to promote a Th1 immune response (Sun et al., 2009). On the other 
hand, aluminium adjuvants are known to bias immune responses towards the Th2 response 
(Marrack et al., 2009) with eosinophil recruitment, which may be beneficial in clearing 
helminth infections (Meeusen and Balic, 2000). Interestingly the use of DEAE-dextran 
adjuvant also showed up regulation of IgE antibodies and eosinophils in vaccinated lambs 
suggesting a Th2-type immune response (Piedrafita et al., 2013). 
 
1.1.7 The development of carbohydrate-based vaccines 
Considering the unsuccessful attempts to create recombinant vaccines against nematode 
parasites discussed in section 1.1.6, new approaches are urgently needed and carbohydrate-
based vaccines can be considered as an alternative to create a well-defined molecular 
approach-based vaccine (Astronomo and Burton, 2010). Carbohydrate-based human vaccines 
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have already been successfully utilized for several years. Currently there are licensed 
carbohydrate-based vaccines against Haemophilus influebza (type b), Neisseria meningitides 
serotypes A, C, W135, Y, Salmonella typhi, Staphylococcuss aureus and Streptococcus 
pneumonia bacteria (Huang and Wu, 2010). However, bacteria tend to be easier to culture 
resulting in easier access of potential antigens, whereas parasites such as H. contortus and D. 
viviparus are not readily available as they require host donors to produce them. Therefore 
together with advancements in carbohydrate synthesis methodologies it is more attractive to 
generate synthetic carbohydrate-based vaccines (Astronomo and Burton, 2010). 
Although an attractive target for vaccine development, carbohydrate molecules are usually 
considered as poor immunogens as they activate B-cells and trigger antibody production, but 
in most cases they are not presented on MHC II complex and according to previously held 
beliefs do not interact with T-cell receptors (TCR) on CD 4+ T-helper cells (Mond et al., 
1995a; Mond et al., 1995b). The resultant T-cell-independent response is known to be strong 
but short-lived without immunological memory and without antibody class-switching mainly 
consisting of IgM antibodies (Mond et al., 1995a; Mond et al., 1995b). For these reasons for 
most carbohydrates to elicit the long-lived immunogenic responses, their conjugation to an 
immunogenic protein is required, ensuring the generation of immunological memory. Carrier 
proteins which are known to be highly immunogenic such as diphtheria toxin CRM197, 
keyhole limpet haemocyanin (KLH), tetanus toxoid (TT) and bovine serum albumin (BSA) 
have been used (Astronomo and Burton, 2010) (Nyame et al., 2004). The choice of linker 
molecule must be considered as it needs to provide appropriate chemistry to link the 
carbohydrate and protein, as well as being flexible and not triggering strong immune 
responses in the vaccine recipient. A schematic diagram of the synthetic glycoconjugate 
vaccine candidate against trematode Schistosoma mansoni developed by Cummings and 
colleagues (Nyame et al., 2004) is shown in Figure 4. In this case the modified asparagine-
linked N-glycan with two GalNAcβ1-4GlcNAc (LDN) antennae (see section 1.2.1) has been 
reacted with 2-iminothiolane (Traut’s reagent) and subsequently with maleimide-activated 
carrier protein BSA (Nyame et al., 2004). 
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Figure 4 The Shistosome mansoni glycoconjugate vaccine candidate construct                             
The construct has been reported by (Nyame et al., 2004). For monosaccharide structures see 
section 1.2.1. 
 
Recently the cellular and molecular mechanisms of how glycoconjugate carbohydrate 
vaccines trigger the immune response have been revealed as shown in the Figure 5 (Avci et 
al., 2011). The glycoconjugate vaccines have been shown to be depolymerized in the antigen-
presenting cell (APC) endosome (Avci et al., 2011). Superoxide and hydroxyl, but not 
hydroperoxide radicals have been demonstrated to be responsible for the carbohydrate 
portion degradation (Avci et al., 2011). Then in contrast to previous belief, Kasper and co-
workers demonstrated that the carbohydrate portion of the glycoconjugate vaccine attached to 
the peptide can be presented onto the MHC II complex. They proposed that the peptide 
portion interacts with the MHC II molecule and the carbohydrate part interacts with the T-cell 
receptor (TCR) of CD 4+ T-helper cells resulting in IL-2 and IL-4 secretion and activation of 
antibody-producing B-cells with subsequent isotype switching and immunological memory 
(Avci et al., 2011). Furthermore, to support the carbohydrate-TCR interactions, they isolated 
T-helper cells which recognized carbohydrates only and termed them Tcarbs cells (Avci et al., 
2012). In addition bacterial zwitterionic capsular polysaccharides carrying alternating 
positive and negative charges (Cobb et al., 2004), CD1d molecule-bound glycolipids (Brigl 
and Brenner, 2004) and glycopeptides (Dzhambazov et al., 2005; Gad et al., 2002) have all 
been demonstrated to be able to be recognized by T-cells. These observations indicate that it 
is not the recognition of carbohydrates by T-cells, but their presentation onto MHC-like 
molecules, that could be a limiting factor in causing long-lived immunogenic responses. 
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Figure 5 The processing of glycoconjugate vaccine by B-cell and its presentation to T-carb 
cells 
 
Since carbohydrate synthesis in organisms is not template driven it is therefore technically 
challenging to produce large quantities of specific carbohydrates. This contrasts to the 
situation with DNA and proteins where amplification technologies such as PCR and cloning 
and expression systems can be utilized. Bearing in mind the complexity of carbohydrate 
chemistry, due to the very similar properties of different hydroxyl groups present in 
monosaccharides and the importance of linkage position between them, carbohydrate 
synthesis is still not an easy task. Various chemo- and/or enzymatic strategies have been 
employed together with genetically modified expression systems to produce desired glycans 
or glycoproteins for various applications (Mrazek et al., 2013). However, in vaccine 
development chemical synthesis still remains the method of choice. 
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The first fully synthetic carbohydrate-based vaccine was developed in 1988 in Cuba against 
Haemophilus influenza type b pathogen, widely known as Hib vaccine it was involved in a 
national vaccination programme in that country. This vaccine is based on ribosylribitol 
oligomers attached to thiolated TT protein (Verez-Bencomo et al., 2004). Other examples of 
fully synthetic carbohydrate-based vaccines are against Streptococcus pneumonia and 
Neisseria meningitides bacteria (Astronomo and Burton, 2010). Although there are no 
vaccines against human parasitic infections and only a few vaccines are commercially 
available to tackle life stock parasites (Knox and Redmond, 2006) there is a range of attempts 
going on in this field and quite a few of them exploit carbohydrate epitopes.  
Seeberger and colleagues used an automated solid-phase synthesis to create a Man4-
glycosylphospatidylinossitol (GPI)core structure found in the malaria parasite Plasmodium 
falciparum and conjugated it to ovalbumin (OVA) and KLH proteins (Hewitt et al., 2002; 
Schofield et al., 2002). Although mice immunized with the synthetic vaccine showed reduced 
mortality it did not prevent parasite proliferation. Further development of this anti-malarial 
vaccine is on-going. Another example of a potential future vaccine candidate is the 
synthetically synthesised Manα1-2Manα1-2(Galβ1-4)Man1 tetrasaccharide which caps the 
lipophosphoglycans (LPG) in Leishmania donovani parasites. This synthetic epitope was 
linked to succinimide-activated influenza hemagglutinin (HA) and was loaded into immune-
potentiating reconstituted influenza virosome (IRIV) constructs (Liu et al., 2006) which also 
act as an adjuvant (Gluck, 1992). Immunization studies showed that mice produced glycan 
specific IgG antibodies that recognize Leishmania parasites demonstrating its potential as a 
vaccine candidate against this human and other mammalian parasite (Liu et al., 2006).  
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1.2 Structural and functional Glycomics in nematode species 
1.2.1 Introduction into glycobiology 
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Figure 6 Most common monosacharides found in nematodes. The symbolic nomenclature is 
used in the thesis as outlined by the Consortium for Functional Glycomics Nomenclature 
Committee (May 2004) (Varki et al., 2009). Full documentation available from: 
http://glycomics.scripps.edu/CFGnomenclature.pdf. 
 
Carbohydrates are the most abundant class of biomolecules on Earth and for a long time have 
been mainly considered as energy and structural molecules. In the last few decades this 
perception has changed with the advent of the glycobiology field which studies the structure 
and function of sugars in cells and organisms. The research has shown that this class of 
molecules is extremely important not only providing structural support for cells but also 
maintaining the integral three-dimensional shape of proteins (Wormald and Dwek, 1999), 
performing protein folding quality control, intracellular trafficking (Aebi et al., 2010) and 
also mediating cell-cell communication in multicellular organisms (Cummings and Pierce, 
2014).  
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Glycans are sugar molecules made of one or more monosaccharides (see Figure 6) which are 
attached to proteins or lipids forming glycoconjugates. In contrast to RNA transcription or 
protein translation the synthesis of glycans is not a template driven process and requires a 
range of enzymes called glycosyltransferases and glycosidases to add or remove 
monosaccharides from the growing oligosaccharide chain. Different glycosyltransferases or 
glycosidases are usually required to add or remove different monosaccharides in a linkage 
specific manner. Each monosaccharide can be added to different hydroxyl groups of the 
acceptor mono/oligosaccharide resulting in different glycans with different properties thus 
tremendously increasing the biodiversity of glycans and the range of functions they can 
perform.  
There are two types of glycoconjugates in the cell. Glycoproteins can be N-glycosylated 
meaning the sugar portion is attached to the protein via a nitrogen atom or O- glycosylated 
meaning glycans are attached via an oxygen atom to the protein and glycolipids. Usually 
glycoproteins and glycolipids are found on the surface of the cell and form a dense layer 
called the glycocalyx. Glycoconjugates are also found in the extracellular matrix (ECM) and 
body fluids. In addition a specific form of protein glycosylation called O-GlcNAc-ylation is 
found in the cytoplasm and nucleus of cells (Hardiville and Hart, 2014). 
 
1.2.2 N-glycan biosynthesis in nematodes 
1.2.2.1 Overview of N-linked glycosylation in nematodes  
N-linked glycosylation is a post-translational protein modification present in all eukaryotes. 
The early stages of this process include the synthesis of a lipid-linked oligosaccharide 
precursor which is subsequently transferred to a protein. These stages are conserved amongst 
eukaryotic organisms with the majority of the experimental elucidation coming from yeast 
studies. Later stages of N-glycan biosynthesis, which involve both hydrolysis and addition of 
new monosachharides, can be substantially different amongst species resulting in different 
glycan structures. The novel features of nematode N-linked glycosylation include N-glycans 
with unusual chitobiose cores and non-reducing antennae modifications often not seen in 
other organisms. In this chapter I will describe in detail N-glycan biosynthesis in the non- 
parasitic Caenorhabditis elegans nematode as this model organism is the most heavily 
researched and therefore best characterised nematode.  
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1.2.2.2 The biosynthesis of the lipid-linked Glc3Man9GlcNAc2 N-glycan precursor and 
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Figure 7 The biosynthesis of lipid-linked GlcNAc2Man9Glc3 N-glycan precursor and its 
transfer to the protein in the ER. The C.elegans transcripts corresponding to eukaryotic genes 
used in this diagram can be found in the Table 2. 
 
The biosynthesis of the lipid-linked Glc3Man9GlcNAc2 N-glycan precursor with the 
subsequent transfer of the N-glycan onto the protein (see Figure 7) is a conserved process 
amongst eukaryotes. Understanding of it came mainly from studies on yeast protein 
glycosylation (Aebi, 2013), however corresponding genes have been found in the nematode 
model organism C. elegans (Akiyoshi et al., 2015; Schachter, 2004).  
The biosynthesis of N-glycans starts on the cytoplasmic side of the Endoplasmic Reticulum 
(ER) membrane. The Man5GlcNAc2 precursor is assembled on the lipid dolichol made of 
condensed five-carbon isoprene units. The monosaccharide donors are UDP-GlcNAc and 
GDP-Man. Subsequently the Man5GlcNAc2-dolichol precursor is translocated across the ER 
membrane. Although the identity of the flippase protein remains unknown, in 2008 Sanyal 
and collegues provided the biochemical basis for Man5GlcNAc2-dolichol  flippase. They 
suggested it sediments at 4S, is trypsin-sensitive and operates in an ATP-independent manner 
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by facilitated diffusion (Sanyal et al., 2008). Later they showed that this protein candidate is 
very specific for the lipid-linked Man5GlcNAc2 oligosachcaride. It requires dolichol made of 
α-saturated isoprene (Sanyal and Menon, 2010), an exact number of mannoses present in a 
specific configuration (Sanyal and Menon, 2009, 2010) and specific oligosaccharide 
molecule enantiomer (Sanyal and Menon, 2010). After the Man5GlcNAc2-dolichol precursor 
has been flipped across the ER membrane, addition of sugar residues continues inside the ER 
with the oligosaccharide chain becoming Glc3Man9GlcNAc2 Interestingly the RNAi silencing 
of most genes responsible for lipid-linked oligosaccharide synthesis in the cytoplasmic, but 
not luminal side of the ER such as human alg7, alg13, alg14, alg2 and alg11 orthologs in C. 
elegans (see Figure 7) cause severe phenotype changes (Akiyoshi et al., 2015) confirming 
the importance of these genes in worm development. 
Table 2 The C. elegans genes corresponding to eukaryotic analogues shown in the Figure 7 
Eukaryotic gene C.elegans transcript Reference 
alg7 T08D2.2, Y60A3A.14 (Schachter2004), (RNAi) 
alg13 R10D12.12 (RNAi) 
alg14 M02B7.4 (RNAi) 
alg1 T26A5.4 (Schachter2004), (RNAi) 
alg2 T23F2.1, F09E5.2 (Schachter2004), (RNAi) 
alg11 B0361.8 (RNAi) 
alg3 K09E4.2 (Schachter2004), (RNAi) 
alg9 C14A4.3 (Schachter2004),(RNAi) 
alg12 ZC513.5 (RNAi) 
alg6 C08B11.8 (Schachter2004), (RNAi) 
alg8 C08H9.3 (Schachter2004), (RNAi) 
alg10 T24D1.4 (Schachter2004), (RNAi) 
OST subunits-coding genes  T22D1.4, M01A10.3, 
ZK686.3, T09A5.11, 
F57B10.10, T12A2.2,  
(Schachter2004), (RNAi) 
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The synthesised dolichol-linked Glc3Man9GlcNAc2 oligosaccharide is then transferred onto 
the protein in the lumen of the ER by the enzyme oligosaccharyltransferase (OST) (Knauer 
and Lehle, 1999). For the oligosaccharide chain to be added onto the protein it needs to meet 
specific requirements. Firstly the N-glycan is added onto asparagine residues in the protein 
sequence Asn-X-Ser or Asn-X-Thr where X can be any amino acid except proline. There are 
rare cases when the protein is glycosylated at Asn-X-Cys sequence (Chi et al., 2010). It is 
important to note that not all Asn-X-Ser or Asn-X-Thr sequences get glycosylated. In terms 
of protein 3D shape the N-glycans are usually found on the surface of the protein making 
good energetic rational for relatively hydrophilic protein modification and not to be in the 
hydrophobic interior of the protein. Finally, as the addition of the N-glycan chain occurs in 
the lumen of the ER it ensures that only the extracellular portions of plasma membrane 
proteins and secretory proteins acquire N-glycan modifications. The RNAi silencing of gene 
orthologs coding for OST in C. elegans resulted in a germline phenotype and small body size 
of worms (Akiyoshi et al., 2015) indicating the importance of this protein in organism 
development.  
 
1.2.2.3 The conversion of Glc3Man9GlcNAc2 N-glycan into truncated Man2GlcNAc3 
structure based on model nematode C. elegans studies  
Once the Glc3Man9GlcNAc2 oligosaccharide is transferred to the protein the trimming of the 
hexoses begins in the ER and Golgi apparatus. Initially C. elegans α1-2 ER glucosidase I 
MOGS-1 trims the terminal glucose and subsequently C. elegans α1-3 ER glucosidase II 
AAGR-3 removes the other two glucoses. The functions of MOGS-1 and AAGR-3 enzymes 
are proposed based on sequence homology and have not been cloned and characterized 
(Schachter, 2004). 
In 2012 α-mannosidases homologous to the yeast S. cerevisiae class I mannosidases were 
discovered in C. elegans which act on a Man9GlcNAc2 N-glycan, namely MANS-1, MANS-
2, MANS-3 and MANS-4(Wilson, 2012). ER-resident MANS-3 and MANS-4 from C. 
elegans α-mannosidases remove one α-mannose from the ‘middlemost’ branch of the 
Man9GlcNAc2 N-glycan (Wilson, 2012). Golgi-resident C. elegans MANS-1 and MANS-2 
enzymes efficiently remove up to 3 α-mannose residues, two from the ‘lower’ α1-3 branch 
and one from the ‘upper’ branch (Wilson, 2012). Together these four enzymes result in the 
conversion of N-linked Man9GlcNAc2 glycan to the Man5GlcNAc2 structure. 
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The next step in C. elegans N-glycan biosynthesis is the addition of GlcNAc to the ‘lower’ 
α1-3 branch of the Man5GlcNAc2
 substrate by the Golgi-resident Gly-13 gene-coded GlcNAc 
transferase which is a mammalian GlcNAcT I homologue (Chen et al., 2003). There are two 
other enzymes coded by gly-12 and gly-14 genes which are able to carry out the same 
reaction in C. elegans. However, only gly-13 gene knockout worms are arrested in L1 
developmental stage making GLY-13 the major ‘lower’ α1-3 branch GlcNAc transferase in 
these nematodes (Chen et al., 2003). 
After addition of GlcNAc to the ‘lower’ α1-3 branch of the Man5GlcNAc2 N-glycan, the 
Golgi resident C. elegans mannosidase II coded by aman-2 gene removes both terminal α1-3 
and α1-6 mannoses (Paschinger et al., 2006). Subsequently the putative C. elegans α-
mannosidase (which to date has not been characterized) removes the α1-6 mannose resulting 
in a Man2GlcNAc3 structure which can undergo other structural modifications as described 
further. All these N-glycan modifications from Glc3Man9GlcNAc2 to truncated Man2GlcNAc3 
N-linked glycan structure described in this section are depicted in Figure 8. 
 
Golgi lumen
MOGS-1 AAGR-3
MANSI-1/
MANS-2
MANSI-3/
MANS-4
putative
-mannosidaseα
AMAN-2 GLY-1  3
Key: proteinGlcNAc, Glu, Man,
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Cytoplasm
Figure 8 The biosynthesis of truncated Man2GlcNAc from Glc3Man9GlcNAc2 N-glycan in 
the ER and Golgi compartments. Those C. elegans proteins which have been cloned and 
characterized are put into circles.  
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1.2.2.4 Chitobiose core modifications of Man2GlcNAc3 N-linked glycan in C. elegans 
model nematode  
 Figure 9 The chitobiose core modification pathways in C. elegans.                                      
The addition of α1-2 galactose to the distal GlcNAc-linked fucose by putative α1-2 
galactosyltransferase is not shown. The figure is based on (Yan et al., 2013) 
 
The Chitobiose core of C. elegans N-linked glycans can be modified with up to three fucoses 
attached to the 3-positions of proximal and distal GlcNAc and the 6-position of proximal 
GlcNAc. Three different fucosyltransferases are responsible for these modifications. The 
fucoses in turn can be capped with galactoses (Hanneman et al., 2006; Titz et al., 2009; Yan 
et al., 2012). The biosynthetic machinery for these modifications in C. elegans has been 
partially elucidated (see Figure 9). 
The first fucosyltransferase characterized in 2004 by I.B.H. Wilson and colleagues was FUT-
1 which adds fucose to the 3-position of the proximal GlcNAc (Titz et al., 2009). The action 
of the enzyme was inhibited by the presence of non-reducing end terminal GlcNAc (Titz et 
al., 2009) which was later re-confirmed by the same group in 2013 (Yan et al., 2013). N-
linked glycans carrying the 6-linked fucose on the proximal GlcNAc without non-reducing 
terminal GlcNAc can also act as substrates for the FUT-1 enzyme (Yan et al., 2013). The 
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authors also proposed that FUT-1 enzyme should work on N-glycans bearing the 3-linked 
fucose on the distal GlcNAc although it has not been proven directly (Yan et al., 2013). 
Another C. elegans FUT-8 fucosyltransferase transfers fucose to the 6-position of the 
proximal GlcNAc (Paschinger et al., 2005). In contrast to FUT-1 enzyme it requires the non-
reducing terminal GlcNAc to be present in order for the proximal GlcNAc 6-position 
fucosylation to occur, hence its requirement for the prior action of GlcNAc transferase I 
carried out mainly by the GLY 13 enzyme in C. elegans as mentioned earlier (Chen et al., 
2003). In addition FUT-8 enzymatic action is inhibited by the presence of α1-3 fucose on 
either the proximal or distal GlcNAc (Paschinger et al., 2005; Yan et al., 2013). 
The last of the three C. elegans chitobiose core fucosyltransferases characterized was the 
FUT-6 enzyme which fucosylates the distal GlcNAc at the 3-position (Yan et al., 2013). In 
terms of its substrate specificity it has been determined that the non-reducing terminal 
GlcNAc can be present or absent for the reaction to occur (Yan et al., 2013). It also acts on 
FUT-8 reaction products carrying fucose 6-linked to the proximal GlcNAc (Yan et al., 2013). 
The authors also predicted the enzyme’s ability to fucosylate FUT-1 reaction products 
carrying α1-3-linked fucose to the proximal GlcNAc although more evidence is needed to 
support this (Yan et al., 2013). Interestingly the FUT-6 enzyme is blocked by the presence of 
α1-6, but not α1-3-linked mannose on the trimannosyl core (Yan et al., 2013), hence its pre-
requisite for the action of the putative α1-6 mannosidase. 
All aforementioned fucoses in C. elegans can be capped with galactose (Hanneman et al., 
2006; Titz et al., 2009; Yan et al., 2012). The galactose capping the fucose 6-linked to the 
proximal GlcNAc has been proven to be β1-4 linked (Hanneman et al., 2006). The GALT-1 
galactosyltransferase carrying out this reaction in C. elegans has been characterized by I.B.H. 
Wilson and colleagues who showed its structural substrate preferences for the non-reducing 
terminal GlcNAc although in vitro the reaction can be carried out but at a slow rate (Titz et 
al., 2009). Later on in 2013 they showed that, similarly to the FUT-8 enzyme, the GALT-1 
enzyme is inhibited by the presence of α1-3 fucose on either proximal or distal GlcNAc 
generated by the FUT-1 and FUT-6 enzymes respectively (Yan et al., 2013). 
The galactose capping the α1-3 fucose linked to the proximal GlcNAc has been proposed to 
be also β1-4 linked based on MSn evidence (Hanneman et al., 2006). In contrast α1-3 fucose 
linked to the distal GlcNAc can be modified by the α1-2 linked galactose (Yan et al., 2012), 
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however the galactosylation machinery carrying out these two reactions has not been 
characterized yet.   
. 
1.2.2.5 Antennae modifications of N-linked glycans in C. elegans model nematode 
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Figure 10 The N-glycan antennae modifications found in C. elegans organisms 
 
Based on the current knowledge of the N-linked glycan biosynthetic pathway there is no 
rigorous evidence suggesting that these organisms can synthesize elongated complex N-
glycans as commonly seen in mammals. The non-reducing end termini of C. elegans N-
linked glycans can be modified with single non-reducing end terminal GlcNAc residues and 
corresponding GlcNAc transferases have been suggested. The mammalian GnT V analogue 
GLY 2 in C. elegans was proposed to add β1-6 linked GlcNAc to the 6-linked mannose of 
the trimannosyl core (Warren et al., 2002). The mammalian GnT II analogue GLY 20 was 
suggested to add β1-2 linked GlcNAc to the same ‘upper’ 6-linked mannose residue (Chen et 
al., 2002). The earlier mentioned C. elegans enzymes GLY -12/13/14  which are analogues to 
mammalian GNT I add β1-2 linked GlcNAc to the ‘lower’ 3-linked trimannosyl core 
mannose with the main enzyme being GLY-13 (Warren et al., 2002) (Chen et al., 2003). 
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The attached non-reducing end GlcNAc residues in C. elegans can be modified further by the 
nematode-specific post-translational modification which involves attachment of a 
phosphorylcholine (PC) group to the GlcNAc residue 6-position (Haslam et al., 2002). The 
biosynthetic details of this reaction are not completely understood however 
phosphatidylcholine as a PC unit donor and fukutin-related family protein as potential PC 
transferase have been suggested (Harnett et al., 2010). 
Another antennae modification present in C. elegans is capping of the trimannosyl core with 
galactose which can be further modified at the 2-position with fucose (Haslam et al., 2002). 
Some evidence also suggests fucose being attached to mannose residues (Altmann et al., 
2001). Interestingly, C. elegans glycome sequencing revealed over 20 putative α1, 2-
fucosyltransferases and one of them has been characterized (Zheng et al., 2002) revealing its 
unique substrate requirements. This C. elegans enzyme named by authors CE2FT-1 (Zheng et 
al., 2002) prefers terminal galactose with the penultimate residue being neither GlcNAc nor 
glucose thus making it a potential α1, 2-fucosyltransferase which modifies the terminal 
galactose in the C. elegans N-glycome. All the possible antennae modifications described for 
C. elegans above are summarized in the Figure 10. 
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1.2.3 N-linked glycosylation in H. contortus parasite 
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Figure 11 The N-glycan core and antennae modifications found in H. contortus organisms. 
High-mannose structures present in many different organisms are not shown. 
 
The most rigorous studies on H. contortus N-glycosylation using mass-spectrometry-based 
techniques were conducted by Haslam and colleagues revealing a high degree of chitobiose 
core fucosylation (Haslam et al., 1996) as seen in the Figure 11. The proximal GlcNAc was 
shown to be able to carry up to two fucoses which are 3- and 6-linked and the distal GlcNAc 
is modified with an, at that time, previously unseen fucosylation at the 3-position (Haslam et 
al., 1996). This was subsequently shown to be stage specific as it is absent in the L3 stage of 
H. contortus (Haslam et al., 1998).The data generated from FAB-MS studies also suggested 
the presence of high mannose structures and complex N-glycans bearing GalNAcβ1-
4GlcNAc (LDN) and GalNAcβ1-4(Fucα1-3)GlcNAc (LDNF) antennae (see Figure 11) 
(Haslam et al., 1996). The presence of the latter structure was also proposed by (Geldhof et 
al., 2005; van Stijn et al., 2010b; Vervelde et al., 2003) based on antibody responses to H. 
contortus infection and Western Blot studies. In addition vaccination studies revealed the 
presence of antibodies against the Galα1-3GalNAc epitope and extracts from adult H. 
contortus were shown to contain a galactosyltransferase that was able to synthesize this 
epitope (van Stijn et al., 2010b). Although the biosynthetic machinery carrying out these N-
glycan modifications remains unknown the recent genome sequencing and generation of the 
extensive transcriptomics datasets for H. contortus (Laing et al., 2013) gives an optimistic 
perspective for cloning and characterizing the glycosyltransferases and glycosidases 
responsible for the glycome of this parasitic nematode. 
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1.2.4 N-linked glycosylation in D. viviparus parasite 
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Figure 12 The N-glycan structures found in D. viviparus parasite                                      
High-mannose structures present in many different organisms are not shown. 
 
The only structural studies on the glycome of D. viviparus were performed by Haslam and 
collegues using FAB-MS instrumentation in 2000 (Haslam et al., 2000). The major N-glycan 
families seen were high mannose structures with general composition Hex5-9HexNAc2, 
truncated cores with and without fucose matching the composition Hex2-4Fuc0-1HexNAc2, 
and complex bi, tri- and tetra-antennary structures with general composition of Hex3-7Fuc0-
5HexNAc3-6. The fragment ion analysis of these structures confirmed the presence of up to 
four Lewisx epitopes on these glycans. The structures are summarised in Figure 12. 
Unfortunately the genome of D. viviparus has not been sequenced yet and no details about 
biosynthetic machinery of glycans are available, although the similarity of parasite N-glycans 
to mammalian structures infers that enzymes homologous to mammalian could operate in this 
nematode.  
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1.2.5 N-linked glycosylation in other nematode species 
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Figure 13 N-glycan core and antennae modifications found in different nematode species. 
Only structures 4, 5 and 6 are typically found in mammals. The structure 4 is usually being 
further decorated with sialic acid.  
 
As mentioned earlier, the main features of nematode N-glycosylation in comparison to 
mammalian are antennae and chitobiose core modifications. In addition to earlier described 
C. elegans and H. contortus organisms the porcine roundworm A. suum was shown to have 3, 
6-difucosylated proximal GlcNAc. Later the presence of Galβ-4Fuc on the 6-position of 
proximal GlcNAc and Galα1-2Fuc on the 3-position of the distal GlcNAc was demonstrated 
in this nematode (Yan et al., 2012). 
The attachment of the phosphorylcholine (PC) moiety to the 6-position of non-reducing end 
GlcNAc in C. elegans has been described earlier (Haslam et al., 2002). This type of post-
translational modification has been also found in the intracellular mammalian skeletal muscle 
parasite T. spiralis (Morelle et al., 2000), the bovine filarial parasite O. gibsoni (Haslam et 
al., 1999), the human filarial worm O. volvulus (Haslam et al., 1999), the porcine roundworm 
A. suum (Poltl et al., 2007) and the rodent filarial nematode A. viteae  (Haslam et al., 1997). 
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Another N-glycan antennae modification not seen in mammals but present in T. spiralis 
parasite is capping of LDNF antennae with the rare dideoxy sugar tyvelose (Reason et al., 
1994). The N-glycans of this nematode contain up to 4 LDNF epitopes and surprisingly 
virtually all of them are capped with this sugar (Reason et al., 1994). Other antennae present 
in nematodes include the Galα1-3Gal sequence in white-tailed deer parasite P. tenuis (Duffy 
et al., 2006) which is also found in its host, and the LacNAc structure in abomasal cattle 
nematode O. ostertagi (Meyvis et al., 2008) and likely in A. vitae (Haslam et al., 1997). The 
latter parasite is also likely to have LDN and LDNF antennae modifications as well, based on 
characteristic FAB-MS fragment ions and GC-MS data (Haslam et al., 1997). In addition 
chito-oligomers made of poly-GlcNAc with a capping HexNAc have been reported in three 
filarial nematodes (Haslam et al., 1999). Finally the most conserved and widespread high-
mannose and pauci-mannose N-glycans are seen amongst a wide range of nematodes H. 
contortus (Haslam et al., 1996), D. viviparus (Haslam et al., 2000), T. spiralis (Morelle et al., 
2000), A. vitae (Haslam et al., 1997). The summary of nematode N-linked glycosylation can 
be seen in the Figure 13. 
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1.2.6 O- glycan biosynthesis in nematodes 
 1.2.6.1 Overview of mucin-type O-linked glycosylation  
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Figure 14 Different O-glycan Core structures found in mammals 
Mucin type O-linked glycosylation is the process of adding glycans to the hydroxyl group of 
Serine and Threonine residues in a protein. In contrast to N-glycosylation, O-glycosylation 
does not involve pre-synthesised and en-block glycan transfer. Instead all monosaccharides 
present in the structures are added one by one to the O-glycan chain. In addition O-glycans 
do not have a consensus sequence within the protein. However, as O-glycosylation is a post-
folding event only Ser and Thr residues on the surface of a protein can be O-glycosylated. 
This makes intrinsically disordered regions such as linkers, coils and turns to be usually 
favoured which is supported by the computational O-glycosylation sites prediction strategies 
(Hansen et al., 1995; Nishikawa et al., 2010). This type of post-translational modification 
happens in the Golgi apparatus and in the same way as N-glycosylation is a non-template 
driven process. Glycosyltransferases add one by one sugar residues to the nascent O-linked 
glycans resulting in at least, in mammals, 8 different potential Core structures (Wopereis et 
al., 2006) as seen in Figure 14 with Core 1 and Core 2 structures being most common. The 
Core structures can in turn be further modified with other residues such as sialic acid residues 
in humans.  
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1.2.6.2 Mucin-type O-linked glycosylation in nematodes 
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 Figure 15 The O-glycans found in nematode parasites  
In contrast to N-glycans and their biosynthetic pathways, O-glycosylation is much less 
characterised in nematodes even in the model organism C. elegans. In 1998 Hagen and 
Nehrke cloned and expressed 11 UDP-N-acetyl-D-galactosamine:Polypeptide-N-
Acetylgalactosaminyltransferases which are homologous to human pp-GalNAc-Ts (EC 
2.4.1.41). This enzyme family initiates the first step in mucin type O-glycan biosynthesis by 
adding α-GalNAc to the protein Ser/Thr hydroxyl group (Hagen and Nehrke, 1998). The core 
1 O-glycan T-synthase, which initiates the formation of Core-1 structures by adding a β-
galactose onto the 3-position of GalNAc, has been cloned and characterized from C. elegans 
(Ju et al., 2006). Interestingly, in contrast to mammalian core 1 O-glycan T-synthase, the C. 
elegans analogue does not require the Cosmc chaperone for correct folding,  although the fact 
that expression of functional enzyme is achieved in insect, not mammalian cell lines, might 
indicate the requirement for some unidentified invertebrate- specific factors (Ju et al., 2006). 
Later another galactosyltransferase generating Core 1 structures in C. elegans was proposed 
(Palaima et al., 2010) based on knock-out studies although the gene has not been cloned and 
characterized. 
62 
 
The amount of characterized enzymes to date potentially involved in mucin-type O-glycan 
biosynthesis in the model nematode C. elegans does not reflect the complexity of O-glycan 
structures in this organism which were most rigorously characterized by Guerardel and 
colleagues employing both MS and NMR strategies (Guerardel et al., 2001). The study 
revealed an abundance of unusual Core 1 structures to which glucose can be attached to the 
6-position of the reducing-end GalNAc (Guerardel et al., 2001). These structures can be 
further modified with glucose residues in various positions together with glucuronic acid 
(Guerardel et al., 2001). To add to this, β-galactose can be 6-linked to the GalNAc residue of 
the Core 1 structure forming the Galβ1-6(Galβ1-3)GalNAc Schisto Core structure. The 
Galβ1-6(Galβ1-3)GalNAc structure has been coined ‘Schisto Core’ by me for the purpose of 
this thesis as it has been previously characterised in the parasitic trematode S. mansoni 
(Huang et al., 2001). Finally one O-glycan in C. elegans has been found linked to the protein 
via a GlcNAc residue (Guerardel et al., 2001). 
The literature information about O-glycosylation in other nematodes is rather scarce. O-
glycans from the dog-infecting nematode T. canis have been rigorously characterized and two 
structures have been proposed (Khoo et al., 1991). Both of them bear the Core-1 structure 
with 2-methyl-α-fucose capping galactose at the 2-position. An additional methyl group at the 
4-position of the Core 1 galactose can be present or absent (Khoo et al., 1991). The closely 
related cat-infecting T. cati nematode was also proposed to have similar O-glycan structures 
with dominant structure being a dimethylated, not monomethylated trisaccharide (Khoo et al., 
1991). Another nematode that has had its O-glycans characterized is the deer parasite P. 
tenuis. MS-structural studies of its O-glycans proposed Core 1 and α1-2 fucosylated Core 1 
structures to be present (Duffy et al., 2006). The O-glycans found in nematodes can be seen 
in the Figure 15. 
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1.2.7 Overview of glycolipids in nematodes 
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Figure 16 The glycosphingolipids reported in various nematodes 
The second major class of glycoconjugates found in cells are glycolipids. These molecules 
contain the glycan portion attached to the lipids embedded in the plasma membrane. Together 
with N- and O-glycans attached to the transmembrane proteins, glycolipids constitute the 
layer of sugars around the cell called the glycocalyx. Glycolipids can be divided into two 
broad classes, glycophospholipids and glycosphingolipids based on the type of lipid the sugar 
portion is attached to. The presence of glycophospholipids together with its biosynthetic 
machinery has been reported in C. elegans where the phosphatidyl glycerol molecule is 
modified with inositol to which the Manα1-2Man α1-6-[PEtN-2]Man α1-4GlcN α1-6- sugar 
moiety is attached forming the so-called GPI anchor for proteins (Murata et al., 2012). 
The second class of glycolipids in nematodes is based on glycosphingolipids in which the 
glycan is attached to a lipid called ceramide made of fatty acids and the long- chain amino 
alcohol sphingosine. All reported nematode glycosphingolipids (see Figure 16) have glucose 
as the first residue which in mammals is added by the action of the Glu transferase CGluT  in 
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the ER lumen  and the structure is extended in the Golgi compartment by the sequential 
action of other glycosyltransferases (Kapitonov and Yu, 1997; Schaeren-Wiemers et al., 
1995; Schulte and Stoffel, 1993). The structures of glycosphingolipids have been reported for 
C. elegans (Gerdt et al., 1997; Griffitts et al., 2005), O. volvulus (Wuhrer et al., 2000), A. 
suum (Friedl et al., 2003; Lochnit et al., 1998; van Riet et al., 2006), A. lumbricoides (van 
Riet et al., 2006) and A. viteae (Houston et al., 2002) nematodes. All of the reported 
nematode glycosphingolipids are based on the Galα1-3GalNAcβ1-4GlcNAcβ1-3Manβ1-
4Glcβ-Cer structure or its precursors. Attachment of a phosphorylcholine (PC) moiety to the 
6-position of the GlcNAc has been observed in all four nematodes with 
phosphorylethanolamine being attached to the same position in A. suum (Lochnit et al., 1998; 
van Riet et al., 2006). A. suum and O. volvulus can also have PC attached to the 6-position of 
the GalNAc residue (Lochnit et al., 1998; Wuhrer et al., 2000). A. lumbricoides 
glycosphingolipids have been shown to have α-galactose modified with β-galactoses at 3- and 
6- positions (van Riet et al., 2006) and the closely related A. suum most likely has the same 
terminal glycosphingolipid modifications which can be further modified with Hex, Fuc and 
HexNAc residues (Friedl et al., 2003). In C. elegans the non-reducing end has been shown to 
be modified with other galactose residues which in turn are modified with fucose and 2-O-
methylated fucose residues (Griffitts et al., 2005). 
 
1.2.8 Functions of parasite glycans in shaping the immunity of the host 
1.2.8.1 Overview on parasite glycan-host immunity relationship 
The hallmark of nematode and general helminth infections is the ability to alternatively 
activate antigen presenting cells (APCs) such as macrophages and dendritic cells (DCs) and 
also to induce Tregs and subsequently shift the immune response towards an anti-inflammatory 
Th2 (T-helper cell 2) type response. In contrast, classical bacterial infection, as an example, 
causes polarization of the immune system towards pro-inflammatory Th1 cell responses. This 
modulation of the immune system by helminths seems to be beneficial for both the parasite 
and the host since the absence of acute pro-inflammatory immune responses results in less 
damage to the host as well as allowing better survival of the parasite. 
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For a long time the exact molecular details of the Th2 immune response polarization by 
helminths were unknown. In 1999 Okano et al. showed that altering glycan structures on 
soluble schistosome egg antigens (SEA) with sodium metaperiodate abolished SEA’s ability 
to cause CD4+ Th2 responses in mice (Okano et al., 1999). Subsequently Tawill et al. showed 
that sodium periodate treatment also abolished the Th2 immune response in both parasitic 
Brugia malayi and non-parasitic C. elegans nematodes (Tawill et al., 2004). In this way two 
independent elegant studies revealed that helminth glycans must play a functional role in 
skewing host immune responses towards anti-inflammatory Th2. However the exact role of 
the glycans in the process was not revealed in these studies. 
Later a substantial body of evidence, mainly through work on the parasitic trematode S. 
manosni suggested critical roles of C-type lectin receptors (CLRs) and Toll-like receptors 
(TLR), collectively known as pattern recognition receptors (PRRs), in binding parasitic 
glycans. This subsequently leads to alternative activation of APCs such as DCs and 
macrophages and causes an anti-inflammatory Th2 immune response (Prasanphanich et al., 
2013; Tundup et al., 2012; van Die and Cummings, 2010). The helminth’s strategy of 
survival by modulating host immune response via glycan-CLRs/TLRs interactions was 
coined ‘glycan gimmickry’ (van Die and Cummings, 2010). 
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1.2.8.2 Helminth glycan-host CLR interactions on dendritic cells 
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Figure 17 Different dendritic cell C-type lectin-pathogen glycan interactions                             
MR-mannose receptor, MGL-macrophage galactose lectin, DC-SIGN- Dendritic cell-specific 
Intercellular adhesion molecule-3-Grabbing Non-integrin. 
 
Dendritic cells are antigen presenting cells (APCs) which link the innate immune response to 
the adaptive and thus orchestrate the latter immune branch in the organism (Steinman, 2012). 
Upon phagocytosis of the pathogen, DCs migrate into lymph nodes where they present 
antigen to naïve T cells thus polarizing their development into specific subsets. Although 
other APCs such as macrophages also instruct T cells in lymph nodes, DCs are considered to 
be the most important in this process since they alone were able to induce Th2 differentiation 
in mice upon S. mansoni infection (MacDonald et al., 2001). 
As well as Toll-like receptors (TLR) involved in pathogen recognition by DCs,previously 
mentioned CLRs ) are also crucial for DC activation and T cell subset expansion (van Die 
and Cummings, 2010). The types of CLRs present on DC s are Dendritic Cell-Specific 
Intercellular adhesion molecule-3-Grabbing Non-integrin (DC-SIGN), macrophage 
galactose-type C-type lectin (MGL) as well as the mannose receptor (MR). All these CLRs 
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have been shown to be able to interact with a wide range of glycan structures. DC-SIGN was 
shown to interact with Lex, Ley, LDNF and high mannose structures (Frison et al., 2003; Guo 
et al., 2004; van Liempt et al., 2006). The MGL receptor recognizes glycans bearing terminal 
α− or β- GalNAc residues such as LDN and the Tn antigen (Suzuki et al., 1996; Tsuiji et al., 
2002; van Vliet et al., 2005). The MR is known to bind various mannose-containing glycans 
(Martinez-Pomares et al., 2001). The summary of lectins found in nematodes and other 
helminths and their suggested glycan binding partners are depicted in Figure 17. 
 
1.2.8.3 Downstream events in dendritic cells upon helminth glycan-host CLR 
interactions  
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Figure 18 Two different signalling cascades happening in dendritic cells upon Lewisx and 
high-mannose N-glycans engaging with the DC-SIGN receptor.  
 
Based on S. mansoni soluble egg antigen (SEA) studies, the glycans that bind to the C-type 
lectins DC-SIGN, MGL and MR are internalized by dendritic cells and targeted to MHC II+ 
lysosomes with subsequent modulation of immune response towards Th2 type thus 
confirming the endocytotic nature of these C-type lectins (van Liempt et al., 2007). 
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The signalling cascades inside DC upon CLR activation have not been clearly defined, 
however emerging data points to the complexity of events happening inside the cell. For 
example, Gringhuis and colleagues showed that activation of DC-SIGN on DCs by mannose-
containing glycans from M. tuberculosis or HIV-1 caused recruitment of effector proteins 
LARG and RhoA to the already existing, resting-state DC-SIGN signalosome which consists 
of scaffold proteins LSP1, KSR1 and CNK and Raf-1 (Gringhuis et al., 2009). The recruited 
effectors activated Raf-1 by phosphorylating it with subsequent p65 acetylation (Gringhuis et 
al., 2009). As a result, there was an up-regulation of interleukins Il-10, Il-12, Il-6 indicating a 
Th1 pro-inflammatory response (Gringhuis et al., 2009). 
Surprisingly the same study showed that stimulation of DC-SIGN on DCs by the Lex  
containing bacteria H. pylori which shares similar glycan structures with S. mansoni and is 
also known to be able to modulate immune response towards Th2 type (Bergman et al., 2004) 
results in opposite effects. The KSR-1-CNK-Raf-1 protein triad dissociates from already 
existing, resting-state DC-SIGN signalosome causing up-regulation of IL-10, but down-
regulation of IL-12 and Il-6 and blocking the pro-inflammatory Th1 response thus promoting 
Th2 cell expansion instead (Bergman et al., 2004). 
In addition, glycolipids from adult worm of S. mansoni were shown to be able to induce pro-
inflammatory Th1 response in human DCs and both TLR4 and DC-SIGN were needed as 
shown by blocking either receptor with monoclonal antibodies (van Stijn et al., 2010a). These 
results indicate that signalling through DC-SIGN in DCs does not necessarily polarize 
immune response to Th2 as well as suggesting cross-talk between TLR and CLR signalling 
pathways (van Stijn et al., 2010a). The downstream signalling pathways activated by glycan-
lectin interactions in parasites, to the extent they are known, are shown in the Figure 18. 
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1.2.8.4 Helminth Glycan-host soluble galectin interactions in the immune system 
Apart from CLRs present on the surface of APCs, helminth glycans are also able to interact 
with soluble extracellular lectins such as galectins. These receptors are able to recognize 
terminal galactose as well as terminal GalNAc. Galectin-3 has been demonstrated to be able 
to bind both neoglyconjugates carrying LDN as well as S. mansoni soluble egg antigens (van 
den Berg et al., 2004), species known to contain terminal GalNAc as well as galactose (Jang-
Lee et al., 2007; Meevissen et al., 2010). In addition high levels of galectin-3 were localised 
in liver granulomas of S. mansoni-infected hamsters, together with localization of LDN and 
galectin-3 on parasite eggshells (van den Berg et al., 2004). To add to this study, galectin-3 
was shown to be able to mediate the phagocytosis of LDN-glycans by macrophages (van den 
Berg et al., 2004). Another study showed that LDN antigens can cause Th2 immune 
response-associated formation of liver granulomas in mice with concomitant up-regulation of 
galectin-3 (Van de Vijver et al., 2006). The role of galectin-3 in Th2 immune response-
mediated granuloma formation was supported by the knock-out of galectin-3 in mice which 
resulted in down-regulation of granuloma formation (Breuilh et al., 2007; Oliveira et al., 
2007). All these data support the potential role of parasite glycan-host galectin interactions in 
modulating the host immune system towards a Th2 response which is known to happen upon 
infection of nematodes and other helminths. 
 
1.2.8.5 Host immune system modulation by PC-containing glycans 
N-glycans from many nematode species, namely T. spiralis (Morelle et al., 2000), O. gibsoni 
(Haslam et al., 1999), O. volvulus (Haslam et al., 1999), A. suum (Poltl et al., 2007), A. viteae 
(Haslam et al., 1997), and C. elegans (Haslam et al., 2002) have been shown to contain the 
phosphorylcholine (PC) moiety which is known to be able to modulate the host immune 
response (Helmby, 2009; Pineda et al., 2014). A lot of data about the effects of nematode-
derived phosphorylcholine came from studies on the ES-62 protein from A. viteae, which was 
demonstrated to contain N-glycans bearing PC-modified terminal GlcNAc residues (Harnett 
et al., 2003). Later by attaching PC to ovalbumin (OVA) (Harnett et al., 2008) it was 
demonstrated that the majority of ES-62 immunomodulatory properties can be ascribed to the 
PC moiety. To my knowledge there are no reports of PC- containing glycans interacting with 
lectins. However , nematode-derived PC-containing ES-62 glycoprotein was demonstrated to 
interact with TLR-4 on bone-marrow derived mast cells (BMMC) causing degradation of 
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protein kinase C (PKC)-α needed for the mast cell activation (Melendez et al., 2007). ES-62 
may be targeting other PKC isoforms such as PKC-ε and PKC-θ with the overall result being 
downregulation of pro-inflammatory cytokines IL-6 and TNF-α (Bell et al., 2015). Similar 
pathway was demonstrated to be present in other types of mast cells, namely peritoneal-
derived mast cells (PDMC) and connective tissue-derived mast cells (CTMC) (Ball et al., 
2013). In addition nematode-derived PC-containing ES-62 glycoprotein was demonstrated to 
interact with TLR-4 on APC as well as disrupting BCR and TCR signalling, resulting in mast 
cell desensitization and blockage of Th17 cells (Rzepecka et al., 2013). The ES-62-derived 
PC moiety was demonstrated to be able to mimic helminth infection in mice, causing Th2-
shifted immune responses (Houston et al., 2000). Similarly in the chronic inflammatory 
arthritis (CIA) disease model, ES-62 was shown to supress pro-inflammatory Th1 responses 
(McInnes et al., 2003). Surprisingly in an airway inflammation disease model, ES-62 caused 
up-regulation of interferon-gamma (IFN-γ) production (Rzepecka et al., 2013), which is one 
of the Th1 response indicators, thus demonstrating that shifting of the immune response by 
PC towards Th1 or Th2 may depend on the inflammatory environment already present in the 
host. As a consequence of these studies small drug-like compounds based on PC moiety of 
ES-62 were developed and showed promising results in treating autoimmune diseases such as 
systemic lupus erythematosus (Rodgers et al., 2015), oxazolone-induced ear inflammation 
(Al-Riyami et al., 2015) and rheumatoid arthritis (Pineda et al., 2015). 
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1.3 Mass spectrometry as a tool for structural glycomics 
1.3.1 Overview and historical background of mass spectrometry: from 
electrons to glycoproteins 
Mass spectrometers are instruments which measure the mass/charge ratio (m/z values) of 
gaseous ionised molecules. The common features of mass spectrometers are the ionisation 
chamber where a sample is ionised, the analyser where gaseous sample ions are separated 
from each other according to their m/z and the detector where the separated ions are 
measured and quantitated. Nowadays mass spectrometry instruments are commonly found in 
many biology and biochemistry laboratories where they are applied in proteomics, 
lipidomics, metabolomics and as in my case glycomics research.  
 The first MS instruments appeared more in physics laboratories and it took years for the 
transition from physics applications to biological applications to occur. The instrument which 
was later considered as the first mass spectrometer was built around the beginning of the 20th 
century in the prestigious Cambridge’s Cavendish Laboratory led by J.J. Thomson (Griffiths, 
2008). Subsequently he measured the mass-to-charge ration of the electron, e/m for which in 
1906 he was awarded the Nobel Prize. Later his work was extended by his student F. Aston 
who applied the first MS instrument built by J.J. Thomson to measure the masses of charged 
atoms. This led to the discovery that many elements such as neon and chlorine are made of 
different isotopes. For this work in 1922 Aston himself was awarded the Nobel Prize in 
Chemistry. 
During World War II mass spectrometry was successfully applied to isolate and study the 
radioactive U-235 isotope for nuclear weapon development (Nier 1989). At the same time 
mass spectrometry started to find applications in other fields. Alfred Nier was one of the 
pioneers in bringing mass spectrometry to a wider scientific community. He performed 
studies such as the determination of the age of the Earth by the Pb-207/Pb-206 ratio for 
geologists and studies of C-13 isotope which was later extensively used for metabolic studies 
by biologists (Nier 1989). 
The early ionisation method of the molecules used by J.J. Thompson was called electric 
discharge and in the post-war period was replaced by the Electron Impact Ionisation (later 
called the Electron Ionisation or EI) (McLafferty, 2011). The EI ionisation method (see 
section 1.3.7.2) was softer and did not induce as extensive fragmentation of parental ions. 
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Consequently it allowed the detection of molecular ions as well as fragment ions. This 
prompted the usage of mass spectrometry to analyse not only hydrocarbons but also for the 
first time small biomolecules found in natural sources (Biemann, 2002). 
 Scientists started to collect large volumes of spectra and utilize them for the characterisation 
of fragmentation reactions. As an example, one of the pioneers in this field Fred Mc Lafferty 
whilst at Dow Chemical Company collected about 4000 spectra before coming up with his 
famous ‘Mc Lafferty rearrangement’ for the β-cleavage of keto-group containing compounds 
(McLafferty 1959). Another pioneer Klaus Biemann at the Massachusetts Institute of 
Technology started to apply mass spectrometry to study alkaloids and to figure out their 
fragmentation patterns (Biemann, 2002). He also established the early rules for peptide 
fragmentation thus laying the foundation for current proteomics research (Biemann, 2014). In 
the United Kingdom the key player in developing Mass Spectrometry applications to 
biomolecules was Howard Morris who showed that mass spectrometry could be applied to 
problems such as the study of the Vitamin D metabolism with the consequent establishment 
of treatment for kidney failure patients (Lawson et al., 1971). 
At the beginning of the proteomics era in late 1960-s two important inventions appeared in 
the mass spectrometry field. The first one was the chemical ionisation method which was a 
softer ionisation method than the Electron Ionisation (see section 1.3.7.2) and induced little 
fragmentation in the peptide ions. The second invention was gas chromatography-mass 
spectrometry (GC-MS) instruments (see section 1.3.7) which allowed the coupling of mass 
spectrometry with gas chromatography and allowed the separation of peptides online with the 
subsequent introduction into the MS instrument without the need to have a pure sample 
(Gohlke 1959; Ryhage 1964). Nevertheless the main obstacle at that time was the fact that by 
nature peptides were difficult to ionise hence there was a need for their derivatization. Klaus 
Biemann developed the poly-amino alcohol derivatization approach for peptides using GC-
MS instruments (Nau et al., 1973). In a competitive strategy Howard Morris adopted the 
sugar permethylation reaction initially discovered by Hakomori (Hakomori, 1964) and 
together with the N-acetylation of the N-termini applied it to create N-acetylated permethyl 
peptide derivatives (Morris et al., 1971). This work for the first time demonstrated the 
application of mass spectrometry to analyse mixtures of peptides as at that time only the 
analysis of single peptides was considered feasible (Morris et al., 1971). 
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In the late 1970s Fast Atom Bombardment (FAB) (see section 1.3.4) was invented by 
Michael Barber at the University of Manchester Institute of Science and Technology (Barber, 
Bordoli et al. 1981) and quickly revolutionised the field of MS-based biopolymer analysis. It 
did not require the tedious sample derivatization and allowed the analysis of native 
oligosaccharides and peptides (Morris et al., 1981). Although the technique was limited to the 
analysis of molecules of a few thousand Daltons (Barber, Bordoli et al. 1981), at that time it 
was a remarkable achievement.  Later the FAB ionisation method (see section 1.3.4) got 
replaced by softer ionisation techniques such as electrospray ionisation (ESI) (Fenn et al., 
1989) and matrix-assisted laser desorption ionisation (MALDI) (Karas and Hillenkamp, 
1988). These two soft ionisation methods allowed the analysis of much bigger biomolecules. 
MALDI (see section 1.3.5) has been extensively used for glycan analysis during my PhD 
studies. 
 
1.3.2 Tandem mass spectrometry 
One of the later important advancements in the field of mass spectrometry was the creation of 
tandem, or MS/MS, mass spectrometry in the period 1971-1973 by J.H. Beynon (Beynon, 
Cooks et al. 1973). As the name suggests, this type of experiment involves two stages of 
analysis. In the first stage molecular ions from the sample are produced and analysed. In the 
second individual ions with specific m/z value from the first experiment are selected, 
fragmented and further analysed. The first tandem mass spectrometer had two sector 
analysers (Beynon, Cooks et al. 1973) and this type of approach is called tandem in space as 
two separate analysers are used. Later other tandem in space instruments were developed 
such as TOF-TOF. One way to achieve fragmentation of the selected molecular ions is CID 
(collision-induced dissociation). In the CID experiment a stream of neutral gas such as argon 
is collided with the selected ions inside a collision cell. In this way the internal energies of the 
selected molecular ions are increased causing them to fragment. An alternative to the tandem 
in space approach is tandem in time instrumentation where only one analyser, usually an ion 
trap, is used to perform different stages of MS analysis at different times. The ionised 
molecules from the sample are trapped inside the trap with the desired ion of a certain m/z 
value being kept in the trap whilst other ions are released. Then CID is performed and 
resulting fragmented ions are expelled into an analyser. If needed, fragmentation of a 
fragment ion can be performed allowing MSn experiments to be performed. Throughout my 
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thesis I have used tandem in space MALDI-TOF-TOF (see section 1.3.5) as well as tandem 
in time MALDI-QIT-TOF (see section 1.3.6) instruments. 
 
1.3.3 Other trends in modern mass-spectrometry 
The invention of soft ionisation techniques, namely MALDI (see section 1.3.5.2) (Karas, 
Bachmann et al. 1985) and ESI (Fenn et al., 1989) revolutionized the area of mass 
spectrometry allowing large biomolecules to be analysed. In the 21st century one of the major 
trends in mass spectrometry advancements is the rise of hybrid instruments where different 
analysers are combined together. One such an instrument having Q-TOF configuration was 
conceived at Imperial College by Howard Morris and built by Micromass Ltd (Morris, Dell et 
al. 1996). Another example of a hybrid instrument is the MALDI-QIT-TOF (see section 
1.3.6) developed by Shimadzu and this instrument has been used throughout my PhD studies 
(Ding, Kawatoch et al. 1999).  
 
1.3.4 Fast Atom Bombardment mass spectrometry as an early technique 
for glycan analysis 
In 1980 at the Symposium on Soft Ionization Biological Mass Spectrometry held at Imperial 
College London the new ionisation technique later coined Fast Atom Bombardment (FAB) 
and invented by Barber at University of Manchester Institute of Science and Technology was 
introduced to the scientific community (Barber, Bordoli et al. 1981). This ionisation method 
involves sample deposition on a solid plate often dissolved it in a matrix such as glycerol 
(Dell, 1987). An accelerated ion or atom beam is directed at the sample and the sample 
molecules are ionised via ion sputtering (Barber, Bordoli et al. 1981 as seen in the Figure 19.  
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Atom or ion gun
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Figure 19 Fast Atom Bombardment (FAB) Ionization Source                                              
This type of ionisation was used for older days glycomics analysis where the accelerated 
high-energy beam of neutral atoms or ions from the laser is focused on the sample and matrix 
mix deposited on the probe making sample to ionise.  
 
 FAB brought big excitement into the scientific community and quickly revolutionised the 
field of the mass spectrometry-based biopolymer analysis. As compared to earlier used MS 
methods it offered a lot of advantages with the most obvious one being the ability to ionise 
large underivatized macromolecules (Barber, Bordoli et al. 1981). In addition the ionisation 
process generated both molecular and fragment ions thus providing a high level of structural 
information about the analyte molecule (Barber, Bordoli et al. 1981). Although nowadays 
spectra of more than ten thousands Da molecular weight molecules are obtained using 
different technologies (Angelini et al., 2010) in the early eighties FAB ionisation coupled 
with magnetic sector analyser rendered it possible to obtain the spectra of molecules of a few 
thousand Da molecular weight, which was a great achievement at that time (Barber, Bordoli 
et al. 1981). 
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 As the scientific community quickly adopted the new methodology for glycoconjugates, 
FAB spectra were successfully generated from much larger oligosaccharides. Notably the 
structure of the sialylated fucosyl lactosaminoglycan from human neutrophil granulocytes 
was proposed (Fukuda et al., 1984). Although the molecular ion peak of the glycan was not 
observed due to the m/z limitations of the instrument, the FAB-generated fragment ion data 
suggested tetra-antennary N-glycans with poly-lactosaminyl side chains, some of which were 
decorated by terminal sialic acid and fucose α1-3 linked to GlcNAc residues (Fukuda et al., 
1984). FAB-MS instruments were also used to characterize the glycomes of H. contortus 
(Haslam et al., 1996; Haslam et al., 1998) and D. viviparus (Haslam et al., 2000), the 
parasites of my PhD research interest. 
 
1.3.5 AB 4800 MALDI-TOF- TOF instrument as a replacement for the 
FAB-MS sector mass spectrometer used in glycomics studies 
1.3.5.1 Overview 
Over the past decade or so MALDI-based instruments have replaced FAB-MS instruments 
and have established themselves as an indispensable tool for quick and sensitive glycan 
profiling. The main advantages of MALDI are a soft ionization leaving large biomolecules 
intact, a relative tolerance to salt and other impurities and a pulsed nature of ionization with 
small consumptions of the sample during the analysis. Combining MALDI with TOF-TOF 
analysers, as seen in the Applied Biosystems AB 4800 MALDI-TOF-TOF instrument, allows 
scientists to perform not only MS profiling of glycans but also their MS/MS fragmentation. 
In contrast to FAB-MS sector instruments, where generated spectra had a mixture of both 
molecular and fragment ions, MALDI-TOF-TOF instruments allows the selection of specific 
molecular ions for further MS/MS fragmentation. With the advent of improved MALDI-
based techniques the FAB-MS data of the glycans for H. contortus and D. viviparus has been 
revisited. 
 
1.3.5.2 Matrix Assisted Laser Desorption Ionisation 
The projects carried out during my PhD studies mainly utilised matrix assisted laser 
desorption ionisation (MALDI) instruments. To compare to older FAB-mass sector machines 
these are more modern and powerful type of instrumentation were a MALDI ionisation 
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source (see Figure 20) is coupled to the time-of-flight analyser in a MALDI-TOF MS and the 
related tandem MALDI-TOF/TOF MS instruments. A laser pulse is applied to the sample, 
which is dissolved in the low-molecular weight matrix, capable of absorbing ultraviolet light 
at the same wavelength as the incident laser. This results in a softer ionisation method, thus 
rendering MALDI a more sensitive type of ionisation with reduced chemical noise 
background compared to the older FAB technology, though at a cost of losing the majority of 
fragment ions. Nevertheless some ions can undergo fragmentation inside the MALDI source 
and after leaving it in a process called post-source decay. 
The discovery of MALDI can be traced back to 1985 when Michael Karas and Franz 
Hillenkamp realised that when a mixture of alanine and tryptophan is analysed by Laser 
Desorption Mass Spectrometry the signal for alanine is much stronger than when it is ionised 
alone (Karas, Bachmann et al. 1985). In other words, according to Hillenkamp ‘aliphatic 
amino acid was riding piggyback on tryptophan’(Griffiths, 2008) and ‘tryptophan thus must 
be regarded as an absorbing matrix resulting in molecular ion formation of the nonabsorbing 
alanine’ and the process was coined ‘Matrix- Assisted Laser Desorption’(Karas, Bachmann et 
al. 1985). In addition part of the Nobel Prize for Chemistry in 2002 ‘for their development of 
soft desorption ionisation methods of mass spectrometric analyses of biological molecules’ 
was awarded to Koichi Tanaka. He showed that the Laser Ionisation TOF mass spectrometer 
could in principle be used to analyse the biopolymers like proteins up to m/z 100000 when 
they are deposited on a solid surface using suspension of the fine metal powder and glycerol 
(Tanaka, Waki et al. 1988) although his method did not ionise molecules as well as MALDI 
invented by Karas and Hillenkamp.  
As well as proteomics MALDI quickly found application in the field of the glycomics. The 
superiority of MALDI over older FAB-type instrumentation was shown by Babu and 
colleagues (Babu et al., 2009a) when analysing neutrophil N- and O-glycans using MALDI-
TOF and MALDI-TOF-TOF techniques. They managed to show the presence of glycans up 
to m/z 6500 whereas the previous glycomics data from neutrophil granulocytes using FAB-
MS instrument (Fukuda et al., 1984) showed the highest molecular weight species with m/z 
1897. Furthermore using MALDI techniques Haslam and colleagues (North et al., 2010a) 
reported poly-LacNAc- containing N-glycans with up to 13000 m/z previously unseen in 
Chinese Hamster Ovary cell lines (North et al., 2010a) and mouse lung tissue (Bern et al., 
2013) clearly demonstrating the ultra-sensitivity of the MALDI instrument at high molecular 
weight .  
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Figure 20 Matrix-assisted-Laser-Desorbtion-Ionisation (MALDI) Ionization Source               
The laser pulse is directed onto the sample embedded in the matrix. The matrix absorbs the 
energy pulse and transfers it to the sample via mechanisms which are not well understood 
making sample to ionise. This ionisation type instrument is utilised for the glycomics 
experiments in this project.  
 
1.3.5.3 Time-of-flight (TOF) Analyser 
The concept of the Time-of-flight (TOF) analyser was introduced for the first time by 
Stephens in 1946 (Wolff, Stephens 1953). In 1955 Wiley and McLaren published the design 
of the linear TOF (Wiley, McLaren 1955) which later became commercialised. In the 1980s 
interest in TOF geometry instruments was renewed since they fitted very well with laser 
desorption ionisation and the creation of MALDI-TOF instruments opened up new research 
horizons in biopolymer mass spectrometry.  
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1.3.5.4 Linear TOF analyser  
In the linear TOF analyser the ions expelled from the ionisation source are accelerated by the 
same voltage potential resulting in ions having equal potential energy which depends on 
applied voltage and charge of the particle. When ions are introduced into the analyser the 
potential energy is converted into kinetic energy which is proportional to the mass and the 
velocity squared of the particle. It is important to note that since the voltage applied to the 
particles is the same, the kinetic energy is also the same for different particles. From there it 
follows that particles with different mass to charge ratio will have different speeds in the 
analyser and the heavier and less charged the particle is, the longer it takes to reach the 
detector. 
 
1.3.5.5 Reflectron TOF and delayed pulsed extraction   
The linear TOF geometry offers very high upper mass limits as well as sensitivity. However 
one of its drawbacks is poor mass resolution. The reflectron TOF and delayed pulsed 
extraction were created to overcome these issues. 
The reflectron TOF concept was suggested by Mamyrin in 1973 (Mamyrin, Karataev et al. 
1972) and consists of a series of grids and ring electrodes which serve as retarding ion 
mirrors by acting electrostatically on the ions in the TOF analyser. They not only increase the 
path of flight of an ion, but also correct the dispersion of the kinetic energy of the particles by 
letting ions with slightly higher kinetic energy but the same m/z value to penetrate deeper into 
the reflector and catch up with the ions having the same m/z value but slightly smaller kinetic 
energy. 
Another improvement of the linear TOF analyser was created by Wiley and McLaren, and 
called delayed pulsed extraction (Wiley, McLaren 1955). The idea consists of letting ions 
formed in the ionisation source enter the field-free region only after a nano- to microsecond 
delay. This is achieved by the application of a short pulse of voltage in contrast to the 
continuous ion extraction where ions formed in the ionisation source are extracted 
immediately into the analyser by means of the applied voltage. This allows the correction of 
the kinetic energy dispersion for ions with the same m/z values leading to improved 
resolution of the spectrum. 
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1.3.6 MALDI-QIT-TOF instrument  
1.3.6.1 Overview of the MALDI-QIT-TOF instrument  
The Shimadzu KRATOS AXIMA-QIT is unique in the market of instruments in that it 
combines a MALDI source with a quadrupole ion trap (QIT) (see Figure 21) as opposed to 
the more conventional electrospray ionisation (ESI)-QIT combination. Since during the 
ionisation process high molecular weight molecules generate ions with high kinetic energy, 
early attempts to combine MALDI ion source with QIT were not particularly successful due 
to the difficulty of introducing and keeping high m/z molecular ions inside the trap (He and 
Lubman, 1997) (Kaiser, Cooks 1991). The Shimadzu scientists improved the method by 
introducing the near orthogonal laser irradiation of the sample, by keeping the radio 
frequency (RF) voltage field switched off when ions enter the trap and subsequently 
switching it on once the ions are inside and by applying the retarding field in the QIT to 
reduce the kinetic energy of an ion inside the trap. With all these improvements they 
managed to create a sensitive MALDI-QIT-TOF instrument which has high trapping 
efficiency of high molecular weight ions (Ding, Kawatoch et al. 1999). The soft MALDI 
ionisation method is extremely suited for analysing glycans and the presence of the QIT, in 
contrast to the other MALDI instrument used during my PhD studies, the AB 4800 MALDI-
TOF-TOF, offers the possibility to perform MSn analysis revealing extra details of glycan 
structure and linkage between monosaccharides. 
N  Laser2
Lens
Mirror
MALDI source QIT Detector TOF analyser Reflectron
Sample
Ring electrodes
Endcap electrodes
Figure 21 The schematic representation of the MALDI AXIMA QIT instrument.                                 
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 For principles of MALDI and TOF operation, see sections 1.3.5.2 and 1.3.5.3. 
‘ 
1.3.6.2 Principles of the QIT operation 
Initially invented by Paul and Steinwedel (Paul, Steinwedel 1960) in 1960 and modified into 
a useful and commercially available mass spectrometer by Stafford and colleagues in 1980s 
(Stafford, Kelley 1984), the quadrupole ion trap (QIT) shares similarities with the 
quadrupolar analyser (see section 1.3.7.3). Quadrupole analysers use voltages in two 
dimensions to change the trajectory of the ions whereas the QITs have voltages in all three 
dimensions (Paul, Steinwedel 1960). The 3D voltage environment is achieved by applying 
the alternating current (AC) to end cap electrodes and direct current (DC) to a ring electrode. 
The essential difference between the QIT and quadrupole analyser is that in a quadrupole 
analyser ions with a stable trajectory will reach the detector whereas in the mass-selective 
instability mode operating QIT ions with an unstable trajectory are trapped inside (Stafford, 
Kelley 1984). Later by scanning the radio frequency (RF) voltage ions are emitted from the 
trap into another analyser such as TOF or the detector. 
 
1.3.7 GC-MS instrument  
1.3.7.1 Overview 
The Perkin Elmer Clarus 500 and Bruker SCION SQ 456-GC are the GC-MS (gas 
chromatography- mass spectrometry) instruments used throughout my PhD studies and 
comprise a gas-chromatography column linked to an Electron Ionisation -Quadrupole 
analyser (EI-Q) mass spectrometer. The main use of these instruments throughout my studies 
was to perform linkage analyses of monosacharides derived from permethylated glycans that 
were hydrolysed, reduced to generate free hydroxyl groups that are labelled with acetyl 
groups. The resultant partially methylated alditol acetates of different monosaccharides in 
most cases have different retention times on the GC column. In addition simultaneously 
acquired mass spectra provide the characteristic fragment ions allowing the confirmation of 
the linkage of the monosaccharide. Since mass spectrometry alone cannot distinguish 
different monosaccharides isomers of the same mass, such as mannose, glucose or galactose, 
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the GC-MS instrument is a useful complementary tool to prove the presence of the 
specifically linked monosaccharides in the sample. 
 
1.3.7.2 Electron Ionisation 
The Electron Ionisation source was invented by Dempster in 1917 (Dempster 1918) and 
improved by Bleakney (Bleakney 1929) and Nier (Nier, 1947). The principle of this 
ionisation technique is depicted in the Figure 22. The heated filament gives off electrons 
which are accelerated towards the anode trap. The gaseous sample molecules are introduced 
into the ionisation source where they interact with the accelerated electrons.  
A consequence of the electron ionisation process is that there remains a lot of excess energy 
which results in extensive fragmentation of the analyte molecule and thus is considered a 
‘harder’ ionisation technique. Although molecular ions are often not seen in the spectrum the 
fragment ions generated by extensive fragmentation are very useful in the structural 
elucidation of the analyte.  
Sample in
M
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Figure 22 The schematic diagram of the Electron Ionisation.                                                           
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1.3.7.3 Quadrupolar Analyzer 
The quadrupolar analyser was devised by Paul and Steinweden at Bonn University in 1953 
(Paul, Steinweden 1953). It consists of four parallel rods to which alternating positive and 
negative potentials are applied. The forces induced by oscillating electric fields affect the 
trajectory of ions which are travelling between the rods. The ions which hit the rods are 
discharged and hence do not reach the detector. The ions with a certain m/z value have a 
stable trajectory. By continuously varying the applied voltage, the range of m/z values can be 
scanned allowing ions with a certain m/z value only to reach the detector. The schematic 
diagram of the quadrupolar analyser is shown in the Figure 23 below. 
+
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ion with m/z2
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Quadrupole rods with alternating voltage
Stable ion trajectoryUnstable ion trajectory
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Figure 23 The schematic diagram of the quadrupole analyser 
 
1.3.8 Derivatization of glycans 
Glycans being relatively polar molecules pose a greater challenge for ionization compared to 
less polar peptides. The decreased ionization efficiency results in a more difficult analysis of 
this class of biomolecules especially when dealing with minor components of a complex 
heterogeneous mixture. To overcome this problem the permethylation of hydroxyl and amido 
groups in glycan molecules was introduced which not only increases the ionisation efficiency 
but also directs the fragmentation of the glycan molecular ions in a less random, more 
predicted fashion. 
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Initial attempts to perform the permethylation reaction were carried out by Haworth (Haworth 
1915) and Purdie (Purdie, Irvine 1903). The first method employed sodium or potassium 
hydroxide acting both as a base and a solvent with dimethyl sulphate acting as a methyl donor 
(Haworth 1915). The second method employed methyl iodide as a solvent and a methylation 
agent together with silver oxide acting as a base (Purdie, Irvine 1903). The major limitation 
of these methods was the need to repeat the experiment many times to achieve complete 
methylation with reaction times extending over a month or longer (Haworth 1915; Purdie, 
Irvine 1903). 
In 1964 Hakomori proposed the alternative permethylation method which involved DMSO 
acting as a solvent, methyl iodide as a methylating agent and dimsyl anion as a base 
(Hakomori, 1964). Although it did not offer high yields this reaction could be completed 
within few days rather than months. Later Ciucanu and Kerek realised that hydroxide ions 
could remove protons more efficiently from the glycan hydroxyl groups than dimsyl anions. 
In 1984 they published a modified permethylation protocol where, in contrast to the 
Hakomori method, dimsyl anions are replaced with hydroxide ions (Ciucanu, Kerek 1984), 
see Figure 24. This method offers excellent permethylation yields, can be achieved within 
minutes and was used to permethylate glycans in my experiments. 
R-OH + OH-.. R-O + H O
-
2
R-O  +  CH I
3
R-OCH  + I3
-
-
 
Figure 24 The mechanism of the permethylation reaction                                                         
The mechanism is proposed by Ciucanu and Kerek (Ciucanu, Kerek 1984). Hydroxide anion 
acts as a base by abstracting the proton from the sugar hydroxyl group. The resultant sugar 
alkoxide anion denoted as ‘R-O -‘subsequently reacts with the alkylating reagent methyl 
iodide. 
 
1.3.9 Overview of the strategy for interpreting MS spectra 
In order to assign the composition of molecular ions we need to consider the masses of 
permethylated sugar monomers listed in Figure 25 (a), the masses of reducing and non-
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reducing ends of permethylated structures (Figure 25 (b)) and the mass of the sodium ion 
used to ionise the molecule. The general assignment formula can be expressed as: X= Σ 
(M)+46+23 where X is the m/z value of the peak, Σ (M) corresponds to the sum of 
permethylated residue masses present in the glycan, 46 is the permethylated mass of the 
reducing and non-reducing ends and 23 is the mass of a sodium ion. 
As MS analyses give us only the composition of the glycans, knowledge of biosynthetic 
pathways is typically used as a powerful method for determining potential structures. To get 
more structural information, MS/MS analysis of peaks of interest is performed, whereby 
molecular ions of the interest are selected, broken down into smaller fragments and their 
masses measured. 
 
Figure 25 Symbolic nomenclature and permethylated masses of monosacharides                       
a) Symbolic nomenclature as outlined by the Consortium for Functional Glycomics 
Nomenclature Committee (May 2004) (Varki et al., 2009). Full documentation available 
from: http://glycomics.scripps.edu/CFGnomenclature.pdf. 
 b) The mass of a permethylated sugar is calculated by adding the sum of the increment (or 
residue) masses of the sugars (a) to the sum of the masses of the reducing and non-reducing 
ends  Figure is adopted from (North et al., 2010b) and is the courtesy of Dr. Simon North. 
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1.3.10 Overview of glycan fragmentation pathways  
An overview of the glycan fragmentations happening upon MS/MS and MSn experiments is 
outlined in Figure 26 and the fragments are named according to the nomenclature proposed 
by Domon and Costello (Domon, Costello 1988). 
MeO
O
MeO
OMe
O
NMe
O
O
OMe
OMe
OMe
O R
Z-type ion
C-type ion
Y-type ion
B-type ion
A-type ion3,5
A-type ion2,4X-type ion
2,6
 
Figure 26 The glycan fragmentation pathways                                                                        
The nomenclature is proposed by Domon and Costello (Domon, Costello 1988). 
 
One of the common classes of fragments observed during tandem mass spectrometry are ‘C-
type’ ions (Domon, Costello 1988). They form when the glycosidic bond oxygen abstracts 
the proton from one of the carbons forming a 4-membered intermediate and the charge 
remains on the non-reducing end fragment (see Figure 27). The analogous fragmentation 
pathway happens upon the ‘Y-type’ formation where the glycosidic bond oxygen abstracts 
the proton from the non-reducing end sugar, carbon two. If the glycosidic bond is cleaved on 
the reducing-end side with the charge staying on the same side, ‘Z-type’ ions are formed. 
They are favoured when the reducing-end monosaccharide is a 3-linked HexNAc since the 
resultant double bond between carbons two and three is in resonance with the nitrogen lone 
pair and the acetyl group (see Figure 27). These fragments are extremely useful in 
identifying 3-linked GlcNAc and GalNAc residues. ‘B-type’ ions are formed based on a 
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similar principle where the double bond between carbon one and two is resonating with the 
nitrogen lone pair and the acetyl group. This information allows us to deduce that the 
resultant ‘B-type’ ion most likely has a reducing-end GlcNAc or GalNAc.  
O
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O R
H..
Na+
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O H
O
NMe
O
O R
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O H
O
NMe
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Na+
Na+
..
OMe
OMe
OMe
OMe
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OMe
OMe
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Figure 27 The proposed mechanisms for the formation of glycan ‘C-type’ and ‘Z-type’ ions 
The nomenclature is proposed by Domon and Costello (Domon, Costello 1988). 
 
Cross-ring cleavages (see Figure 28) usually require more energy than glycosidic bond 
cleavages and are typically observed when fragmenting small molecular weight ions such as 
in MSn experiments. The example of the cross-ring fragment formation mechanism is 
depicted in Figure 28 where reverse Diels-Alder fragmentation is taking place in the already 
formed ‘B-type’ ion (Ashline et al., 2005). The presence of the double bond between carbon 
one and two in the parental ion was proposed to favour the reverse Diels-Alder fragmentation 
pathway (Ashline et al., 2005) although in its absence analogous cross-ring fragmentations 
can also happen (Domon, Costello 1988). In MSn experiments the cross-ring fragments can 
be very informative in determining linkage information between monosaccharides.  
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Figure 28: The proposed reverse Diels-Alder cross-ring fragmentation mechanism                  
The formation of the examplar ‘3,5A-type’ and other ions was described by (Ashline et al., 
2005). 
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1.4 Aims of the thesis 
The aims of my thesis are to epmploy ultra-sensitive MALDI-TOF-TOF and MALDI-QIT-
TOF-based techniques as well as GC-MS to structurally characterize H.contortus and D. 
viviparus glycomes. The specific aims are: 
1. To revisit adult and L3 stage H.contortus N- glycans which have been investigated 
earlier with FAB-MS instrumentation. 
2. For the first time to analyse adult and L3 stage H.contortus O- glycans. 
3. To revisit adult D.viviparus N- glycans previously characterized using FAB-MS 
instrumentation. 
4. For the first time to analyse adult D.viviparus O- glycans as well as L3 stage N- and 
O- glycans. 
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Chapter 2 
 
Materials and Methods 
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2.1 Materials  
2.1.1 Biological samples 
Adult and L3 stage Haemonchus contortus as well as adult and L3 stage Dictyocaulus 
viviparus nematodes were kindly provided by Dr. G. Coles, University of Bristol, School of 
Veterinary Sciences. The D. viviparus and H. contortus L3 stage larvae were collected by 
Baermann apparatus, purified by sucrose gradient and thoroughly washed with tap water. The 
adult parasitic worms were hand picked from humanely slaughtered animals ensuring that 
worms are free of any remaining abomasal or lung debris. The picked worms were washed 
with Earle’s balanced salt solution. 
 
2.1.2 General chemicals and reagents 
Iodoacetic acid (IAA), sodium acetate, potassium borohydride (KBH4), 2-amino-2-
hydroxymeethyl-propane-1,3-diol (TRIS), α-cyano-4-hydroxycinnamic acid, 2,5-
dihydroxybenzoic acid (DHB) were purchased from Sigma-Aldrich (Poole, UK). 
Acetonitrile, ammonia solution, methanol, chloroform, dimethylsulphoxide (DMSO), propan-
1-ol, ammonium hydrogen bicarbonate (AMBIC), sodium hydroxide, acetic acid, 
trifluoroacetic acid (TFA) were purchased from Romil (Cambridge, UK). Dithiothreitol 
(DTT) and 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate hydrate (CHAPS) 
were acquired from Roche Applied Science (East Sussex, UK). Methyl iodide was purchased 
from Alfa Aesar (Lancaster, UK). Ethylenediaminetetraacetic acid (EDTA) and formic acid 
were obtained from Fluka (Poole, UK). 18 MΩ.cm3 distilled (MiliQ®) water was produced 
by the Purite Neptune water purification system from Purite Ltd (Oxfordshire, UK). 
 
2.1.3 Enzymes 
Trypsin, Jack bean α-mannosidase and β1-4 specific galactosidase from Streptococcus 
pneumonia were obtained from Sigma-Aldrich (Poole, UK). Recombinant β1-4 specific 
galactosidase was kindly provided by Prof. Iain Wilson, University of Natural resources and 
Life Sciences, Vienna. Recombinant PNGase F and PNGase A from sweet almond meal were 
purchased from Roche Applied Sciences (East Sussex, UK.). Green coffee bean α(1-3,4,6)-
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galactosidase, bovine testes β(1-3,4,6) galactosidase, recombinant β(1-3,6) galactosidase 
(from Xanthomonas manihotis, expressed in E. coli) were purchased from ProZyme, CA, 
USA. 
 
2.1.4 Equipment and consumables 
Oasis® HLB and Sep-Pac C18 Classic cartridges were purchased from Waters Ltd 
(Hertfordshire, UK). Thermo Savant ModuloD freeze dryer, SnakeSkin® Pleated Dialysis 
Tubing, 70000 MWCO, 22mm dry diameter and Thermo Savant SPD121P Speed Vac 
concentrator were obtained from Thermo Scientific (Basingstoke, UK). Lo-bind® 
Eppendorfs tubes were purchased from Sigma-Aldrich (Poole, UK). Multi-tube vortexer, 
Vibra-CellTM homogenizer, Falcon tubes, glass culture tubes (13x100 mm Cornig, 7.5 ml), 
screw caps (disposable phenolic GPI 13-415 threaded with PTFE liner) and glass Pasteur 
pipettes were from VWR International Ltd (Lutterworth, UK.) 
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2.2 Methods  
2.2.1 Overview 
Adult/L3 nematodes
-Homogenisation, see  
   -Reduction and carboxymethylation, 
section 2.2.2
see  section 2.2.3
Reduced, carboxymethylated (glyco)proteins
-Trypsin digestion and purification, 
    see  section 2.2.4
(Glyco)peptides
-PNGase F digestion and separation,
    see  andsections 2.2.5  2.2.6
Free N-glycansRemaining (glyco)peptides
-PNGase A digestion and separation, 
     see  section 2.2.7 - optional: HF treatment,
     exoglycosidase treatment(s) with separation, 
     see  and
(
sections 2.2.9  2.2.10)
Permethylated glycans
-Permethylation and purification, see  section 2.2.11
Free N-glycansRemaining (glyco)peptides
-reductive elimination and purification, 
     see  section 2.2.8
Free O-glycans
 -Permethylation and purification, 
    see  section 2.2.11
- optional: exoglycosidase treatment(s) 
       with separation, see  and
(
sections 2.2.9  2.2.10)
-Permethylation and purification, 
    see  section 2.2.11
-(
sections 2.2.9  2.2.10)
optional: exoglycosidase treatment(s) 
     with separation, 
     see  and
MS, MS/MS, MS   analyses
n
-Sample preparation, 
    see  section 2.2.13
GC-MS linkage analysis
Figure 29 Overview of glycomic methods used in the PhD thesis 
 
The methods of N- and O-glycan preparations and analyses by MALDI instrumentation are 
based on previous report (North et al., 2010b)and are summarized in the Figure 29. Briefly 
worms were homogenized and extracted (glyco)proteins were digested into smaller 
(glyco)peptides by trypsin. PNGase-F enzyme was then used to remove N-glycans from 
glycopeptides. The remaining (glyco)peptides were then subject to PNGase A treatment. This 
enzyme, in contrast to PNGase F, is capable of releasing N-glycans carrying α1-3-linked 
fucose on the proximal GlcNAc. This assists with establishing the position of fucoses present. 
The O-glycans are then released from remaining (glyco)peptides by reductive elimination. in 
order to obtain more structural information the released N- and/or O-glycans were subject to 
exoglycosidase and/or HF treatment. Finally the free glycans were permethylated and 
analysed by MALDI instruments. Compositional glycan profiling was obtained by MALDI-
TOF MS instruments. Additional levels of structural information were obtained by MALDI-
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TOF-TOF MS/MS and MALDI-QIT-TOF MSn instrumentations. Finally the permethylated 
glycans were subject to GC-MS linkage analyses which allows us to establish the 
monosaccharide configurations and linkages. 
 
2.2.2 Worm homogenization 
To clean the homogenizer the metal tip was placed into a beaker with 33% water, 33% 
methanol, 33% formic acid (v/v/v) solution and kept in the sonicator for 10 minutes. Then the 
metal tip was put back onto the homogenizer and cleaning continued by turning the 
homogenizer on for 1 minute in each of the following solutions: 1) 33% water, 33% 
methanol, 33% formic acid solution 2) methanol 3) 50% methanol, 50% chloroform solution 
4) methanol 5) ultrapure water. Finally the homogenizer was kept on for one minute in an 
empty Falcon tube to get rid of all the remaining droplets. 
For sample homogenization on average 0.2g of wet of material (L3 or adult H. contortus/ D. 
viviparus worms) was homogenized by adding 5 ml of ice cold homogenisation buffer (25 
mM TRIS, 150 mM NaCl, 5 mM EDTA, and 1% CHAPS, pH 7.4 adjusted with dilute acetic 
acid) to the sample and by activating the homogenizer for 10 seconds three times with 15 
seconds intervals on ice in between. Subsequently the homogenate was transferred to the 
SnakeSkin® pleated dialysis tubing, sealed with clips and put into the beaker with 4.5 litres of 
dialysis buffer (50 mM ammonium bicarbonate, pH 7.6) and kept for 48h at 4 degrees. Over 
that time the dialysis buffer was changed eight-ten times. 
 
2.2.3 Reduction and carboxymethylation 
A TRIS-acetate buffer, 0.6 M pH 8.5 was degassed with a stream of nitrogen for 30 minutes. 
To the dialysed and lyophilized samples 1 ml of degassed 2 mg/ml DTT in TRIS buffer 
solution was added. The reaction was incubated for 60 min at 37 ºC. The protection of 
disulphide bridges was performed by adding 1ml 12 µg/ml iodoacetic acid (IAA) in Tris 
buffer and incubating for 90min at room temperature in the dark. Then the reduced and 
carboxymethylated homogenate was transferred into the SnakeSkin® pleated dialysis tubing, 
sealed with clips and put into the beaker with 4.5 litres of dialysis buffer (50 mM ammonium 
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bicarbonate, pH 7.6) and kept for 24h at 4 ºC.. Over this period the dialysis buffer was 
changed five-six times. 
2.2.4 Trypsin digestion and subsequent (glyco)peptide purification 
To the dialysed and lyophilized sample 300 µl of 1mg/ml trypsin in 50 mM AMBIC buffer, 
pH 8.4 solution was added. The reaction was incubated at 37 ºC for 14h. The trypsin was 
deactivated by adding one drop of acetic acid to the solution. Subsequently the purification of 
(glyco)peptides using C18 chromatography was performed. An Oasis ® HLB Plus cartridge 
was attached to a 20 ml plastic syringe and conditioned successively with 5 ml of methanol, 5 
ml of 5% acetic acid, 5 ml of propan-1-ol, 15 ml of 5% acetic acid. Then the sample was 
diluted in 5 % acetic acid and loaded onto the cartridge and washed with 20 ml of 5% acetic 
acid. The bound (glyco)peptides were gradually eluted from the C18 column by passing 
successively 4 ml of 20% propan-1-ol in 5% acetic acid, 4 ml of 40% propan-1-ol in 5% 
acetic acid and 4 ml of 100% propan-1-ol. All three propanol-based eluent fractions were 
collected and their volume was reduced in a SpeedVac®. Finally three fractions were 
combined and lyophilized. 
 
2.2.5 PNGase F digestion 
The lyophilised sample was dissolved in 150 µl of 50 mM, pH 8.4 AMBIC buffer. 5 U (5 µl) 
of PNGase F enzyme solution were added and the reaction was carried out for 24 hours at 37 
ºC. About the half-way though the reaction course another 5 U (5 µl) of PNGase F enzyme 
solution was added. Then the solution was frozen and lyophilized. 
 
2.2.6 Sep-Pak separation of PNGase-F released N-glycans from remaining 
(glyco)peptides 
A Sep-Pak C18 Classic cartridge was attached to the glass syringe and washed successively 
with 5 ml of methanol, 5 ml of 5% acetic acid, 5 ml of propan-1-ol and 15 ml of 5% acetic 
acid. The sample was dissolved in 200 µl of 5% acetic acid and loaded onto the cartridge. 
Then 5ml of 5% acetic acid, 4 ml of 20 % propanol-1-ol in 5% acetic acid, 4 ml of 40 % 
propanol-1-ol in 5% acetic acid, 4 ml of 100 % propanol-1-ol were successively passed 
through the cartridge and all the fractions were collected and the volumes reduced in the 
96 
 
SpeedVac®. The N-glycans-containing 5% acetic acid fraction was then lyophilised and 
subject to exo-glycosidase treatment(s) (see section 2.2.10), HF treatment (see section 2.2.9) 
or permethylation reaction ( see section 2.2.11). The (glyco)peptides-containing 20%, 40% 
and 100% propanol fractions were combined, had their volumes reduced and were 
lyophilized prior to to PNGase A digestion. 
 
2.2.7 PNGase A digestion and subsequent N-glycan separation from remaining 
(glyco)peptides 
The combined and lyophilised 20%, 40% and 100% propanol fractions after PNGase F 
digestion (see section 2.2.6) were dissolved in 150 µl of 50 mM ammonium acetate buffer, 
pH 5.0. Then 5 mU (10 µl) of PNGase A enzyme solution were added and the reaction was 
carried out for 24 hours at 37 ºC. About half-way though the reaction course another 5 mU 
(10 µl) of PNGase A enzyme solution was added. Then the reaction was freezed and 
lyophilized. The PNGase A- released N-glycans were separated from remaining 
(glyco)peptides as described in section 2.2.6. The N-glycans-containing 5% acetic acid 
fraction was then lyophilised and subject to exo-glycosidase treatment(s) (see section 2.2.10) 
or permethylation reaction (see section 2.2.11). The (glyco)peptides-containing 20%, 40% 
and 100% propanol fractions were combined, had their volumes reduced and were 
lyophilized prior to reductive elimination as described further in section 2.2.8. 
 
2.2.8 Reductive elimination of O-glycans and their subsequent purification 
The combined and lyophilised 20%, 40% and 100% propanol fractions after PNGase A 
digestion (see section 2.2.7) were subject to reductive elimination by adding 400 µl of 1 M 
KBH4 in 0.1 M KOH solution and incubating for 16h at 45 ºC. The reaction was stopped by 
adding 5 drops of acetic acid until fizzing stopped. Then the sample was loaded onto a 
desalting column loaded with Dowex 50W-X8(H) beads which was pre-washed by passing 
15 ml of 5% acetic acid. After the sample was loaded, the column was eluted with 5 ml of 5% 
acetic acid. The desalted sample was collected and the volume reduced in the SpeedVac® and 
lyophilized. Excess of borates were removed by co-evaporation with 10% (v/v) acetic acid in 
methanol under a stream of nitrogen at room temperature. 
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2.2.9 HF treatment of PNGase F released N-glycans 
PNGase F released N-glycans were lyophilised in a plastic Eppendorf tube and subsequently 
50 µl of 48% hydrofluoric acid was added using a plastic micropipette tip. The sample was 
incubated on ice at 4 ºC for 48h. The reaction was stopped and the sample dried under a 
gentle stream of nitrogen.  
 
2.2.10 Exoglycosidase(s) treatment of N- and O-glycans  
Free glycans were dissolved in 200 µl of 50 mM sodium acetate buffer, pH 5 and 1.5 U of 
Jack bean α-mannosidase from Canavalia ensiformis (Sigma, M7257, EC 3.2.1.24) were 
added to the sample over a total incubation time of 48h at 37 ºC.  
For β1-4 specific galactosidase digestion 30 mU of Streptococcus pneumoniae enzyme 
(Sigma-Aldrich, G0413) or 32 µg of recombinant β1-4 specific galactosidase kindly provided 
by Iain Wilson, University of Natural resources and Life Sciences, Vienna were added to the 
sample and incubated for 30h at 37 ºC in 50 mM ammonium acetate buffer, pH 5.75. 
For α-galactosidase digestion total of 5 U of Glyko® α(1-3,4,6)-galactosidase from green 
coffee bean (Prozyme, GKX-5007) were added to the sample over 48h and incubated at 37 ºC 
in 50 mM ammonium acetate buffer, pH 6.0. 
For broad specificity β- galactosidase Digestion- total of 0.5 U of Glyko® β(1-3,4)-
galactosidase from bovine testes (Prozyme, GKX-5013) were added to the sample over 48h 
and incubated at 37 ºC in 50 mM ammonium acetate buffer, pH 4.6.  
For β1-3, 6 galactosidase digestion total of 0.2 U of of Glyko® β(1-3,6)-galactosidase 
(recombinant from Xanthomonas manihotis, expressed in E.coli,; Prozyme, GK80120) were 
added to the sample over 48h and incubated at 37 ºC in 50 mM ammonium acetate buffer, pH 
5.0. 
Finally the N- or O- glycans were separated from the added enzyme by the Sep-Pak C18 
chromatography as described in the section 2.2.6. 
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2.2.11 Permethylation procedure with subsequent glycan purification 
5 pellets of sodium hydroxide per sample were ground in a dry mortar with pestle. 2 ml of 
dimethylsulphoxide (DMSO) were added to the ground powder and the slurry transferred to a 
glass tube containing N- or O-glycans. Subsequently 0.6 ml of methyl iodide were added and 
the sample was agitated for 20 min at room temperature. The reaction was terminated by the 
addition of few ml of ultra-pure water until the fizzing stopped. Then 1 ml of chloroform was 
added to the sample and the chloroform layer was washed three times with 3-4 ml of 
ultrapure water. After extraction the chloroform layer was dried under the nitrogen and re-
dissolved in 200 µl of 50%/50% methanol/water solution.  
A Sep-Pak C18 Classic cartridge was attached to a glass syringe and sequentially washed 
with 5 ml of methanol, 5 ml of water, 5 ml of acetonitrile and 15 ml of water. To purify the 
permethylated glycans the re-dissolved sample was loaded onto the cartridge and the column 
was washed with 5 ml of water. The bound permethylated glycans were sequentially eluted 
with 15%, 35%, 50%, 75% acetonitrile in water solutions. The volume of the fractions was 
reduced in a SpeedVac® with the subsequent freezing and lyophilisation of the sample for 
glycomics analysis (see next section 2.2.12). All fractions were collected however usually the 
glycans were detected in the 35% and 50% acetonitrile fractions. 
 
2.2.12 MS analysis 
The lyophilised permethylated glycans were dissolved in 10 µl of methanol. 1 µl of the 
solution was then mixed with 1 µl of 10mg/ml DHB in 70% (v/v) methanol-water solution 
for ABI Voyager-DE STR MALDI-TOF analysis. For the AB 4800 MALDI-TOF-TOF and 
AXIMA Resonance MALDI-QIT-TOF instrument (Kratos, Shimadzu, Manchester) 
instruments 1 µl of the sample solution was mixed with 1 µl of the 20 mg/ml DABP in 75% 
(v/v) acetonitrile-water solution. The mixture was then spotted onto the MALDI-plate and 
dried at room temperature. Usually for MALDI-MS experiments ABI Voyager-DE STR 
MALDI-TOF and AB 4800 MALDI-TOF-TOF were used and most of the MALDI-TOF-
TOF experiments were performed by the AB 4800 MALDI-TOF-TOF instrument. The MSn 
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experiments were performed on a AXIMA Resonance MALDI-QIT-TOF instrument (Kratos, 
Shimadzu, Manchester, courtesy of Dr. Roberto Castangia). All mass spectra were acquired 
in the positive ion mode. 
2.2.13 Sample preparation for GC-MS linkage analysis 
After MALDI analyses the permethylated samples were hydrolysed by adding 200 µl 2 M 
trifluoroacetic acid (TFA) and incubating for 2h at 121 ºC. Subsequently into a cooled and 
nitrogen-dried sample 200 µl of 10 mg/mL NaBD4 in 2 M NH4OH solution was added and 
the reaction was carried out for 2h at room temperature. The reaction was terminated by 
adding 5 drops of acetic acid and allowing it to dry (not completely) under a stream of 
nitrogen. The excess of borates was removed by co-evaporation with 10% (v/v) acetic acid in 
methanol under a stream of nitrogen. Then 200 µl of acetic anhydride was added and 
incubated for 1h at 100 ºC with subsequent drying under a stream of nitrogen. The sample 
was then purified by adding 1 mL of chloroform and washed three times with a few ml of 
water discarding the upper water layer. Subsequently the remaining chloroform was dried 
down under a stream of nitrogen. The resultant partially methylated alditol acetates (PMAA) 
were dissolved in 5-50 µl of hexane and injected manually into Bruker SCION SQ 456-GC or 
PERKIN Elmer Clarus 500 instruments. 
 
2.2.14 Data reproducibility  
MALDI analyses of PNGase F, PNGase A released N-glycans, reductively eliminated O-
glycans of adult and L3 stage H. contortus were repeated three times (except PNGase F 
released adult N-glycans 50 % acetonitrile fraction which was analysed twice). β1-4 specific 
glycosidase digestions on PNGase-F and PNGase- A released adult H. contortus N-glycans 
were repeated twice. Hydrofluoric acid treatment (HF) on PNGase F released adult H. 
contortus N-glycans was performed twice. The rest of the experiments for Chapter 3 were 
performed once. 
MALDI analyses of adult D. viviparus O-glycans were performed two times. MALDI 
analyses of PNGase F released L3 stage D. viviparus N-glycans were performed twice. 
Reductively eliminated L3 stage D. viviparus O-glycans were analysed three times. The rest 
of the experiments for Chapter 4 were performed once. 
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For calculations of the mean relative abundance value, the formula: mean = (RAs1 + RAs2 
+RAs3)/3 was used where RA stands for relative abundance; s1, s2, s3 stands for samples 
one, two and three. For variance calculations the formula: variance = ((RAs1-mean)^2 + 
(RAs2-mean)^2 + (RAs3-mean)^2)/3 was used. For standard deviation (SD) calculations the 
formula: SD=√variance was used. For standard error of the mean (SEM) the formula: 
SEM=SD/√3 was used. 
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Chapter 3 
 
Structural characterization of  
Haemonchus contortus N- and O-glycomes 
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3.1 Introduction 
As introduced in section 1.1, Haemonchus contortus is an economically important 
gastrointestinal parasite infecting small ruminants such as goats and sheep. By feeding on 
animal blood the parasite causes anaemia, weight loss, reduction in milk production and 
occasional death of the host thus causing huge economic losses worldwide. Current control 
methods, anthelmintics are often failing due to increased resistance worldwide including the 
new anthelmintic class aminoacetonitrile derivatives (Scott et al., 2013).For this reason an 
alternative control strategy is urgently needed and the development of an effective and cheap 
vaccine is desired. Early immunization studies showed native excretory/secretory (ES) and 
gut-derived glycoproteins to be promising vaccine candidates. However, all attempts to create 
a recombinant glycoprotein vaccine to date have failed (Knox et al., 2003; Roberts et al., 
2013). An alternative solution is the development of a carbohydrate-based vaccine 
(Astronomo and Burton, 2010). However, one of the bottlenecks in their development is the 
limited number of well-defined carbohydrate structures available from the parasite. 
As discussed in section 1.2.3 in 1996 Haslam and colleagues performed the most rigorous 
structural studies on H. contortus N-glycans using FAB-MS instrumentation (Haslam et al., 
1996). They revealed the previously unseen distal GlcNAc core fucosylation at the 3-position 
(Haslam et al., 1996). Interestingly this chitobiose core modification was not detected in the 
L3 stage (Haslam et al., 1998). In addition other structural features were revealed such as 
fucosylation of proximal GlcNAc at the 3-and 6- positions, presence of GalNAcβ1–4GlcNAc 
(LDN), GalNAcβ1–4(Fuc α1–3)GlcNAc (LDNF) antennae and high mannose structures. The 
presence of LDNF structure was also proposed by other researchers based on antibody 
response to H. contortus infection and Western Blot and glycan array studies (Geldhof et al., 
2005; van Stijn et al., 2010b; Vervelde et al., 2003). In addition one of the groups proposed 
the Galα1-3GalNAc epitope based on Western blot glycan array studies using antibodies 
from sheep immunized with H. contortus ES products (van Stijn et al., 2010b). No structural 
data of O-glycans for either adult or L3 stage H. contortus has been reported to date. 
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As discussed in section 1.3, since the original studies on H. contortus N-glycans in 1996 
(Haslam et al., 1996) the FAB-MS instrumentation has been largely superseded by the 
instruments with MALDI ionisation (Karas, Bachmann et al. 1985) which offers better signal 
to noise-ratio and higher sensitivity above m/z 3000 rendering the detection of minor 
structures more feasible (Dell and Morris, 2001). The superiority of MALDI-MS over FAB-
MS instruments has been elegantly demonstrated by Babu and colleagues (Babu, North et al. 
2009) and North and colleagues (North et al., 2010a) who reported previously unseen 
Chinese Hamster Ovary cell N-glycans up to m/z 13000 demonstrating the ultra-sensitivity of 
MALDI instrument at higher molecular weight. 
In the studies described in this chapter my objective was to utilize next-generation MALDI-
TOF-TOF and MALDI-QIT-TOF-based techniques to revisit the N-glycomes of adult and L3 
stage H. contortus. Since no O-glycans data has been reported to date, in addition the O-
glycomes of adult and L3 stage have also been characterised using the same MALDI-MS 
technologies aiming to discover new glycan structures which can be potentially used for 
carbohydrate-based vaccine development against this parasite. 
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3.2 Structural characterization of the N-glycome of adult H. 
contortus 
3.2.1 MALDI-MS analysis of permethylated PNGase F released N-glycans from adult H. 
contortus 
In order to investigate the N-glycome of H. contortus by using MALDI-TOF MS 
instrumentation the glycoproteins extracted from adult worms were subjected to PNGase F 
digestion and the released N-glycans were permethylated. N-glycans were recovered in both 
the 35% acetonitrile and 50 % acetonitrile C18 chromatography fractions. The first one 
contained the largest diversity of N-glycans as seen in the Figure 30, top and Table 3 
whereas the 50% acetonitrile fraction was mainly predominated by abundant Hex5-9HexNAc2 
high-mannose structures as seen in the Figure 30, bottom and Table 4. The most abundant 
group of N-glycans observed in the MALDI-MS spectrum from the 35% acetonitrile shown 
in Figure 30, top and Table 3 are paucimannose (or truncated) structures with or without 
fucose and having the general composition of Hex2-4Fuc0-2HexNAc2. The second less 
abundant group of N-glycans corresponds to complex structures with or without fucose and 
general composition of Hex2-4Fuc0-2HexNAc3-5. Most of the molecular ion peaks except those 
at m/z 1386, 1590, 1661, 1906, 2039, 2254 were observed earlier using the FAB-MS 
technology (Haslam et al., 1996). At this point it has to be emphasized that the MALDI-TOF 
MS data provides the compositional data only and in order to obtain more structural 
information MALDI-TOF-TOF fragmentations of molecular ions at m/z 1141, 1315, 1345, 
1386, 1416, 1519, 1549, 1590, 1661, 1835, 2009, 2039, 2213 seen in the Figure 30 were 
performed. 
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Fig.30 MALDI MS spectra of PNGase F released adult H. controtus N-glycans                                                                 
The 35% acetonitrile fraction is at top and 50% acetonitrile fraction is at the bottom. The 
structures marked with asterisk* were later subject to MALDI-TOF-TOF analyses. The blue 
dashed lines denote the positions of the minor peaks. The higher molecular weight region of 
the upper spectrum marked with the black horizontal line has been magnified vertically 12 
times. It is important to note that MALDI-TOF-MS experiments provide compositional data 
only shown in Tables 3 and 4 and the proposed structures are based on other experiments 
described further in the chapter. 
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m/z    
value 
composition RA s1 RA s2 RA s3 Mean Variance SD SEM 
967 HexNAc2Hex2 0.24 0.16 0.40 0.27 0.0099 0.099 0.058 
1141 HexNAc2Hex2Fuc1 0.58 0.36 0.52 0.49 0.0086 0.092 0.054 
1171 HexNAc2Hex3 0.90 0.78 1 0.89 0.0081 0.089 0.052 
1315 HexNAc2Hex2Fuc2 0.26  0.15 0.10 0.17 0.0045 0.066 0.039 
1345 HexNAc2Hex3Fuc2 1 1 0.96 0.99 0.00036 0.018 0.011 
1375 HexNAc2Hex4 0.32 0.24 0.24 0.27 0.0014 0.037 0.022 
1386 HexNAc3Hex2Fuc1 0.025  0.026 0.022 0.024 2.8E-06 0.0017 0.0010 
1416 HexNAc3Hex3 0.098 0.073 0.12 0.097 0.00037 0.019 0.011 
1519 HexNAc2Hex3Fuc2 0.17  0.11 0.066 0.12 0.0018 0.042 0.025 
1549 HexNAc2Hex4Fuc1 0.099  0.07 0.037 0.069 0.00064 0.025 0.015 
1579 HexNAc2Hex5 0.74  0.68 0.22 0.55 0.054 0.23 0.13 
1590 HexNAc3Hex3Fuc1 0.064  0.049 0.054 0.056 3.8E-05 0.0062 0.0036 
1661 HexNAc4Hex3 0.037  0.032 0.022 0.030 3.8E-05 0.0062 0.0036 
1783 HexNAc2Hex6 0.037  0.033 0.011 0.027 0.00013 0.011 0.0066 
1835 HexNAc4Hex3Fuc1 0.039 0.034 0.017 0.030 8.8E-05 0.0094 0.0054 
1906 HexNAc5Hex3 0.0041 0.0084 0.0046 0.0057 3.7E-06 0.0019 0.0011 
2009 HexNAc4Hex3Fuc2 0.024  0.023 0.0046 0.017 8.0E-05 0.0089 0.0051 
2039 HexNAc4Hex4Fuc1 0.0073  0.011 0.0046 0.0076 6.9E-06 0.0026 0.0015 
2080 HexNAc5Hex3Fuc1 0.0032 0.0084 N/D N/A N/A N/A N/A 
2213 HexNAc4Hex4Fuc2 0.0067  0.012 N/D N/A N/A N/A N/A 
2254 HexNAc5Hex3Fuc2 0.0028 0.0063 N/D N/A N/A N/A N/A 
Table 3. Assignment and quantification of PNGase F released adult H. controtus N-glycans                             
The molecular ions were observed in 35% acetonitrile MALDI-TOF-MS spectrum shown in 
Figure 30, top. The relative abundance (RA) was calculated by measuring the total ion count 
(TIC) of each peak and dividing the value by the TIC of the most abundant peak. RA-relative 
abundance, SD- standard deviation, SEM- standard error of the mean, N/D- not detected, 
N/A- non applicable, s- sample. For formulas and calculations of the mean, variance, SD, 
SEM see section ‘2.2.14’. 
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m/z value composition RA s1 RA s2 
1141 HexNAc2Hex2Fuc1 0.017 N/D 
1171 HexNAc2Hex3 0.042 0.084 
1315 HexNAc2Hex2Fuc2 0.058 0.074 
1345 HexNAc2Hex3Fuc2 0.59 0.34 
1375 HexNAc2Hex4 0.14 0.14 
1416 HexNAc3Hex3 0.0039 N/D 
1519 HexNAc2Hex3Fuc2 0.70 0.26 
1549 HexNAc2Hex4Fuc1 0.041 0.057 
1579 HexNAc2Hex5 1 1 
1590 HexNAc3Hex3Fuc1 0.023 N/D 
1783 HexNAc2Hex6 0.48 0.32 
1835 HexNAc4Hex3Fuc1 0.011 0.032 
1987 HexNAc2Hex7 0.52 0.32 
2009 HexNAc4Hex3Fuc2 0.011 N/D 
2191 HexNAc2Hex8 0.52 0.25 
2213 HexNAc4Hex4Fuc2 0.038 0.030 
2395 HexNAc5Hex3Fuc2 0.26 0.13 
Table 4. Assignment and quantification of PNGase F released adult H. controtus N-glycans                             
The molecular ions were observed in 50% acetonitrile MALDI-TOF-MS spectrum shown in 
Figure 30, bottom. The relative abundance (RA) was calculated by measuring the total ion 
count (TIC) of each peak and dividing the value by the TIC of the most abundant peak. RA 
stands for relative abundance, N/D for not detected, s for sample.  
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3.2.2 GC-MS linkage analysis of oligosaccharides released by PNGase F 
Elution 
time 
Characteristic fragment ions Assignment Relative abundance 
12.81 115,118,131,162,175 Terminal fucose 0.47 
13.80 118, 143, 203 4-linked fucose 0.01 
14.03 87, 89, 115, 130, 131, 175, 190 2-linked fucose 0.01 
14.28 102,118,129,162,161, 205 Terminal mannose 1.00 
14.52 102,118,129,162,161, 205 Terminal galactose 0.12 
15.36 129, 130, 161, 190 2-linked mannose 0.25 
15.56  101, 118, 129, 161, 234 3-linked mannose 0.11 
15.76 102, 118, 129, 189, 233 6-linked mannose 0.04 
16.87 129, 130, 189, 190 2,6-linked mannose 0.01 
17.08 118, 129, 189, 234 3,6-linked mannose 0.57 
17.74 117, 159, 205 Terminal GlcNAc 0.04 
18.25 117, 159, 205 Terminal GalNAc 0.04 
18.63 117, 159, 233 4-linked GlcNAc  0.46 
19.45 117, 159 3,4-linked GlcNAc 0.03 
19.92 117, 159, 261 4,6-linked GlcNAc 0.05 
Table 5. GC-MS analysis of partially methylated alditol acetates obtained from H. contortus 
N-glycans released by PNGase F. The relative abundance was calculated by measuring the 
total ion count (TIC) of each peak and dividing the value by the TIC of the most abundant 
peak. 
 
The GC-MS linkage data analyses from PNGase F released N-glycans are summarized in 
Table 5. The elution peaks at 14.52 and 13.80 show the presence of terminal galactose and 4-
linked fucose in H. contortus supporting the presence of the Galβ1-4Fuc moiety (see sections 
3.2.3, 3.2.4 and 3.2.7). The presence of 2-linked fucose is consistent with the proposed 
Galα1-2Fuc structure 3-linked to distal GlcNAc (see sections 3.2.13 and 3.2.15) and the 
novel modified LDNF structure where αGal is 2-linked to fucose (see section 3.2.9) . The 
presence of terminal, 3-linked, 6-linked, 2-linked, 3, 6-linked mannoses are consistent with 
the presence of paucimannosidic and high mannose structures. The 2, 6-linked and 2-linked 
mannoses suggest the potential attachment sites for non-reducing end GlcNAcs in complex or 
hybrid glycans whose presence is also supported by the terminal GlcNAc. 4-linked GlcNAc 
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is consistent with the distal chitobiose core GlcNAc as well as the LDN structure (see section 
3.2.8). The presence of 3, 4-linked GlcNAc agrees with fucosylation at the 3-position of the 
chitobiose core distal GlcNAc as well as LDNF structures (see section 3.2.8). 4, 6-linked 
GlcNAcitol is consistent with fucosylation of reducing-end GlcNAc at 6-position in PNGase-
F released N-glycans. The presence of terminal GalNAc supports the presence of LDN and 
Galα1-2Fuc-modified LDN structures (see sections 3.2.8 and 3.2.9, respectively). 
 
3.2.3 MALDI-MS/MS analysis of permethylated PNGase-F released N-glycans  
GlcNAc,mannose,hexose, fucose,
1549 
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Figure 31 MALDI-TOF-TOF MS/MS spectrum of permethylated PNGase F released m/z 
1549 from adult H. contortus N-glycan. The blue arrowed horizontal lines represent the loss 
of indicated structural fragments from the parental molecular ion. . The upper case ‘M’ 
indicates the major isomer, the lower case- ‘m’ minor isomer.  
 
Exemplar MS/MS data are described for the molecular ion at m/z 1549 with the composition 
of Fuc1Hex4HexNAc2 (see Figure 31). Unexpectedly the most abundant fragment ions at m/z 
894 and 678 showed the presence of the Hex-Fuc structure attached to the Asn-linked 
proximal GlcNAc. This chitobiose core modification was not previously detected by the 
FAB-MS instrumentation (Haslam et al., 1996). In addition no peak at m/z 1139 was 
observed, which would correspond to the Z-type rather than Y-type loss (Domon, Costello et 
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al. 1988) of a Hex-Fuc structure, which is favourable when fucose is 3-linked to the HexNAc. 
The non-reducing end of this structural isomer consisting of three hexoses, most likely 
mannoses based on a previous publication (Haslam et al., 1996), is supported by the fragment 
ion at m/z 667. All these data therefore suggest that the Asn-linked GlcNAc is modified at the 
6-position with the Hex-Fuc structure which has not previously been observed in H. 
contortus. In addition the fragment ions at m/z 474 and 1098 correspond to the fucosylated 
proximal GlcNAc. Together with the fragment ion at m/z 871 corresponding to the four non-
reducing end hexoses, these fragment ions indicate that the minor structural isomer with all 
four hexoses is at the non-reducing end of the glycan, as would have been predicted from 
previous analysis of H. contortus N-glycosylation (Haslam et al., 1996). The Hex-Fuc 
modification of the proximal GlcNAc was also observed upon the MALDI-TOF-TOF 
MS/MS fragmentation of the N-glycans at m/z 1519, 1549 and 2213. 
 
3.2.4 MALDI-QIT-TOF MS 3analysis of permethylated PNGase F released N-glycan 
Figure 32 MALDI-QIT-TOF MS3 spectrum of m/z 678 fragment ions from permethylated, 
PNGase F released m/z 1549 N-glycan. Dashed arrowed lines on the proposed structure 
represent glycosidic bond cleavages and cross-ring fragments.  
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To obtain additional linkage information about the novel Hex-Fuc structure the fragment ion 
at m/z 678 from the permethylated PNGase F released m/z 1549 N-glycan (see Figure 31 ) 
was subject to MS3 analysis on a MALDI-QIT-TOF instrument (see Figure 32). The 
fragment ions at m/z 241, 460 and 259 confirmed the presence of a terminal hexose and 
fragment ions at m/z 433 and 286- internally linked fucose. The cross-ring fragments at m/z 
299 and 342 indicated that the hexose is 4-linked to the fucose. The cross-ring fragments at 
m/z 475, 489 and 505 once again confirmed that the Hex-Fuc structure is 6-linked to the Asn-
linked GlcNAc.  
 
3.2.5 MALDI-MS analysis of permethylated PNGase F released, α-mannosidase 
digested N-glycans  
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Figure 33 MALDI-TOF MS spectrum of permethylated, α-mannosidase digested N-glycans 
released from the H. contortus adult parasite by PNGase F enzyme (35% acetonitrile 
fraction). The structures proposed are based on further MALDI-TOF-TOF MS/MS 
fragmentations (fragmented peaks are marked with an asterisk*), previous publication 
(Haslam et al., 1996) and the knowledge of biosynthetic pathways in other organisms.  
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An α-mannosidase digest was performed on PNGase F released N-glycans to trim the α-
mannose residues on the non-reducing end of the N-glycans, thus reducing the structural 
heterogeneity (see Figure 33). The spectrum is dominated by molecular ions at m/z 763-
HexHexNAc2, m/z 937-Fuc1HexHexNAc2, m/z 967-Hex2HexNAc2, m/z 1141-
Fuc1Hex2HexNAc2 and m/z 1171-Hex3HexNAc2. Di-fucosylated molecular ions were also 
observed at m/z 1315- Fuc2Hex2HexNAc2, m/z 1560-Fuc2Hex2HexNAc3 and m/z 2010-
Fuc2Hex3HexNAc4.  
The remaining Hex-Fuc chitobiose core modifications seen after the MALDI-TOF-TOF 
MS/MS analyses (for MS/MS of m/z 1141 and 1315 peaks see Figures 35 A) and 36 A)) also 
diminish the likelihood of them being Man-Fuc structures as seen in the opportunistic 
amoebal parasite Acanthamoeba (Schiller et al., 2012). 
 
3.2.6 The β1-4 specific galactosidase treatment coupled with MALDI-MS analysis of 
permethylated PNGase F released, α-mannosidase digested N-glycans 
The PNGase F released, α-mannosidase digested N-glycans were subject to β1-4 specific 
galactosidase digest in order to define the hexoses in Hex-Fuc structure with the resultant 
MALDI-TOF MS spectrum seen in the Figure 34. As seen by the relative abundance of 
molecular ion peaks alone, initial MALDI-MS comparison did not reveal any significant 
changes when compared to the MS spectrum of PNGase F released, α-mannosidase digested, 
N-glycans. This can be explained by the presence of several structural isomers constituting 
the MALDI-MS molecular ion peaks. For this reason MALDI-TOF-TOF MS/MS analysis 
was undertaken to compare molecular ions before and after exoglycosidase digestion. 
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Figure 34 MALDI-TOF MS spectra of permethylated, α-mannosidase digested N-glycans 
released from the H. contortus adult parasite by PNGase F enzyme (35% acetonitrile fraction) 
prior (top) and after (bottom) the β1-4 galactosidase digestion. ‘m’ denotes the minor isomer 
present. The structures proposed are based on further MALDI-TOF-TOF MS/MS 
fragmentations (fragmented peaks are marked with an asterisk*), previous publication 
(Haslam et al., 1996) and the knowledge of biosynthetic pathways in other organisms.  
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3.2.7 The β1-4 specific galactosidase treatment coupled with MALDI-MS-MS analysis of 
permethylated PNGase F released, α-mannosidase digested N-glycans 
The MALDI-TOF-TOF MS/MS analysis of the m/z 1315 molecular ion prior to enzymatic 
treatment revealed the presence of two structural isomers as annotated in Figure 35 A) where 
the Hex-Fuc structure is linked either to the 3-position of the internal GlcNAc or the 6-
position of the Asn-linked GlcNAc residues. The first structural isomer is best represented by 
the fragment ions at m/z 474 and 864 corresponding to the fucosylated proximal GlcNAc and 
its loss from the molecular ion. This structural isomer is also supported by the ‘Z-type’ 
(Domon, Costello 1988) fragment ion at m/z 905 indicating the elimination, not cleavage of 
the Hex-Fuc structure confirming it being 3-linked. The second structural isomer is best 
represented by the fragment ions at m/z 678 and 660 corresponding to the Hex-Fuc modified 
proximal GlcNAc structure and its loss from the molecular ion. This structure is also 
supported by the abundant Z-type’ (Domon, Costello 1988) fragment ion at m/z 1109 
corresponding to the elimination of the fucose 3-linked to the distal GlcNAc. 
Upon β1-4 specific galactosidase treatment as seen in Figure 35 B) we observe the virtually 
complete disappearance of the fragment ions at m/z 660 and 678 suggesting the 
disappearance of the structural isomer bearing Hex-Fuc unit 6-linked to the Asn-linked 
GlcNAc residue (seen on the right in Figure 35 A)). These results are also supported by the 
disappearance of the fragment ion at m/z 1109 suggesting no fucose linked to the 3-position 
of the GlcNAc present in the molecular ion. All these data put together define the presence of 
Galβ1-4-Fuc 6-linked to the Asn-linked GlcNAc residue. 
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Figure 35 MALDI-TOF-TOF MS/MS spectra of  permethylated PNGase F released, α-
mannosidase trimmed m/z 1315 N-glycan (top) and permethylated PNGase F released, α-
mannosidase and subsequently β1-4 specific galactosidase trimmed m/z 1315 N-glycan 
(bottom). The blue arrowed horizontal lines represent the loss of indicated structural 
fragments from the parental molecular ion.  
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The exemplar MALDI-TOF-TOF MS/MS is also shown for the molecular ions at m/z 1141 
prior and after the β1-4 specific galactosidase digestion. After the α-mannosidase digestion 
alone three structural isomers represent the molecular ion at m/z 1141 as seen in the Figure 
36 A). The first structural isomer has the Hex-Fuc structure on the 3-position of the distal 
GlcNAc (see Figure 36 A) top left) and is best represented by the ‘Z- type’ (Domon, Costello 
1988) fragment ions at m/z 864 and 731 corresponding to the eliminations of the proximal 
GlcNAc and Hex-Fuc structures respectively. The second structural isomer is core 
fucosylated on the 6-position of the proximal GlcNAc (see Figure 36 A) top right). Its 
presence is supported by the fragment ions at m/z 474, 690 and 463. The third structural 
isomer has the Hex-Fuc modification on the 6-posistion of the proximal GlcNAc (see Figure 
36 A) bottom left) and is best represented by the fragment ions at m/z 678 and 486 
corresponding to the Hex-Fuc-GlcNAc fragment ion and its loss from the parental molecular 
ion. 
Upon the β1-4 specific galactosidase treatment (see Figure 36 B)) the disappearance of 
fragment ions at m/z 678 and 486 was observed. These results indicate the disappearance of 
the third structural isomer with the Hex-Fuc proximal GlcNAc modification thus confirming 
this structure having the Galβ1-4Fuc modification of the proximal GlcNAc. 
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Figure 36 MALDI-TOF-TOF MS/MS spectra of permethylated PNGase F released, α-
mannosidase trimmed m/z 1141 N-glycan (top) and permethylated PNGase F released, α-
mannosidase and subsequently β1-4 specific galactosidase trimmed m/z 1141 N-glycan 
(bottom). The blue arrowed horizontal lines represent the loss of indicated structural 
fragments from the parental molecular ion.  
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3.2.8 MALDI-MS-MS analyses of permethylated PNGase F released m/z 1661, 2010 N-
glycans 
967
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676
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953
1157
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HO 1384
HO
MS/MS of m/z 1661  
HC adult PNGase-F 35% acn
GlcNAc,mannose, GalNAc
Figure 37 MALDI-TOF-TOF MS/MS spectrum of permethylated PNGase F released m/z 
1661 adult H. contortus N-glycan. The blue horizontal arrowed lines represent the loss of 
depicted fragments from the parental molecular ion. 
 
To investigate whether two non-reducing end HexNAc’s of the molecular ion at m/z 1661are 
joined together forming putative LDN antennae or form two separate putative terminal 
GlcNAc’s, this molecular ion was subjected to MALDI-TOF-TOF analysis. Due to the low 
abundance of the molecular ion, the spectrum seen in the Figure 37 is not of high quality and 
not all of the expected fragment ions are observed. On the other hand the fragment ions at m/z 
527 and 1157 compositionally match the LDN structure. The fragment ion at m/z 953 
corresponding to the loss of putative  GalNAc-GlcNAc-Man together with the fragment ion 
at m/z 676 corresponding to the additional loss of reducing-end GlcNAc confirm the 
proposed non-reducing end GalNAc-GlcNAc structure. The fragment ions at m/z 1384 and 
1402 represent the loss of reducing-end GlcNAc and non-reducing end GalNAc accordingly 
and are consistent with the proposed structure seen in the Figure 37. Although MALDI-TOF-
TOF data cannot distinguish different HexNAc’s, the presence of the terminal GalNAc and 4-
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linked GlcNAc seen in the GC-MS data (see section 3.2.2) makes HexNAc-HexNAc 
structure observed very likely to be LDN. 
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Figure 38 MALDI-TOF-TOF MS/MS spectrum of permethylated PNGase F released m/z 
2010 adult H. contortus N-glycan. The blue horizontal arrowed lines represent the loss of 
depicted fragment(s) from the parental molecular ion. 
 
To investigate whether the molecular ion at m/z 2010 contains both fucoses on the chitobiose 
core or is fucosylated on the non-reducing end antennae, the MALDI-TOF-TOF analysis of 
this molecular ion was performed as seen in the Figure 38. As in the case of the previously 
described m/z 1661 molecular ion, due to low abundance of the parental ion, the spectrum 
produced is not of the highest quality. On the other hand the abundant fragment ions at m/z 
701 and 1332 correspond to HexNAc2Fuc fragment ion and its loss from the molecular ion 
respectively. The fragment ion at m/z 1751 corresponds to the loss of the non-reducing end 
HexNAc. Together these data suggest the presence of the HexNAc-(Fuc)HexNAc non-
reducing end antennae where fucose is linked to the innermost HexNAc. Together with the 
presence of the terminal GalNAc and 3, 4-linked GlcNAc observed in the GC-MS experiment 
(see section 3.2.2), these data strongly suggest the presence of the LDNF structure. The 
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fragment ions at m/z 474 and 1559 correspond to the fucosylated reducing-end GlcNAc and 
its loss, respectively and are consistent with the proximal GlcNAc fucosylation at 6-position 
as seen in the proposed structure in the Figure 38. 
 
3.2.9 MALDI-QIT-TOF MSn analyses of permethylated PNGase F released m/z 2213 N-
glycan 
Figure 39 MALDI-QIT-TOF MS2 spectrum of permethylated PNGase F released m/z 2213 
N-glycan. The blue horizontal arrowed lines represent the loss of depicted fragments from the 
parental molecular ion. 
.  
In order to get more structural information about the higher molecular weight structures the 
permethylated PNGase F released N-glycan at m/z 2213 was subject to MALDI-QIT-TOF 
MS2 analysis (see Figure 39) and indicated the presence of two structural isomers. One of 
them has HexNAc2Fuc non-reducing terminus antenna as indicated by the fragment ions at 
m/z 701 and 1535. The presence of Z-type, not Y-type loss (Domon, Costello et al. 1988) of 
fucose with resulting fragment ion at m/z 2007 indicates fucose being 3-linked suggesting the 
presence of fucosylated LacdiNAc. The proposed fucosylated LacdiNAc structure is also 
supported by the presence of the terminal GalNAc and 3,4-linked GlcNAc as seen in the GC-
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MS linkage analysis (see section 2.2.2) although the latter structure is also coming from the 
3-linked chitobiose core distal GlcNAc.  
The MALDI-QIT-TOF MS2 analysis of m/z 2213 N-glycan also revealed the presence of a 
structural isomer bearing the non-reducing terminal antenna with a composition of 
HexNAc2FucHex as seen by fragment ions at m/z 905 and 1331 (see Figure 39). The Z type 
fragment ion (Domon, Costello et al. 1988) at m/z 1803 suggests the presence of 3-linked 
Hex-Fuc epitope. The absence of the structural isomer having Hex-Fuc 3-linked to core 
GlcNAc suggests the presence of 3-linked Hex-Fuc within m/z 905 HexNAc2FucHex non-
reducing terminus antenna. The fragment ion at m/z 905 has been also observed in PNGase F 
released 50% acetonitrile fraction N-glycan molecular ions at m/z 2040, 2419, 2459 (data not 
shown).  
Figure 40 MALDI-QIT-TOF MS3 spectrum of m/z 905 fragment ions from permethylated 
PNGase F released m/z 2213 N-glycan. Dashed arrowed lines on the proposed structures 
represent glycosidic bond cleavages and cross-ring fragments.  
 
To get more structural information, and to confirm the presence of the Hex-Fuc structure in 
the HexNAc2FucHex fragment ion, the fragment ion at m/z 905 was further fragmented by 
the MALDI-QIT-TOF MS3 analysis as seen in the Figure 40. The fragment ions at m/z 433 
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and 415 confirmed the presence of Hex-Fuc structure. The fragment ions at m/z 282, 300 and 
646 indicate that the Hex-Fuc structure is attached to the innermost HexNAc of the 
HexNAc2FucHex fragment at m/z 905.  
 
Figure 41 MALDI-QIT-TOF MS4 spectrum of m/z 433 fragment ion generated from 
precursor fragment ion m/z 905. The latter was obtained from permethylated PNGase F 
released m/z 2213 N-glycan. Dashed arrowed lines on the proposed structures represent 
glycosidic bond cleavages and cross-ring fragments.  
 
To get the potential Hex-Fuc linkage information the fragment ion at m/z 433 was further 
disassembled by MALDI-QIT-TOF MS4 analysis (see Figure 41). The fragment ions at m/z 
215, 241 and 259 indicate the presence of terminal hexose. The cross-ring fragments at m/z 
301, 315, 343 suggest the hexose is 2-linked to the internal fucose, thus consistent with the 
previously unseen modified LDNF structure were fucose is capped at 2-position with hexose. 
The hexose is assumed to be the galactose monosaccharide based on the presence of the 
Galα1-2Fuc structures in other N-glycans and O-glycans of the H. contortus as will be 
described later in sections 3.2.15 and 3.3.4 respectively.  
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3.2.10 The summary of N-glycan structures released by PNGase F from adult H. 
contortus  
Putting all the data together acquired so far in the thesis about PNGase F released N-glycans 
from adult H. contortus, the proposed structures with the corresponding m/z values can be 
seen below in the Table 6. The linkages for the proposed Gal-Fuc structures, the major focus 
of the section 3.2 have been denoted in the structures as well. 
 
m/z value Proposed structure  
967 
 
1141 
 
1171 
 
1315 
 
1345 
α
1-
2
 
1375 
 
1386 
 
1416 
 
1519 
ß
1-
4
α1
-2
 
1549 
ß1
-4
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1579 
 
1590 
 
1661 
 
1783 
 
1835 
 
1906 
 
1987 
 
2009 
 
2039 
 
2080 
 
2191 
 
2213 
α 1
-2
ß1
-4
 
2254 
 
2395 
 
Table 6 showing the proposed N-glycan structures released by PNGase F from adult H. 
contortus. 
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3.2.11 MALDI-MS analysis of permethylated PNGase A released N-glycans from adult 
H. contortus 
N-glycans resistant to digestion with PNGase F were subjected to PNGase A digestion. This 
enzyme, in contrast to PNGase F, cleaves N-glycans bearing a 3-linked fucose attached to the 
Asn-linked GlcNAc residue. The MALDI-MS spectra from 35% and 50% acetonitrile 
fraction shown in Figure 42 revealed that the major family of N-glycans corresponds to 
heavily fucosylated paucimannose structures with the general composition of Hex2-4Fuc1-
3HexNAc2. Paucimannosidic and high mannose structures with general composition Hex3-
9HexNAc2 are also observed due to their incomplete removal by the PNGase F enzyme.  
The MALDI-TOF MS spectrum in Figure 42 and Tables 7 and 8 display proposed structures 
based on further MS/MS analyses. Thus detailed MALDI-TOF-TOF MS/MS analyses of 
peaks at m/z 1315, 1345, 1489, 1519, 1723, 1897 have been performed. The exemplary data 
for the peaks at m/z 1693 and 1519 will be described in the following sections 3.2.13, 3.2.1 
and 3.2.15. 
 
 
 
126 
 
1345*
1489*
1519*
1693*
1723*
1897*
1315*
1375
1579
1783
MALDI-MS  
HC adult PNGase-A 35% acn
 
1345*
1489*
1519*
1693*
1723* 1897*
1315*
1375
1579
1783 1987
2191
2395
MALDI-MS  
HC adult PNGase-A 50% acn
Figure 42 MALDI MS spectra of permethylated N-glycans released from the H. contortus 
adult stage whole worm extracts by PNGase A enzyme (35% acetonitrile fraction at top and 
50% acetonitrile fraction at the bottom). The structures marked with asterisk* were later 
subject to MALDI-TOF-TOF analyses. For compositional assignment of each peak see 
Tables 7 and 8 below. 
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m/z 
value 
composition RA s1 RA s2 RA s3 Mean Variance SD SEM 
1315 HexNAc2Hex2Fuc2 0.39 0.40 0.25 0.35 0.0047 0.068 0.040 
1345 HexNAc2Hex3Fuc1 0.42 0.49 0.26 0.39 0.0093 0.096 0.056 
1375 HexNAc2Hex4 0.18 0.21 0.16 0.18 0.00042 0.021 0.012 
1489 HexNAc2Hex3Fuc2 1 1 1 1 0 0 0 
1519 HexNAc2Hex3Fuc2 0.85 0.85 0.69 0.80 0.0057 0.075 0.044 
1579 HexNAc2Hex5 0.31 0.30 0.30 0.30 2.2E-05 0.0047 0.0027 
1693 HexNAc2Hex3Fuc3 0.30 0.23 0.24 0.26 0.00096 0.031 0.018 
1723 HexNAc2Hex4Fuc2 0.085 0.080 0.049 0.071 0.00025 0.016 0.0092 
1783 HexNAc2Hex6 0.0099 0.0093 0.017 0.012 1.2E-05 0.0035 0.0020 
1897 HexNAc2Hex4Fuc3 0.0090 0.0068 0.0073 0.0077 8.9E-07 0.00094 0.00054 
 
Table 7. The assignment and relative quantification of molecular ions observed in MALDI-
TOF-MS spectrum (Figure 42, top) of permethylated (35% acetonitrile fraction), PNGase A 
released N-glycans of adult H. contortus. The relative abundance (RA) was calculated by 
measuring the total ion count (TIC) of each peak and dividing the value by the TIC of the 
most abundant peak. RA-relative abundance, SD- standard deviation, SEM- standard error of 
the mean, N/D- not detected, N/A- non applicable, s- sample. For formulas and calculations 
of the mean, variance, SD and SEM see section ‘2.2.14’. 
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m/z 
value 
composition RA s1 RA s2 RA s3 Mean Variance SD SEM 
1315.3 HexNAc2Hex2Fuc2 0.044 0.29 0.15 0.16 0.010 0.10 0.058 
1345.3 HexNAc2Hex3Fuc1 0.31 0.32 0.17 0.27 0.0047 0.068 0.040 
1375.3 HexNAc2Hex4 0.16 0.21 0.16 0.18 0.00056 0.024 0.014 
1489.3 HexNAc2Hex3Fuc2 0.20 1 1 0.73 0.14 0.38 0.22 
1519.4 HexNAc2Hex3Fuc2 0.72 1 0.78 0.83 0.014 0.12 0.069 
1579.4 HexNAc2Hex5 0.67 0.64 0.72 0.68 0.0011 0.033 0.019 
1693.4 HexNAc2Hex3Fuc3 1 0.82 0.89 0.90 0.0055 0.074 0.043 
1723.4 HexNAc2Hex4Fuc2 0.049 0.095 0.082 0.075 0.00037 0.019 0.011 
1783.4 HexNAc2Hex6 0.23 0.085 0.14 0.15 0.0036 0.060 0.035 
1897.4 HexNAc2Hex4Fuc3 0.039 0.059 0.070 0.056 0.00016 0.013 0.0074 
1987.4 HexNAc2Hex7 0.22 0.058 0.11 0.13 0.0046 0.068 0.039 
2191.4 HexNAc2Hex8 0.20 0.044 0.097 0.11 0.0042 0.065 0.037 
2395.5 HexNAc2Hex9 0.023 0.011 0.028 0.021 0.000051 0.0071 0.0041 
 
Table 8. The assignment and relative quantification of molecular ions observed in MALDI-
TOF-MS spectrum (Figure 42, bottom) of permethylated (50% acetonitrile fraction), 
PNGase A released N-glycans of adult H. contortus. The relative abundance (RA) was 
calculated by measuring the total ion count (TIC) of each peak and dividing the value by the 
TIC of the most abundant peak. RA-relative abundance, SD- standard deviation, SEM- 
standard error of the mean, N/D- not detected, N/A- non applicable, s- sample. For formulas 
and calculations of the mean, variance, SD and SEM see section ‘2.2.14’. 
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3.2.12 GC-MS linkage analysis of oligosaccharides released by PNGase A 
The GC-MS linkage data analyses from PNGase A released N-glycans are shown in the 
Table 9. The elution peaks at 18.69 and 18.20 demonstrate the presence of terminal galactose 
and 2-linked fucose in H. contortus which is consistent with suggested Galα1-2Fuc structure 
3-linked to the distal GlcNAc (see sections 3.2.13 and 3.2.15). The terminal fucose is 
consistent with the earlier reported (Haslam et al., 1996) chitobiose core modifications at the 
3-position of the distal GlcNAc and 3, 6-positions of the proximal GlcNAc. The latter is also 
supported by the presence of the 3, 4-linked GlcNAc. The 4-linked GlcNAc is consistent with 
the non-fucosylated distal GlcNAc. The terminal, 2-linked, 3-linked, 3, 6-linked mannoses 
agree with some high mannose structures observed in the MALDI-TOF MS spectrum. 
Although seen in the MALDI spectra, the absence of 4-linked fucose is explained by lower 
abundance of Hex-Fuc structure attached to the Asn-linked proximal GlcNAc compared to 
distal GlcNAc and limitations of GC-MS instrument sensitivity.   
Elution 
time 
Characteristic fragment 
ions 
Assignment Relative 
abundance 
16.93 115,118,131,162,175 Terminal fucose 0.47 
18.20  
87,89,115,130,131,175,190 
2-linked fucose 0.15 
18.42 102,118,129,162,161, 205 Terminal mannose 1.00 
18.69 102,118,129,162,161, 205 Terminal galactose 0.15 
19.58 129, 130, 161, 190 2-linked mannose 0.14 
19.78 101, 118, 129, 161, 234 3-linked mannose 0.16 
21.32 118, 129, 189, 234 3,6-linked mannose 0.06 
23.12 117, 159, 233 4-linked GlcNAc  0.01 
23.97 117, 159 3,4-linked GlcNAc 0.04 
Table 9. GC-MS analysis of partially methylated alditol acetates obtained from H. contortus 
N-glycans released by PNGase A. The relative abundance was calculated by measuring the 
total ion count (TIC) of each peak and dividing the value by the TIC of the most abundant 
peak. 
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3.2.13 MALDI-MS/MS analysis of permethylated PNGase A released N-glycans  
433
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 %
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Figure 43. MALDI-TOF-TOF MS/MS spectrum of 50% acetonitrile permethylated PNGase 
A released m/z 1693 adult H. contortus N-glycan. The blue arrowed horizontal lines represent 
the loss of indicated structural fragments from the parental molecular ion.  
 
The molecular ion at m/z 1693 from the MALDI-TOF MS spectrum of 50% acetonitrile 
PNGase A released N-glycans seen in the Figure 42 was further analysed by the MALDI-
TOF-TOF instrumentation. As seen in Figure 43, the presence of a fragment ion at m/z 433 
suggests the presence of a Hex-Fuc structure and its corresponding Z, not Y-type ion 
(Domon, Costello et al. 1988) at m/z 1283 suggests it is 3-linked. The ions at m/z 648 and 
1068 correspond to the Asn-linked GlcNAc modified with two fucoses at the 3- and 6-
positions as published previously (Haslam et al., 1996). In addition the lack of fragment ions 
at m/z 678, 852, 1056 corresponding to Asn-linked GlcNAc residues modified with Hex-Fuc, 
Hex-Fuc(Fuc), (Hex-Fuc)2 structures, rules out the attachment of the observed Hex-Fuc 
structure to the Asn-linked GlcNAc residue. The ion at m/z 463 represents the fragment 
consisting of two non-reducing end hexoses and the ion at m/z 676 is a double cleavage 
Hex2HexNAc fragment which has lost the Hex-Fuc and Asn-linked GlcNAc modified with 
two fucoses. Although the Hex-Fuc structure attached to the 3-position the internal chitobiose 
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core GlcNAc has been introduced earlier (see Figures 33, 34, 35, 36), the data presented in 
this section for the first time provides a strong evidence for this type of chitobiose core 
modification in H. contortus.  
 
3.2.14 MALDI-QIT-TOF MS nanalyses of permethylated PNGase A released m/z 1693 
N-glycans 
Figure 44 MALDI-QIT-TOF MS2 spectrum of 35% acetonitrile permethylated PNGase A 
released m/z 1693 adult H. contortus N-glycan. The blue horizontal arrowed lines represent 
the loss of indicated structural fragments from the parental molecular ion.  
 
In contrast to the molecular ion at m/z 1693 from the 50% acetonitrile PNGase A released N-
glycans spectrum (see earlier MS and MS/MS Figures 42, bottom and 43), the same 
molecular ion found in the 35% acetonitrile fraction displays an additional major structural 
isomer as seen in the Figure 44 above. The fragment ions at m/z 852 and 864 correspond to 
the HexNAcFuc2Hex fragment. Its loss from the parental molecular ion clearly suggests a 
new structural isomer where proximal GlcNAc is di-fucosylated, as previously reported 
(Haslam et al., 1996), and one of the fucoses is capped with the hexose. At this point we 
already know that the capping hexose can form the Galβ1-4Fuc attached to the 6-position of 
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the proximal GlcNAc (see sections 3.2.3, 3.2.4 and 3.2.7), and the fragment ions at m/z 628 
and 646 suggest its presence, however the hexose can also be attached to the fucose 3-linked 
to the proximal GlcNAc. 
Figure 45 MALDI-QIT-TOF MS3 spectrum of m/z 852 fragment ion from permethylated 
(35% acetonitrile fraction) PNGase A released m/z 1693 N-glycan. Dashed arrowed lines on 
the proposed structures represent glycosidic bond cleavages and cross-ring fragments.  
 
In order to discriminate the 3- and/or 6-linked attachment site for the Hex-Fuc structure on 
the proximal GlcNAc the fragment ion at m/z 852 was further analysed using the MALDI-
QIT-TOF MS3 instrument as seen in the Figure 45. The fragment ion at m/z 646 corresponds 
to Z, not Y ion- type loss (Domon, Costello et al. 1988) of fucose which favours the 3-
position of HexNAc and the most abundant fragment ion at m/z 573 results from Z-ion type 
loss (Domon, Costello et al. 1988) of fucose with concomitant elimination of AcNH(CH3). 
The cross-ring m/z 475 fragment ion indicates the Hex-Fuc epitope is 6-linked to the Asn-
linked GlcNAc. Together with the absence of the m/z 472 peak, which would correspond to 
Z-ion type loss (Domon, Costello et al. 1988) of Hex-Fuc fragment from the 3-position of 
GlcNAc, all the data suggest the Hex-Fuc epitope is 6-linked, rather than 3-linked, to the 
Asn-linked GlcNAc in the PNGase-A released N-glycan pool. The MALDI-TOF-TOF 
analysis of permethylated PNGase A released N-glycan m/z 1897 N-glycan (data not shown) 
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also revealed the presence of a fragment ion at m/z 852. In this case the fragmentation pattern 
also confirmed the Hex-Fuc structure being 6-linked and the fucose 3-linked to Asn-linked 
GlcNAc. 
 
3.2.15 MALDI-QIT-TOF MS 3analysis of m/z 433 fragment ion from permethylated 
PNGase A released m/z 1519 N-glycan 
Figure 46 MALDI-QIT-TOF MS2 spectrum of permethylated PNGase A released m/z 1519 
N-glycan. The blue horizontal arrowed lines represent the loss of indicated structural 
fragments from the parental molecular ion.  
 
The MALDI-QIT-TOF MS2 analysis of permethylated PNGase A released m/z 1519 N-
glycan (see Figure 46) shows the presence of two structural isomers with only one of them 
bearing the Hex-Fuc epitope which is 3-linked to the distal GlcNAc. The presence of the 
Hex-Fuc structure is seen by the fragment ion at m/z 433 and its elimination, not cleavage, 
from the parental molecular ion, as seen by the ‘Z-type’ fragment ion at m/z 1109, indicates it 
is linked to the 3-position of the GlcNAc. This structural isomer (see Figure 46 lower 
structure) carries the monofucosylated proximal GlcNAc as seen by the fragment ions at m/z 
474 and 1068. The second structural isomer (see Figure 46 upper structure) has the 
134 
 
difucosylated proximal GlcNAc, as indicated by the fragment ions at m/z 648 and 894, and 
has no Hex-Fuc modification.  
 
Figure 47 MALDI-QIT-TOF MS3 spectrum of m/z 433 fragment ion from permethylated 
PNGase A released m/z 1519 N-glycan. Dashed arrowed lines on the proposed structures 
represent glycosidic bond cleavages and cross-ring fragments.  
 
As it has now been defined that the Hex-Fuc fragment is certainly coming from the 3-position 
of the distal GlcNAc, to further characterize it the fragment ion at m/z 433 was subjected to 
MALDI-QIT-TOF MS3 analysis (see Figure 47). The fragment ions at m/z 259, 241, 215 
indicate the presence of terminal hexose and internal fucose. The presence of an abundant 
cross-ring fragment at m/z 301 and other cross-ring fragments at m/z 155, 315 and 343 
suggest that the hexose is linked to the 2-position of the internal fucose. The data described, 
together with the presence of the terminal galactose and 2-linked fucose in the GC-MS data, 
(see section 3.2.12) and the knowledge of biosynthetic pathways in closely related C. elegans 
organisms, allows us to propose the Galα1-2Fuc modification of the distal GlcNAc at the 3-
position. The same modification was proposed to be present on the 3-position of the GlcNAc 
in the non-reducing end LDN structure described earlier in the Figure 41. 
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3.2.16 MALDI-MS and MALDI-MS/MS analyses of permethylated PNGase F and 
PNGase A released, broad specificity β-galactosidase and broad specificity α-
galactosidase digested N-glycans  
The adult H. contortus N-glycans released by the PNGase F and PNGase A were also 
subjected to bovine testes broad specificity β-galactosidase and broad specificity green coffee 
bean α-galactosidase digestions with subsequent MALDI-TOF MS and MALDI-TOF-TOF 
MS/MS analyses. No evidence of digestion could be observed (data not shown).  
 
3.2.17 MALDI-MS and MALDI-MS/MS analyses of permethylated PNGase A released, 
reducing end ring-opened N-glycans digested with the range of galactosidase enzymes 
The Galα1-2Fuc structure attached to the distal GlcNAc of the chitobiose core is resistant to 
the broad specificity green coffee bean α-galactosidase enzyme in C. elegans (personal 
communication with Ian B. Wilson), nevertheless the authors managed to show the partial 
removal of the galactose on the HPLC-fractionated N-glycan using high concentration of 
enzyme and long incubation time (Paschinger et al., 2011). To eliminate potential steric 
hindrance of enzyme access, the reducing-end GlcNAc was ring-opened using sodium 
borodeuteride and then the sample was subjected to green coffee bean α-galactosidase, 
bovine testes broad specificity β-galactosidase and β1-4 specific galactosidase digests. No 
differences where observed when comparing the resultant MALDI-TOF MS and MALDI-
TOF-TOF MS/MS spectra prior and after the digests. 
3.2.18 The summary of N-glycan strucutres released by PNGase A from adult H. 
contortus  
 
Putting all the data together acquired so far in the thesis about PNGase A released N-glycans 
from adult H. contortus, the proposed structures with the corresponding m/z values can be 
seen below in the Table 10.The linkages for the proposed Gal-Fuc structures which have 
been the major focus of the section 3.2 ‘Structural characterization of N-glycome of adult 
H. contortus’ have been denoted in the structures as well. 
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m/z value Proposed structure(s) 
1315 
 
1345 
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α1
-2
ß1
-4
 
1723 
ß1
-4
 
1783* 
 
1897 
α1
-2
ß1
-4
 
1987* 
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Table 10 showing the proposed N-glycan structures released by PNGase A from adult H. 
contortus. 
 
3.2.19 MALDI-TOF MS analysis of α-mannosidase digested, hydrofluoric acid treated 
N-glycans released by PNGase F enzyme 
The presence of the phosphorylcholine (PC) moiety on glycans makes them difficult to detect 
by mass-spectrometry due to the PC zwitterionic nature. However, an indirect way to detect 
PC-containing glycans (Haslam et al., 1997) by removing the PC moiety with hydrofluoric 
acid has previously been developed. The appearance or up-regulation of structures with 
terminal HexNAc (Harnett et al., 2010) would usually indicate these N-glycans previously 
being modified by PC. 
In order to investigate the potential sub-population of N-glycans in adult H. contortus 
containing PC moieties, the PNGase F released and α-mannosidase digested N-glycans were 
treated with hydrofluoric acid. The resultant MALDI-TOF MS spectra prior and after the 
treatment are shown in the Figures 48 and 49. Before the HF treatment the PNGase F 
released, α-mannosidase digested N-glycan MS spectrum revealed molecular ion peaks up to 
m/z 3959 with glycans having up to five fucoses and eight HexNAcs. The MALDI-TOF-TOF 
analyses (see proposed structures in the Figure 49) of molecular ions at m/z 1969, 2010, 
2040, 2214, 2388, 2459, 2083, 3328 displayed the fragment ion at m/z 905 in all of the 
MALDI-TOF-TOF MS/MS spectra. These results suggested the presence of the proposed 
Galα1-2Fuc1-3(GalNAcβ1-4)GlcNAc structure (see section 3.2.9) in all of the 
aforementioned molecular ions although for some peaks due to their low abundance more 
detailed structural analysis could not be performed.  
 
After the hydrofluoric acid treatment the MALDI-TOF MS analysis revealed the presence of 
molecular ions with m/z values up to 3868 and structures having up to thirteen HexNAc and 
only one fucose. The MALDI-TOF-TOF MS/MS analyses of molecular ions at m/z 1907, 
2040, 2530, 3020, 3061, 3551 revealed structures with poly-HexNAc antennae with up to 
five residues and there was evidence for two antennae. Fucose, if present, is attached to the 6-
position of the proximal GlcNAc.  
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Figure 48 MALDI-TOF MS m/z 500-5015 range spectra of permethylated, α-mannosidase 
digested N-glycans released from the H. contortus adult parasite by PNGase F enzyme (50% 
acetonitrile fraction) prior (top) and after (bottom) the hydrofluoric acid treatment. The 
presence of oligomannosyl core is based on the knowledge of biosynthetic pathways in other 
organisms, previous publication (Haslam et al., 1996) and GC-MS data (see section 3.2.2). 
.  
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Figure 
49 MALDI-TOF MS m/z 1900-4000 range spectra of permethylated, α-mannosidase digested 
N-glycans released from the H. contortus adult parasite by PNGase F enzyme (50% 
acetonitrile fraction) prior (top) and after (bottom) the hydrofluoric acid treatment. The 
structures proposed are based on the further MALDI-TOF-TOF MS/MS fragmentations 
(peaks marked with an asterisk*), the knowledge of biosynthetic pathways in other organisms 
and data described in the thesis.  
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3.2.20 MALDI-TOF-TOF MS/MS analysis of α-mannosidase digested, hydrofluoric acid 
treated N-glycans released by PNGase F enzyme 
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Figure 50 MALDI-TOF-TOF MS/MS spectrum of permethylated PNGase F released m/z 
3551 N-glycan digested with α-mannosidase and treated with hydrofluoric acid. The blue 
arrowed horizontal lines represent the loss of indicated structural fragments from the parental 
molecular ion.  
 
The molecular ions at m/z 1907, 2040, 2530, 3020, 3061, 3551 from the MALDI-TOF MS 
spectrum (see Figure 49) were further analysed by the MALDI-TOF-TOF MS/MS 
instrumentation and the exemplary data is shown for the molecular ion at m/z 3551 in the 
Figure 50. The fragment ion at m/z 3100 indicates the fucosylated proximal GlcNAc. The ‘B-
type’ (Domon, Costello 1988) fragment ions at m/z 772 and 1017 indicate the presence of the 
HexNAc3 and HexNAc4 fragments. The sequential loss of up to five HexNAcs as seen by the 
fragment ions at m/z 3292, 3047, 2802, 2557, 2312 suggest the presence of the linear poly-
HexNAc antenna with up to 5 HexNAcs. The fragment ions at m/z 2053, 1808 and 1563 
indicate the presence of two separate antennae with up to 4 HexNAc residues on each. 
Together all this data suggest the most probable structure with two poly-HexNAc antennae 
with up to five units on each although other structural isomers are not excluded. 
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3.3 Structural characterization of the O-glycome of adult H. 
contortus 
3.3.1 MALDI-MS analysis of permethylated O-glycans released by reductive 
elimination from adult H. contortus  
To date there are no literature reports on O-glycomic data of H. contortus. To investigate 
whether any O-glycans are present the glycopeptides remaining after the PNGase A digestion 
were subject to the reductive elimination followed by the MALDI-TOF MS analysis (see 
Figure 51, Table 11). 
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Figure 51 MALDI MS spectrum of permethylated O-glycans released from the H. contortus 
adult stage whole worm extracts by reductive elimination (35% acetonitrile fraction). The 
structures marked with asterisk* were later subject to MALDI-TOF-TOF analyses. For 
compositional assignment of each peak see Table 11. The 50% acetonitrile fraction has not 
been shown as no new structures have been detected. 
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m/z 
value 
composition RA s1 RA s2 RA s3 Mean Variance SD SEM 
534 HexHexNAc 1.0 1.0 1.0 1.0 0.0 0.0 0.0 
575 HexNAc2 0.50 0.22 0.18 0.30 0.020 0.14 0.082 
738 Hex2HexNAc 0.29 0.15 0.16 0.20 0.0041 0.064 0.037 
779 Hex HexNAc2 0.47 0.25 0.23 0.32 0.012 0.11 0.063 
912 FucHex2HexNAc 0.060 0.024 0.017 0.034 0.00035 0.019 0.011 
942 Hex3HexNAc 0.080 0.012 N/D N/A N/A N/A N/A 
953 FucHexHexNAc2 0.030 0.010 N/D N/A N/A N/A N/A 
983 Hex2HexNAc2 0.020 0.0074 N/D N/A N/A N/A N/A 
1157 FucHex2HexNAc2 0.060 0.043 0.025 0.043 0.00020 0.014 0.0083 
1198 FucHexHexNAc3 0.24 0.098 0.056 0.13 0.0062 0.079 0.045 
1361 FucHex3HexNAc2 0.020 0.075 0.050 0.048 0.00051 0.022 0.013 
1402 FucHex2HexNAc3 0.020 0.49 0.37 0.29 0.040 0.20 0.12 
1606 FucHex3HexNAc3 0.090 0.073 0.053 0.072 0.00023 0.015 0.0087 
Table 11. The assignment and relative quantification of molecular ions observed in MALDI-
TOF-MS spectrum (see Figure 51) of permethylated (35% acetonitrile fraction), reductively 
eliminated O-glycans of adult H. contortus. The relative abundance (RA) was calculated by 
measuring the total ion count (TIC) of each peak and dividing the value by the TIC of the 
most abundant peak. RA-relative abundance, SD- standard deviation, SEM- standard error of 
the mean, N/D- not detected, N/A- non applicable, s- sample. For formulas and calculations 
of the mean, variance, SD and SEM see section ‘2.2.14’. 
.  
As seen in the Figure 51 and Table 11 the MALDI-TOF MS spectrum reveals the previously 
unreported presence of O-glycans in H. contortus together with some of their potential 
structural features. At this point based on the compositional analysis alone we can propose 
certain core structures likely present in the H. contortus O-glycome. The molecular ion at m/z 
534 can potentially represent a core 1 structure Galβ1-3GalNAc. The molecular ion at m/z 
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575 could be a Core 6 structure GlcNAcβ1-6GalNAc. Based on the previously described 
schistosome-specific Galβ1–3(Galβ1–6)GalNAc ‘Shisto’ core (Huang et al., 2001) the 
molecular ions at m/z 738, 912, 942 could potentially have this type of Core structure. 
Abundant Core 2 Galβ1-3(GlcNAcβ1-6)GalNAc structure are also possible for the molecular 
ions at m/z 779, 953, 983, 1157, 1198, 1361, 1402 and 1606.  
At this point it is important to emphasize that MALDI-TOF MS experiment provides us only 
with compositional information about the glycans but not their arrangement, linkage or 
conformational isomerism such as glucose, galactose or mannose. For this reason caution 
must be taken when proposing specific Core structures especially for structures with higher 
molecular weight. 
 
3.3.2 GC-MS linkage analysis of partially methylated alditol acetates of O-glycans 
released by reductive elimination from adult H. contortus  
Elution 
time 
Assignment Characteristic fragment ions Relative abundance 
12.79 Terminal fucose 115,118,131,162,175 0.18 
14.01 2-linked fucose 87,89,115,130,131,175,190 0.06 
14.52 Terminal galactose 102,118,129,162,161, 205 1.00 
15.31 GalNAc-itol  88,89,130,174,218,262 0.64 
16.43 3-linked GalNAc-itol 88,130,133,246,290 0.16 
17.10 6-linked GalNAc-itol 88, 101, 117, 130, 161, 174, 218 0.01 
17.73 Terminal GlcNAc 117,143,145,159,203,205 0.06 
18.18 3,6-linked GalNAc-itol 88, 130, 161, 246, 318 0.11 
18.23 Terminal GalNAc 117, 143, 145, 159, 203, 205 0.08 
18.60 4-linked GlcNAc 117, 159, 233 0.07 
19.21 3-linked GalNAc 99, 101, 117, 129, 159, 161 0.05 
19.44 3,4-linked GlcNAc 117, 159 0.10 
Table 12. GC-MS analysis of partially methylated alditol acetates obtained from reductively 
eliminated H. contortus O-glycans. The relative abundance was calculated by measuring the 
total ion count (TIC) of each peak and dividing the value by the TIC of the most abundant 
peak. 
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The GC-MS linkage data analyses of partially methylated alditol acetates from the 
permethylated reductively eliminated O-glycans are summarized in the Table 12. The 
terminal galactose is consistent with the earlier proposed core 1, core 2 and Schisto core 
structures. The core 1 structure is also supported by the presence of the 3-linked GalNAc-itol 
Schisto core as well as core 2 structures are supported by the presence of the 3, 6-linked 
GalNAcitol. Terminal GlcNAc provides extra evidence for the core 2 structure as well as 
potential core 6 structure. The latter is also supported by the 6-linked GalNAc-itol.  
 
3.3.3 MALDI-TOF-TOF  analyses of permethylated, reductively eliminated lower 
molecular weight O-glycans  
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Figure 52 MALDI-TOF-TOF MS/MS spectrum of 35% acetonitrile permethylated 
reductively eliminated m/z 534 adult H.contortus O-glycan. The blue arrowed horizontal line 
represents the loss of indicated structural fragment from the parental molecular ion. The 
proposed monosaccharide configurations are based on GC-MS data (see section ‘2.3.2) and 
knowledge of biosynthetic pathways in other organisms. 
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To collect more evidence for the presence of Galβ1-3GalNAc core 1 structure, the molecular 
ion at m/z 534 observed in the MALDI-MS spectrum (see Figure 51) was fragmented by 
MALDI-TOF-TOF as seen in the Figure 52. The most abundant fragment observed is at m/z 
298 corresponding to the reducing end-HexNAc. The ‘Z’, not ‘Y’ type of this ion (Domon, 
Costello 1988) suggest it is 3-linked. The minor ‘Y’-type ion of the reducing-end HexNAc is 
observed at m/z 316. The fragment ion at m/z 259 corresponds to the non-reducing end 
hexose. The characteristic core-1 O-glycan fragmentation, together with the terminal 
galactose and 3-linked GalNAc-itol observed in the GC-MS experiment (see section 3.3.2) 
strongly suggest the m/z 534 molecular ion is a core 1 O-glycan. 
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Figure 53 MALDI-TOF-TOF MS/MS spectrum of 35% acetonitrile permethylated 
reductively eliminated m/z 575 adult H. contortus O-glycan. The blue arrowed horizontal line 
represents the loss of the indicated structural fragment from the parental molecular ion. 
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To obtain more information about the HexNAc2 structure, the molecular ion at m/z 575 seen 
in the Figure 51, was fragmented by the MALDI-TOF-TOF instrumentation. The resultant 
spectrum can be seen in Figure 53. The most abundant fragment ion at m/z 298 corresponds 
to the ‘Z’-type ion (Domon, Costello 1988) of the reducing-end HexNAc suggesting it is 3-
linked. On the other hand the abundant ‘Y’-type ion (Domon, Costello 1988) at m/z 316 may 
suggest the presence of the 6-linked reducing-end HexNAc. The fragment ions at m/z 282 and 
300 correspond to ‘B’- and ‘C’-type ions (Domon, Costello 1988) of the non-reducing 
HexNAc. Together with the terminal GlcNAc, terminal GalNAc, 3-linked GalNAc-itol, 6-
linked GalNAc-itol observed in GC-MS experiment (see section 3.3.2) it may suggest the 
presence of GlcNAcβ1-3GalNAc core 3, GlcNAcβ1-6GalNAc core 6, GalNAcα1-3GalNAc 
core 5, GalNAcα1-6GalNAc core 7 structures. 
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Figure 54 MALDI-TOF-TOF MS/MS spectrum of 35% acetonitrile permethylated 
reductively eliminated m/z 738 adult H.contortus O-glycan. The proposed monosaccharide 
configurations are based on GC-MS data (see section ‘2.3.2) and knowledge of biosynthetic 
pathways in other organisms. 
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To confirm the presence of the Galβ1-3(Gal β1-6)-GalNAc Schisto core (Huang et al., 2001) 
the molecular ion at m/z 738 observed in MALDI-MS spectrum (see Figure 51) was 
fragmented by MALDI-TOF-TOF. The resultant spectrum as seen in the Figure 54 is 
characteristic of the proposed Schisto core structure (Huang et al., 2001). The most abundant 
fragment ion at m/z 502 corresponds to the ‘Z’-type ion (Domon, Costello 1988) of reducing-
end Hex-HexNAc suggesting HexNAc is 3-linked. The minor ‘Y’-type ion (Domon, Costello 
1988) of reducing-end Hex-HexNAc is observed at m/z 520. The fragment ion at m/z 259 
corresponds to the non-reducing end hexose. Together with the terminal galactose and 3, 6-
linked GalNAc-itol observed in GC-MS experiment (see section 3.3.2) these results confirm 
the earlier proposed Galβ1-3(Gal β1-6)-GalNAc Schisto core structure. 
 
3.3.4 MALDI-QIT-TOF MSn analyses of permethylated, reductively eliminated m/z 
1606 O-glycan  
Figure 55  MALDI-QIT-TOF MS2 spectrum of reductively eliminated m/z 1606 O-glycan. 
The blue horizontal arrowed lines represent the loss of indicated structural fragments from 
the parental molecular ion. The proposed monosaccharide configurations are based on GC-
MS data (see section ‘2.3.2’), previously in the thesis described N-glycans data and 
knowledge of biosynthetic pathways in other organisms. 
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In order to get more structural information the highest molecular weight O-glycan at m/z 
1606 was further fragmented by the MALDI-QIT-TOF MSn approach. The MS2 analysis as 
seen in the Figure 55 interestingly revealed the presence of the Hex-Fuc structure seen earlier 
in the N-glycome of the parasite. This structure is supported by the fragment ions at m/z 433 
and 1196. The absence of the fragment ion corresponding to the loss or elimination of the 
fucose residue alone suggests the fucose is internal rather than a terminal residue. The ‘Z-
type’ ion (Domon, Costello 1988) at m/z 1196 indicates the elimination, not cleavage of the 
Hex-Fuc structure strongly suggesting linked to the 3-position of the GlcNAc. The most 
abundant fragment ion at m/z 1143 with fragment ions at m/z 486 and 504 indicate the 
presence of the terminal Hex-HexNAc structure. Other fragment ions assigned in the 
spectrum confirm the proposed modified core 2 where Hex-HexNAc and Hex-Fuc are 
attached to the core 2 GlcNAc residue. 
The Gal-Fuc modifications of the chitobiose core and non-reducing LDNF antennae observed 
in the N-glycome of adult H. contortus together with the terminal galactose observed in the 
GC-MS linkage data of the adult O-glycans (see section 3.3.2) makes the hexose attached to 
the fucose likely to be a galactose residue. The proposed terminal Hex-GalNAc structure is 
based on the presence of the modified LDNF structure in the N-glycome of the parasite 
(although without the terminal hexose) and the 3-linked GalNAc residues in the GC-MS 
linkage data (see section 3.3.2).  
149 
 
Figure 56 MALDI-QIT-TOF MS3 spectrum of m/z 486 fragment ions from permethylated 
reductively eliminated m/z 1606 O-glycan. Dashed arrowed lines on the proposed structures 
represent glycosidic bond cleavages and cross-ring fragments.  
 
To get more linkage information about the putative Hex-GalNAc structure the fragment ion 
at m/z 486 was further fragmented by MALDI-QIT-TOF MS3 as seen in the Figure 56. The 
fragment ions at m/z 259, 241 and 268 confirm the non-reducing end terminal hexose. The 
cross-ring fragment ions at m/z 384 and 412 generated by the reverse Diels-Alder mechanism 
strongly suggest the 3-linkage to HexNAc. Together with the 3-linked GalNAc observed in 
the GC-MS linkage data (see section 3.3.2) these results strongly support a Hex1-3GalNAc 
structure. 
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Figure 57 MALDI-QIT-TOF MS3 spectrum of m/z 433 fragment ion from permethylated 
reductively eliminated m/z 1606 O-glycan. Dashed arrowed lines on the proposed structures 
represent glycosidic bond cleavages and cross-ring fragments.  
 
To determine the linkage of the Hex-Fuc structure, the fragment ion at m/z 433 was further 
fragmented by the MALDI-QIT-TOF MS3 instrumentation as seen in the Figure 57. The 
fragment ions at m/z 259, 241 and 215 confirm the non-reducing end hexose and the linked 
fucose. The most abundant cross-ring fragment ions at m/z 301 together with the cross-ring 
fragment ions at m/z 343 support the presence of the 2-linked fucose. In addition the spectrum 
looks remarkably similar to the MALDI-QIT-TOF MS3 spectrum of the proposed Galα1-
2Fuc structure found on the distal GlcNAc of the chitobiose core N-glycans and modified 
LDNF antennae (see Figures 47 and 41, respectively). The GC-MS data (see section 3.3.2) 
showed the presence of 2-linked fucose and the results seen in the Figure 57 are consistent 
with the Galα1-2Fuc structure. Finally, the proposed Galα1-2Fuc structures found in the N- 
and O-glycomes of adult H. contortus are attached to the 3-position of the GlcNAc in contrast 
to the Galβ1-4Fuc structure attached to the 6-position of the proximal GlcNAc of the N-
glycan chitobiose core. These results suggest that the fucose 3-linked to the GlcNAc’s of the 
distal chitobiose core, LDNF antenna and core-2 O-glycan structures may act as substrates 
for the same putative α1-2 galactosyltransferase in adult H. contortus.  
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3.3.5 MALDI-TOF-TOF MS/MS analyses of permethylated reductively eliminated 
other higher molecular weight O-glycans  
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Figure 58 showing the MALDI-TOF-TOF MS/MS spectrum of reductively eliminated m/z 
1402 O-glycan. The blue horizontal arrowed lines represent the loss of indicated structural 
fragments from the parental molecular ion. The proposed monosaccharide configurations are 
based on GC-MS data (see section ‘3.3.2’), previously in the thesis described N-glycans data 
and knowledge of biosynthetic pathways in other organisms  
 
In order to gain more insight into the structural features of the O-glycans, the abundant peak 
at m/z 1402 was fragmented by MALDI-TOF-TOF MS/MS as seen in the Figure 58. As well 
as for the previously described molecular ion at m/z 1606 (see Figure 55), the Hex-Fuc 
structure was present as indicated by the fragment ions at m/z 433, 992, 733. The MALDI-
QIT-TOF MS3 analysis of the fragment ion at m/z 433 resulted in almost identical 
fragmentation (data not shown) to that obtained earlier for the fragment ion at m/z 433 
originated from the molecular ion at m/z 1606 (see Figure 57) strongly suggesting the 
proposed Galα1-2Fuc structure is present in both structures. The fragment ions at m/z 282, 
300, 1143 indicate the non-reducing end terminal HexNAc. The ‘Z-type’ (Domon, Costello 
1988) nature of the fragment ion at m/z 992 indicates the elimination, not cleavage of the 
152 
 
Hex-Fuc structure strongly suggesting it is linked to the 3-position of the HexNAc. The 
presence of the terminal HexNAc and the Hex-Fuc structure linked to the 3-posisition of the 
HexNAc, together with the fragment ions at m/z 905, 733, 520 provide the evidence for the 
non-reducing end HexNAc-(Hex-Fuc1-3)-HexNAc structure. Combining this information 
with the terminal GalNAc and the 3, 4-linked GlcNAc observed in the GC-MS instrument 
(see section 3.3.2) we can propose a modified LDNF structure where 2-linked fucose is 
capped with galactose. Excitingly this Galα1-2Fuc- modified LDNF structure has been 
proposed for the N-glycome as well (see section 3.2.9) suggesting the potential common 
biosynthetic pathways decorating antennae of both N- and O- glycans H. contortus. 
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Figure 59 MALDI-TOF-TOF MS/MS spectrum of reductively eliminated m/z 1361 O-
glycan. The blue horizontal arrowed lines represent the loss of indicated structural fragments 
from the parental molecular ion. The proposed monosaccharide configurations are based on 
GC-MS data (see section ‘2.3.2’), previously in the thesis described N-glycans data and 
knowledge of biosynthetic pathways in other organisms. 
 
The molecular ion at m/z 1361 was also fragmented by the MALDI-TOF-TOF MS/MS 
approach as seen in the Figure 59. The most abundant fragment ion at m/z 951 together with 
fragment ions at m/z 433, 715 indicate the presence of the earlier described Hex-Fuc structure 
which is proposed to be Galα1-2Fuc (see Section 3.3.4, Figure 57). As seen in the 
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fragmentation of the molecular ions at m/z 1606 and 1402 (see Figures 55 and 58, 
respectively) the ‘Z-type’ (Domon, Costello 1988) nature of the fragment ion at m/z 951 
indicates that the Hex-Fuc structure is 3-linked to the GlcNAc. The fragment ions at m/z 472, 
520, 715, 864 together with the absence of the non-reducing end terminal HexNAc provide 
the evidence for the Hex-(Hex-Fuc1-3) HexNAc structure. The presence of the 3, 4-linked 
GlcNAc and terminal galactose seen in the GC-MS linkage data (see section 2.3.2) make this 
structure likely to be a modified LacNAc structure where GlcNAc is 3-linked to the proposed 
Galα-2Fuc structure.  
 
3.3.6 MALDI-TOF MS analysis of permethylated reductively eliminated, broad 
specificity α1-3, 4, 6 galactosidase digested O-glycans  
To provide more evidence for the conformation and linkage of the hexoses, the reductively 
eliminated O-glycans were subject to Green Coffee Bean broad specificity α1-3, 4, 6 
galactosidase digestion coupled with MALDI-TOF MS and MALDI-TOF-TOF MS/MS 
analyses. The resultant MALDI-TOF MS spectrum can be seen in Figure 60, bottom and the 
most obvious difference in comparison to the MS spectrum prior to the digest (see Figure 60, 
top) is the disappearance of the molecular ion at m/z 1606. Referring to the proposed 
structure of this molecular ion (see section 3.3.4) the two potential hexoses susceptible to the 
α1-3, 4, 6 galactosidase are those capping the fucose and the GalNAc of the proposed 
modified LDNF structure. The hexose attached to the reducing-end GalNAc is assumed to be 
the Galβ1-3 as consistent with the proposed Core 2 structure. The MALDI-TOF-TOF 
analyses of all other molecular ions after the digest (data not shown) did not reveal any 
structural changes in the molecular ions suggesting the resistance of the proposed Galα1-
2Fuc structure to the α1-3, 4, 6 galactosidase. This was also observed in the N-glycome of H. 
contortus (see sections 3.2.16 and 3.2.17) and is most likely explained by the unusual 
presentation of the alpha galactose to the enzyme. On the other hand the absence of the new 
structural isomers in the molecular ion at m/z 1402 and virtually complete absence of the 
molecular ion at m/z 1606 provide the evidence for the non-reducing end GalNAc-capping 
hexose being alpha-linked to galactose. Together with the previous data from GC-MS (see 
section 3.3.2.) and fragment ion at m/z 486 MS3 analysis (see Figure 56), these results 
strongly suggest the modified LDNF Galα1-3GalNAc-(Galα1-2Fuc)GlcNAc- structure, 
which, to our knowledge, is not seen in any other organism. 
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Figure 60 MALDI-TOF MS spectra of permethylated reductively eliminated O-glycans 
before (top) and after (bottom) the broad specificity α-galactosidase digestion. The proposed 
structures are based on the MALDI-TOF-TOF MS/MS analyses (peaks marked with an 
asterisk*), GC-MS data (see section ‘2.3.2’), previously in the thesis described N- and O-
glycans data and knowledge of biosynthetic pathways in other organisms.  
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3.3.7 MALDI-MS and MALDI-MS/MS analyses of permethylated reductively 
eliminated, broad specificity β-galactosidase and β1-4-galactosidase digested O-glycans  
Adult H. contortus O-glycans were also subjected to the broad specificity β-galactosidase and 
β1-4-galactosidase digestions with the subsequent MALDI-TOF MS and MALDI-TOF-TOF 
MS/MS analyses however no structural changes were observed (data not shown).  
 
3.3.8 The summary of reductively eliminated O-glycan structures from adult H. 
contortus  
Putting all the data together acquired so far in the thesis about reductively eliminated O-
glycans from adult H. contortus, the proposed structures with the corresponding m/z values 
can be seen below in the Table 13. Considering that O-glycans from H. contortus have not 
been reported previously, the proposed linkages for most of the structures have been included 
as well. 
 
m/z 
value 
Proposed structure 
534 
ß1-
3
 
575 
1-3
1-6
 
738 ß1-6
ß1-
3
 
779 
ß1-
3
ß1-6
 
912 
ß1-
3
ß1-6
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942 ß1-6
ß1
-3
 
953 ß1-6
ß1
-3
{
 
983 ß1-6
ß1
-3
ß1-4
 
1157 
α1
-3
ß1-6
ß1
-3
ß1-4 ß1-6
ß1
-3
α1
-3
α1-2
 
1198 ß1-4 ß1-6
ß1
-3
α1
-3
 
1361 ß1-6
ß1
-3
α
1 -
3
ß1-4
α1-2
 
1402 ß1-4 ß1-6
ß1
-3
α1
-3
α1-2  
1606 ß1-4α1-3 ß1-6
ß1
-3
α
1-
3
α1-2  
Table 13 showing the proposed O-glycan structures released by reductive elimination from 
adult H. contortus. 
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3.4 Structural characterization of the N-glycome of L3 stage H. 
contortus 
3.4.1 MALDI-MS analysis of permethylated PNGase F released N-glycans from L3 
stage H. contortus  
In order to investigate whether the additional N-glycan structures observed in the adult stage 
are also present in the L3 stage, PNGase F released permethylated N-glycans were analysed 
by MALDI-TOF-MS. As illustrated in Figure 61, top the most abundant structures observed 
in MALDI-MS spectrum of 35% acetonitrile fraction are paucimannose structures with or 
without fucose and having the general composition of Hex2-4Fuc0-1HexNAc2 (m/z 967-1375). 
A second group of structures corresponds to complex N-glycans having the general 
composition of Hex3Fuc0-1HexNAc3-5. The majority of the N-glycans observed in 50% 
acetonitrile fraction (Figure 61, bottom) corresponds to Hex5-9HexNAc2.  As with the adult 
these high mannose N-glycans have not been subject to MS/MS analysis due to the 
established characterisation of these structures. The molecular ions at m/z 1141, 1345, 1416, 
1590, 1835 and 2081 were further characterised by the MALDI-TOF-TOF MS/MS approach.  
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1141*
1835*
1171
1345*
1416* 1590*
2081*
1824
967
1375 1661 1906
1579
m
HC L3 PNGase-F 35% acn 
GlcNAc,mannose, fucose, GalNAc
 
1835
1171
1345
1416
1590
2081
1824
1375
1783
1579
HC L3 PNGase-F 50% acn 
GlcNAc,mannose, fucose, GalNAc1655*
1988
2192
2396
Figure 61 MALDI-TOF MS spectra of permethylated 35% acetonitrile (top) and 50% 
acetonitrile (bottom) N-glycans released from L3 H. contortus by PNGase F enzyme. The 
structures proposed are based on the further MALDI-TOF-TOF MS/MS fragmentation (peaks 
marked with an asterisk*), GS-MS data (see section 3.4.2) and already obtained knowledge 
of N-glycan structures in adult parasite. The peak at m/z 1655 seen in 50% acetonitrile 
fraction corresponds to contaminant. 
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3.4.2 GC-MS linkage analysis of L3 stage H. contortus N-glycans released by PNGase F 
(35% acetonitrile fraction) 
 
Elution 
time 
Characteristic fragment ions Assignment Relative 
abundance 
16.93 115,118,131,162,175 Terminal fucose 0.35 
18.45 102,118,129,162,161, 205 Terminal mannose 1.00 
19.60 129, 130, 161, 190 2-linked mannose 0.46 
21.16 129, 130, 189, 190 2,6-linked mannose 0.11 
21.33 118, 129, 189, 234 3,6-linked mannose 0.65 
22.25 117, 159, 205 Terminal GlcNAc 0.14 
22.69 117, 159, 205 Terminal GalNAc 0.09 
23.14 117, 159, 233 4-linked GlcNAc 0.50 
23.97 117, 159 3,4-linked GlcNAc 0.07 
24.43 117, 159, 261 4,6-linked GlcNAc 0.09 
Table 14. GC-MS analysis of partially methylated alditol acetates obtained from L3 stage H. 
contortus N-glycans released by PNGase F. The relative abundance was calculated by 
measuring the total ion count (TIC) of each peak and dividing the value by the TIC of the 
most abundant peak. 
 
The GC-MS linkage data of partially methylated alditol acetates from the PNGase F released 
N-glycans can be seen in the Table 14. The terminal, 3, 6-linked, 2-linked mannoses are 
consistent with high and truncated mannose structures present. The 2, 6-linked as well as 2-
linked mannoses can be explained by the addition of the initiating GlcNAc antennae on the 
trimannosyl core. 4-linked GlcNAc is consistent with the proximal chitobiose core GlcNAc 
as well as the non-reducing end LDN antennae. The latter is also supported by the presence 
of the terminal GalNAc. The 3, 4-linked GlcNAc is consistent with the minor amounts of the 
distal GlcNAc fucosylation observed in the L3 stage parasite.  
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3.4.3 MALDI-MS/MS analyses of permethylated PNGase F released N-glycans from L3 
stage H. contortus  
Since the MALDI-TOF MS compositional analysis alone cannot reveal structural isomers 
present, the molecular ions have been further fragmented by the MALDI-TOF-TOF MS/MS 
analyses. The exemplary data is shown for the molecular ion at m/z 1345 in the Figure 62, 
top. The fragment ions at m/z 474 and 894 confirm the core fucosylation of the proximal 
GlcNAc at 6-position. The fragment ions at m/z 431 and 667 together with the absence of the 
fragment ion at m/z 463 corresponding to the linear Hex-Hex structure, all these data point to 
the three mannoses on the non-reducing end of the N-glycan arranged in the branched, not 
linear way. These results are supported by the presence of the 3, 6-linked mannose in the GC-
MS linkage data (see Table 14). The ‘1X5-type’ (Domon, Costello 1988) cross-ring fragment 
ion shows the presence of the terminal fucose. Comparing this data to the MALDI-TOF-TOF 
MS/MS analysis of the same molecular ion from the adult parasite (see Figure 62, bottom), 
apart from the structural isomer described, the additional isomer with the proposed Gal-Fuc 
structure linked to the 3-position of the distal GlcNAc is also present as supported by the 
fragment ions at m/z 433, 953, 1068, 463. The fragmentation of other molecular ions (see the 
proposed structures in the MALDI-MS spectrum, Figure 61) showed the absence of the Gal-
Fuc structures in L3 stage parasite.  
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Figure 62 MALDI-TOF-TOF MS/MS spectrum of permethylated PNGase F released m/z 
1345 L3 infective stage H. contortus N-glycan (top). The MALDI-TOF-TOF MS/MS 
spectrum of permethylated PNGase F released m/z 1345 adult H. contortus N-glycan 
(bottom) is given for comparison. The blue arrowed horizontal lines represent loss of 
indicated structural fragments from the parental molecular ion.  
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The MALDI-TOF-TOF spectrum of the molecular ion at m/z 1141 can be seen in the Figure 
63, revealing two structural isomers are present. The major structural isomer is fucosylated 
on the proximal GlcNAc as seen by the fragment ions at m/z 474 and 690. The minor isomer 
is fucosylated on the distal GlcNAc and is represented by the fragment ions at m/z 864 and 
676 which correspond to the loss of reducing-end GlcNAc and an additional fucose, 
respectively. The presence of the fucose 3-linked to the distal GlcNAc is also supported by 
the ‘Z’-type ion (Domon, Costello 1988) at m/z 935. Other fragment ions at m/z 463, 719, 
923, 953 can be ascribed to any of two isomers. It is important to note that previously 
reported data (Haslam et al., 1998) on H. contortus L3 stage N-glycans generated by FAB-
MS instrumentation did not reveal the presence of distal GlcNAc fucosylation. 
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Figure 63  MALDI-TOF-TOF MS/MS spectrum of permethylated PNGase F released m/z 
1141 L3 infective stage H. contortus N-glycan. The blue arrowed horizontal lines represent 
loss of indicated structural fragments from the parental molecular ion. ‘M’ denotes major 
isomer and ‘m’ minor. 
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3.4.4 MALDI-MS analysis of permethylated PNGaseA released N-glycans from L3 stage 
H. contortus 
1
1141*
1345*
1375
1171
1416
1580
1519*
1489*
1315*
HC L3 PNGase-A 35% acn 
GlcNAcmannose, fucose,
Figure 64 MALDI-TOF MS spectrum of permethylated 35% acetonitrile N-glycans released 
from L3 infective stage H.contortus parasite by PNGase A enzyme. The structures proposed 
are based on the further MALDI-TOF-TOF MS/MS fragmentation (peaks marked with an 
asterisk*), GC-MS data (see section 3.4.5) and already obtained knowledge of N-glycan 
structures in adult parasite. The 50% acetonitrile fraction has not been shown as no new 
structures apart from high-mannose have been detected. 
 
The N-glycans remaining on the glycopeptides after the PNGase F digestion were subject to 
the PNGase A digestion with the resultant MALDI-TOF MS spectrum seen in the Figure 64. 
The major N-glycan family observed corresponds to the truncated core-fucosylated structures 
with the general composition Hex2-3Fuc1-3HexNAc2. The oligomannose structures with the 
general composition Hex3-5HexNAc2 as well as one complex truncated Hex3HexNAc3 
structure suggest the incomplete removal of glycans by the PNGase F enzyme.  
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3.4.5 GC-MS linkage analysis of L3 H. contortus parasite N-glycans released by PNGase 
A (35% acetonitrile fraction) 
 
Elution 
time 
Characteristic fragment ions Assignment Relative 
abundance 
16.93 115,118,131,162,175 Terminal fucose 0.14 
18.41 102,118,129,162,161, 205 Terminal mannose 0.82 
19.56 129, 130, 161, 190 2-linked mannose 0.03 
21.32 118, 129, 189, 234 3,6-linked mannose 0.07 
22.23 117, 159, 205 Terminal GlcNAc 0.01 
23.12 117, 159, 233 4-linked GlcNAc 0.07 
23.98 117, 159 3,4-linked GlcNAc 0.02 
24.43 117, 159 (no 261) 4,6-linked GlcNAc traces 
Table 15. GC-MS analysis of partially methylated alditol acetates obtained from L3 H. 
contortus N-glycans released by PNGase A. The relative abundance was calculated by 
measuring the total ion count (TIC) of each peak and dividing the value by the TIC of the 
most abundant peak. 
 
The GC-MS linkage data of partially methylated alditol acetates from the PNGase A released 
N-glycans can be seen in the Table 15. The terminal fucose is consistent with the core-
fucosylated structures observed in the MALDI-TOF MS spectrum (see Figure 61). The 3, 6-
linked mannose is consistent with the branched trimannosyl part of the all N-glycans except 
those where only two mannoses are present such as in the molecular ions at m/z 1141, 1315, 
1489. The 2-linked mannose suggests the attachment site of the non-reducing end terminal 
GlcNAc seen in the molecular ion at m/z 1416. 4-linked GlcNAc is consistent with the non-
fucosylated distal GlcNAc observed in all of the molecular ions except at m/z 1489. The 
distal GlcNAc in the latter molecular ion is represented by the 3, 4-linked GlcNAc.  
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3.4.6 MALDI-MS/MS analyses of permethylated PNGase A released N-glycans from L3 
stage H. contortus  
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Figure 65 MALDI-TOF-TOF MS/MS spectrum of permethylated PNGase A released m/z 
1519 from L3 H. contortus N-glycan.The blue arrowed horizontal lines represent loss of 
indicated structural fragments from the parental molecular ion. 
 
In order to get more structural information the PNGase A released fucosylated molecular ions 
from the MALDI-TOF MS spectrum have been further fragmented by the MALDI-TOF-TOF 
MS/MS approach. The exemplary data are shown for the molecular ions at m/z 1519 in the 
Figure 65. The most abundant fragment ions at m/z 894 together with the fragment ions at 
m/z 648 indicate the di-fucosylation of the proximal GlcNAc. The fragment ions at m/z 667 
correspond to the trimannosyl part of the N-glycan and the fragment ions at m/z 431 together 
with the absence of the fragment ions at m/z 463 provide the evidence for the branched, not 
linear, arrangement of three mannoses. In contrast to the MALDI-QIT-TOF spectrum of the 
PNGase A- released N-glycan molecular ions at m/z 1519 from adult H. contortus parasite as 
seen earlier in the Figure 46, in the L3 stage parasite the structural isomer with Gal-Fuc 
modification on the distal GlcNAc is absent. Together with the MALDI-TOF-TOF MS/MS 
fragmentations of the other PNGase A-released fucosylated structures (see the proposed 
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structures in the MALDI-TOF MS spectrum in the Figure 64) these results suggest the stage 
specificity of the Gal-Fuc chitobiose core modifications observed in adult H. contortus. 
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MS/MS of  1489  m/z
HC L3 PNGase-A 35% acn
Figure 66 MALDI-TOF-TOF MS/MS spectrum of permethylated PNGase A released m/z 
1489 from L3 H. contortus N-glycan.The blue arrowed horizontal lines represent loss of 
indicated structural fragments from the parental molecular ion. 
 
No distal GlcNAc fucosylation has been observed in previous FAB-MS data (Haslam et al., 
1998). However minor amounts have been detected by MALDI instrumentation in PNGase F 
released N-glycans (see Figure 63). To further confirm distal GlcNAc fucosylation the 
molecular ion at m/z 1489 observed in L3 stage H. contortus PNGase-A released N-glycans 
MALDI-MS spectrum (see Figure 64) has been fragmented as seen in the Figure 66. 
Fragment ions at m/z 648 and 864 correspond to di-fucosylated proximal GlcNAc and its loss 
from the molecular ion, respectively. The fragment ion at m/z 463 confirms the presence of 
two mannoses on the non-reducing end. The ‘Z’-type (Domon, Costello 1988) fragment ion 
at m/z 1283 corresponds to elimination of fucose from the 3-position of the GlcNAc. The 
fragment ion at m/z 676 corresponds to the loss of fucose and di-fucosylated proximal 
167 
 
GlcNAc. Overall the data confirms the tri-fucosylated N-glycan with two fucoses being 
attached to the proximal GlcNAc and the third fucose to the distal GlcNAc. 
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3.5 Structural characterization of the O-glycome of L3 stage H. 
contortus 
3.5.1 MALDI-MS analysis of reductively eliminated, permethylated O-glycans from 
infective L3 stage H. contortus parasite 
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Figure 67 MALDI-TOF MS spectrum of permethylated reductively eliminated O-glycans 
from L3 H. contortus (35% acetonitrile fraction). All of the proposed structures are based on 
the MALDI-TOF-TOF MS/MS analyses (peaks marked with an asterisk*), the knowledge of 
biosynthetic pathways in adult H. contortus and other organisms. ‘amu’ stands for atomic 
mass units. 50% acetonitrile fraction has not been shown as no new structures have been 
detected. 
 
To our knowledge there are no literature reports available for O-glycans of L3 H. contortus. 
For this reason the O-glycans from the glycopeptides remaining after the PNGase A digestion 
were reductively eliminated and the MALDI-TOF MS spectrum is seen in Figure 67. A 
simpler spectrum was obtained compared to the adult stage O-glycans (see Figure 60, top) 
with a lack of fucosylated structures. The major molecular ions at m/z 534, 575, and 738 
suggest the presence of Core 1, HexNAc2 and Schisto Core structures. In addition a family of 
putative O-glycans at m/z 628, 832, 926 corresponding to the potential Core 1 structure with 
an extra 94 atomic mass unit modification and the Schisto Core structure with one and two 
169 
 
aforementioned modifications, respectively. A mass increment of 94 is consistent with a fully 
methylated phosphate group. 
 
3.5.2 GC-MS linkage analysis of partially methylated alditol acetates obtained from L3 
H. contortus O-glycans 
 
Elution 
time 
Characteristic fragment ions Assignment Relative 
abundance 
16.93 115,118,131,162,175 Terminal fucose 0.03 
18.42 102,118,129,162,161, 205 Terminal glucose/mannose  0.13 
18.71 102,118,129,162,161, 205 Terminal galactose 0.46 
19.70 88,89,130,174,218,262 GalNAc-itol 1.00 
20.40 102, 118, 129, 189, 233 6-linked galactose  0.85 
20.89 88,130,133,246,290 3-linked GalNAc-itol 0.13 
21.69 88,117,130161,174,218 6-linked GalNAc-itol  0.17 
22.70 117, 159, 205 Terminal GalNAc 0.41 
23.23 117, 159, 233 4-linked GlcNAc 0.07 
Table 16. GC-MS analysis of partially methylated alditol acetates obtained from L3 infective 
stage H. contortus O-glycans released by reductive elimination. The relative abundance was 
calculated by measuring the total ion count (TIC) of each peak and dividing the value by the 
TIC of the most abundant peak. 
 
The GC-MS linkage analysis of partially methylated alditol acetates obtained from L3 O-
gycans is seen in Table 16. The terminal galactose is consistent with the proposed Galβ1-
3GalNAc Core 1 and the Galβ1-3(Galβ1-6)GalNAc Schisto Core structures. The first is also 
supported by the presence of the 3-linked GalNAc-itol. The presence of the terminal GalNAc 
together with the 3- and 6-linked GalNAc-itols may represent potential GalNAcα1-3GalNAc 
Core 5 and GalNAcβ1-6GalNAc Core 7 structures, respectively. The presence of the 6-linked 
galactose may suggest the position of the potential phosphorylation. The presence of the 4-
linked GlcNAc together with the co-eluting glucose/mannose peak can be explained by 
reductive elimination of some residual mannose N-glycan structures and/or often observed 
glucose contamination. The presence of the terminal fucose is also most likely explained by 
reductive elimination of some residual N-glycans. The 3, 6-linked GalNAc-itol has not been 
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observed and it is most likely explained by the decreased detection sensitivity of later time-
eluting monosacharides usually observed in GC-MS linkage analysis as well as signal 
suppression effects of co-eluting contaminants. On the other hand the presence of 3, 6-linked 
GalNAc-itol is strongly suggested by the MALDI-TOF-TOF fragmentation of the molecular 
ion at m/z 738 as seen later in the Figure 70. It is interesting to note the presence of the most 
abundant peak corresponding to GalNAc-itol which acts as a substrate for other O-glycans.  
However, the presence of a single HexNAc was not observed in the MALDI-MS spectra 
(Figure 67) due to the low cut-off mass value of 500 m/z as below this value the spectrum is 
usually dominated by low MW contaminant ions, for example coming from the matrix. 
 
3.5.3 MALDI-MS/MS analyses of reductively eliminated, permethylated O-glycans from 
L3 H. contortus  
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Figure 68 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
534 O-glycan from L3 stage H. contortus. The blue arrowed horizontal; line represents the 
loss of depicted fragment from the parental molecular ion. 
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To confirm the presence of Galβ1-3GalNAc core 1 structure the molecular ion at m/z 534 
(see Figure 67) was fragmented by MALDI-TOF-TOF MS/MS instrumentation. The 
resultant spectrum seen in the Figure 68 demonstrates fragments typical for core 1 O-glycan. 
The most abundant fragment ion at m/z 298 corresponds to the ‘Z’-type (Domon, Costello 
1988) ion of the reducing-end HexNAc suggesting it being 3-linked. The minor ‘Y-type’ ion 
(Domon, Costello 1988) for the reducing-end HexNAc is observed at m/z 316. The fragment 
ion at m/z 259 corresponds to the non-reducing end hexose. Together with the terminal 
galactose and 3-linked GalNAc-itol seen in GC-MS experiment (see section 3.5.2) these 
results strongly suggest the presence of Galβ1-3GalNAc core 1 O-glycan structure. 
 
Figure 69 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
575 O-glycan from L3 stage H. contortus. The blue arrowed horizontal; line represents the 
loss of depicted fragment from the parental molecular ion 
 
To obtain more structural information about the HexNAc2 core, the molecular ion at m/z 575 
has been fragmented by MALDI-TOF-TOF as seen in the Figure 69. One of the most 
abundant ions at m/z 298 is a ‘Z-type’ ion (Domon, Costello 1988) which is favoured when 
the non-reducing end HexNAc is 3-linked to the reducing-end GalNAc. The corresponding 
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‘C-type’ ion (Domon, Costello 1988) is at m/z 300. Together with the 3-linked GalNAc-itol 
observed in the GC-MS data (see section 3.5.2), it provides strong evidence for the 
HexNAc1-3GalNAc-itol structure. On the other hand ‘the Y-type’ ion (Domon, Costello 
1988) at m/z 316, together with the corresponding ‘B-type’ ion (Domon, Costello 1988) at 
m/z 282, suggests that terminal HexNAc may be 4- or 6-linked to the reducing-end GalNAc. 
The GC-MS data (see section 3.5.2) indicates the presence of the 6-linked GalNAc-itol and, 
together with the terminal GalNAc, suggests the possible GalNAcα1-3GalNAc core 5 and/or 
GalNAcβ1-6GalNAc core 7 structures.  
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Figure 70 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
738 O-glycan from L3 H. contortus 
 
To confirm the presence of the proposed Galβ1-3(Galβ1-6)GalNAc Schisto Core structure, 
the molecular ion at m/z 738 has been further fragmented by the MALDI-TOF-TOF MS/MS 
approach (see Figure 70). The molecular ions at m/z 259 and 502 together with the absence 
of the fragment ion at m/z 463, indicate that both hexoses are linked to the reducing end 
GalNAc. The ‘Z-type’ ion for the HexHexNAc fragment at m/z 502 being more abundant that 
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the ‘Y-type’ ion (Domon, Costello 1988) at m/z 520, strongly suggests one of the hexoses 
being attached to the 3-position of the GalNAc. All these results are consistent with the 
proposed Galβ1-3(Galβ1-6)GalNAc Schisto Core structure. 
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Figure 71 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
832 O-glycan from L3 H. contortus. The blue arrowed horizontal line represents the loss of 
depicted fragment from the parental molecular ion.  
 
To test whether the molecular ions at m/z 628, 832, 926 actually correspond to the sugars 
modified with proposed modification(s) of the 94 amu, the molecular ion at m/z 832 has been 
further fragmented by the MALDI-TOF-TOF approach as seen in the Figure 71. Indeed 
fragment ions at m/z 502 and 706 suggest the presence of the modified O-glycan molecular 
ion. The fragment ion at m/z 149 corresponds to the 94 amu modification ion alone and the 
fragment ion at m/z 353 is explained by the 94 amu-modified hexose fragment ion. The 
abundant fragment ion at m/z 502 suggests the modified hexose linked to the 3-position of the 
HexNAc and the fragment ion at m/z 596 to the putative 6-position. The most abundant 
fragment ion at m/z 706 corresponds to the elimination of the proposed modification. The 
most likely explanation for the 94 amu modification is phosphorylation of the sugar where 
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both hydroxyl groups of the phosphate have been methylated during the standard 
permethylation procedure whilst preparing the O-glycans for the MALDI analysis. 
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Figure 72 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
926 O-glycan from L3 stage H. contortus. The blue arrowed horizontal lines represent the 
loss of depicted fragments from the parental molecular ion.  
 
To investigate whether two phosphate groups seen in the molecular ion at m/z 926 are 
attached to one or two separate hexoses, the MALDI-TOF-TOF analysis has been performed 
as seen in the Figure 72. The presence of the fragment ions at m/z 353 and 596 indicate one 
phosphate being attached to one hexose residue. Together with the absence of the fragment 
ions at m/z 447, 502, 520 these results strongly suggest each hexose being phosphorylated by 
the one phosphate group.  
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3.6 Structural conclusions of H. contortus parasite glycomes 
3.6.1. Structural conclusions of adult N-glycans 
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Figure 73: proposed structural conclusions of novel N-glycan structures discovered in the 
Haemonchus contortus adult parasite.  
 
In this thesis I report the discovery of novel Gal-Fuc chitobiose core modifications in adult H. 
contortus (see Figure 73) which were not observed previously using older FAB-MS 
instrumentation (Haslam et al., 1996). When this moiety is 6-linked to the proximal GlcNAc 
it has been unequivocally established as Galβ1-4Fuc. The Galβ1-4Fuc structure 6-linked to 
the proximal GlcNAc has been previously reported in C. elegans (Hanneman et al., 2006). 
The potential galactosyltransferase GALT-1carrying out the galactosylation of 6-linked 
fucose has been found (Titz et al., 2009) and galectins LEC-6, LEC-10 from C. elegans as 
well as CGL2 from ink cap mushroom were shown to be able to bind this type of chitobiose 
core modification (Butschi et al., 2010; Maduzia et al., 2011; Takeuchi et al., 2008). The 
structure has also been found in octopus rhodopsin (Zhang et al., 1997), squid rhodopsin 
(Takahashi et al., 2003), Ascaris suum (Yan et al., 2012), Oesophagostomum dentatum (Yan 
et al., 2012), keyhole limpet haemocyanin (Wuhrer et al., 2004) and planaria Dugesia 
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japonica (Paschinger et al., 2011). Interestingly in keyhole limpet haemocyanin one galactose 
can be further modified at the 4-position with another Galβ1 residue (Wuhrer et al., 2004) 
and in D. japonica it can be capped with methylated hexose (Paschinger et al., 2011). Also 
the opportunistic human pathogen Acanthamoeba also has a Hex-Fuc modification 6-linked 
to the proximal GlcNAc. However, the identity of hexose was proven to be mannose (Schiller 
et al., 2012). Very recently the Hex-Fuc modification on the 6-position of the proximal 
GlcNAc has been reported in H.contortus (Paschinger and Wilson, 2015). Based on the 
knowledge of C.elegans biosynthetic pathways the authors proposed this modification to be 
Gal-Fuc (Paschinger and Wilson, 2015) which is in full agreement with the data presented in 
my thesis. 
The Hex-Fuc structure 3-linked to the distal GlcNAc was first observed in C. elegans by 
Hanneman and colleagues (Hanneman et al., 2006). Later the hex-2 and hex-3 genes coding 
for hexosaminidases, the enzymes removing non-reducing end GlcNAc were knocked out in 
C. elegans (Yan et al., 2012). This strain showed up-regulation of Hex-Fuc structure 3-linked 
to the distal GlcNAc (Yan et al., 2012). MS and MS/MS analysis coupled with α-
galactosidase treatment showed it to be Galα1-2Fuc 3-linked to the distal GlcNAc (Yan et al., 
2012). In our case Gal-Fuc 3-linked to the distal GlcNAc proved to be resistant not only to 
β1-4 specific galactosidase and broad specificity β-galactosidase but also to broad specificity 
α-galactosidase. On the other hand the presence of 2-linked fucose in GC-MS analysis as well 
as indicative cross-ring fragments of this structure suggest that Gal-Fuc 3-linked to the distal 
GlcNAc is most likely a Galα1-2Fuc structure. The inability of broad specificity α-
galactosidase to remove the hexose can be explained by the unusual three-dimensonal 
galactose presentation for the enzyme. In 2015 Wilson and colleagues reported the Galα1-
2Fuc modification on the 3-position of the distal GlcNAc in H. contortus (Paschinger and 
Wilson, 2015). Interestingly they managed to show the partial digestion of galactose from 
this structure by green coffee bean α-galactosidase on the HPLC-purified N-glycan fraction 
(Paschinger and Wilson, 2015). Nevertheless the proportion of the digested N-glycan was 
very small (Paschinger and Wilson, 2015) confirming the earlier proposed difficulties for 
available exoglycosidases to act unusual nematode glycans. 
Unexpectedly the Galα1-2Fuc structure was also observed on non-reducing terminus 
HexNAc2 antenna where it is 3-linked to the innermost HexNAc thus forming to our 
knowledge previously unseen in any organisms modified LDNF structure where fucose is 2-
linked to the capping hexose (likely galactose).  The proposed LDNF structures are also 
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supported by the presence of the terminal GalNAc in the GC-MS data. The presence of 
LDNF structure in H. contortus has been suggested earlier based on vaccination studies in 
sheep (Geldhof et al., 2005; van Stijn et al., 2010b; Vervelde et al., 2003). Upon hydrofluoric 
acid treatment the poly-HexNAc antennae comprising up to 5 and potentially more HexNAc 
units were observed. Due to sample complexity and low abundance it is hard to make 
definitive conclusions, however the presence of up to five fucoses and Hex-Fuc modified 
LDN antennae prior to HF treatment and only fucose being present on the proximal GlcNAc 
after the treatment indicates the α1-3 hydrolysis of Hex-Fuc structures from the modified 
LDN antennae. The presence of poly-Hex-Fuc-(HexNAc)HexNAc antennae prior to HF 
treatment has not been confirmed, but not ruled out due to the low abundance of higher 
molecular weight peaks potentially explaining the nature of poly-HexNAc structures. On the 
other hand it could also be explained by the new family of N-glycans bearing PC moieties 
which have been reported in H. contortus using mass spectrometry (Paschinger and Wilson, 
2015) and Western blot (Kooyman et al., 2009) approaches. Poly-GlcNAc chitobiose 
oligomers with capping GalNAc or GlcNAc structures have been observed in human O. 
volvulus, bovine O. gibsoni and rodent A. vitae parasites. However, the origin of H. contortus 
poly-HexNAc antennae as PC-bearing N-glycans and/or as poly-modified LDNF antennae 
remains an open question. 
 
3.6.2. Structural conclusions of adult O-glycans 
 
In this thesis data on H. contortus O-glycans has been presented for the first time (see Figure 
74). The majority of adult O-glycans are Galβ1-3(GlcNAcβ1-6)GalNAc Core 2 structures 
with modifications on the GlcNAcβ1-6 branch. The GlcNAc can be fucosylated at the 3-
position and then the galactose can be added to the likely 4-position of the GlcNAc forming 
Lewisx terminal structure. Gal α1-2 can also cap the fucose forming the previously unseen 
modified Lewisx structure. Instead of galactose, GalNAc can be added to the 4-position of the 
GlcNAc forming previously reported LDN structures (Vervelde et al., 2003) which can be 
further modified by galactose forming Gal α1-2Fuc structures. In addition galactose can cap 
the terminal GalNAc forming the Galα1-3GalNAc structures previously suggested by (van 
Stijn et al., 2010b) using antibody arrays technology. As previously described Galα1-2Fuc 
modifications have also been observed in the adult N-glycome where it was found on the 3-
position of the distal chitobiose core GlcNAc and 3-position of the non-reducing end LDN 
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antenna GlcNAc monosaccharide. Together these findings may suggest the presence of α1-2 
galactosyltransferase acting on the fucoses attached to the 3-positions of GlcNAc’s. 
However, more than one α1-2 galactosyltransferase is not ruled out. Interestingly the closely 
related C. elegans has been reported to have over 20 putative α1-2 galactosyltransferases 
(Zheng et al., 2002) making it likely that more than one α1-2 galactosyltransferase is active in 
H. contortus. In addition the potential Galβ1-3GalNAc Core 1, GalNAcβ1-6GalNAc Core 6 
and Schisto Core O-glycans (Khoo et al., 2001) have been observed as well in the H. 
contortus adult O-glycome although these type of O-glycans did not form extended families 
as seen for Core-2 structures. 
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Figure 74 proposed structural conclusions of O-glycan structures discovered in the 
Haemonchus contortus adult parasite 
 
 
 
 
 
179 
 
3.6.3. Structural conclusions of L3 stage N- and O-glycans 
 
When comparing the L3 stage N- and O-glycomes with adult H. contortus, the diminished 
complexity of structures detected is consistent with transcriptomics studies of this parasite 
where down-regulation of many genes in L3 stage has been reported (Laing et al., 2013; 
Schwarz et al., 2013). High mannose structures, complex structures with terminal GlcNAc, 
proximal GlcNAc fucosylation at 3- and 6-positions and to a smaller extent fucosylation of 
distal GlcNAc at 3-position, these N-glycan structures were observed in L3 stage as well as 
adult parasites however no chtiobiose core or LDNF galactosylation has been observed in L3 
based on MALDI experiments. The O-glycome of L3 revealed the presence of Galβ1-
3GalNAc Core 1, potential GalNAcα1-3GalNAc Core 5 and GalNAcβ1-6GalNAc Core 7 as 
well as Schisto Core (Khoo et al., 2001) -containing O-glycans. On the other hand no adult 
Core 2 structures with Galα1-2Fuc modifications on 3-positions of GlcNAc’s in LacNAc, 
LDN, Galα1-3GalNAcβ1-4GlcNAc structures were observed. Interestingly the 
phosphorylation of the Schisto Core galactose(s) has been observed however whether it is 
phosphorylation of galactoses only or it forms a larger post-translational modification with 
part of it being lost during preparation procedures remains unknown.  
The phosphorylation of glycans in the form of phosphorylcholine residue is relatively well 
characterized post-translational modification happening in nematodes (Harnett and Harnett, 
2001; Harnett et al., 2010) and recently suggested to be present in H. contortus (Kooyman et 
al., 2009; Paschinger and Wilson, 2015). The phosphorylated mannose has been previously 
observed in lysosome-targeted enzymes (Coutinho et al., 2012) and in α-dystroglycan protein 
(Yoshida-Moriguchi et al., 2010). The mannoses modified at 2- and 6-positions with 
phosphoethanolamine residues are known to be present in GPI-anchors (Paulick and Bertozzi, 
2008).The phosphorylation at 3-position of GlcNAc residue in LacdiNAc-modified 
extracellular matrix glycoproteins has been also reported (Breloy et al., 2012). To our 
knowledge no phosphorylated galactoses have been reported to date. 
 
 
 
 
 
180 
 
 
 
 
 
 
 
 
Chapter 4 
 
Structural characterization of  
Dictyocaulus viviparus N- and O-glycomes 
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4.1 Introduction 
An introduction to Dictyocaulus viviparus is provided in Chapter 1. This section summarises 
significant information that places my thesis work in context. D. viviparus is an economically 
important parasite which infects cattle in the temperate regions across the world. It resides in 
the lungs causing bronchitis, loss of weight and occasional death of the animal bringing 
financial damage to the farmers. To control D. viviparus infection a nematode vaccine called 
‘Huskvac’ or ‘Dictol’ is available based on attenuated L3 larvae. However it has many 
drawbacks such as the need for calf donors, instability, short shelf-live and batch-to batch 
variations (Bain, 1999). Another way to control infection is by using anthelminth drugs. 
However, they also have major limitations such as an increase in parasite resistance (Kaplan, 
2004; Taman and Azab, 2014). Early vaccination attempts with purified D. viviparus 
acetylcholinesterase showed promising results (McKeand et al., 1994a, b). However 
immunization attempts with recombinant acetocholinesterase failed (Matthews et al., 2001). 
With the failure of the recombinant approach the need for cheap, reproducible and effective 
vaccines focused scientific attention onto the development of carbohydrate-based vaccines 
(Astronomo and Burton, 2010). Nevertheless one of the major bottlenecks in their 
development is the lack of well-defined carbohydrate structures. 
The only structural studies on adult D. viviparus glycome were performed by Haslam and 
colleagues in 2000 using FAB-MS technologies (Haslam et al., 2000). The study revealed an 
abundance of Lewisx epitopes in N-glycans as well as the presence of LacNAc, proximal 
GlcNAc fucosylation at the 6-position and high mannose structures (Haslam et al., 2000). No 
data have been reported for adult O-glycans. Neither has structural characterization been 
performed on L3 stage N- or O-glycans. As discussed in sections 1.3.4 and 1.3.5, with the 
advent of new mass-spectrometry technologies FAB has been replaced by MALDI ionisation 
method and new MALDI-TOF instruments have proven to be more sensitive, detecting 
glycans with higher m/z ratios and have lower signal to noise ratios (Babu et al., 2009b; North 
et al., 2010a) compared to older FAB-MS instruments (Fukuda et al., 1984). For this reason 
the aim of the studies described in this chapter was to revisit structural characterization of 
adult D. viviparus N-glycans using MALDI-MS instrumentation as well as for the first time 
to provide data for N-gycans of L3 stage and O-glycans of both L3 and adult stage parasites. 
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4.2 Structural characterization of the N-glycome of adult D. 
viviparus 
4.2.1 MALDI-MS analysis of permethylated PNGase F released N-glycans from adult D. 
viviparus  
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Figure75 MALDI-TOF MS spectrum of permethylated 50% acetonitrile fraction N-glycans 
released from D. viviparus adult stage whole worm extracts by PNGase F (35% acetonitrile 
fraction is not shown as no new structures have been detected). The structures proposed are 
based on the further MALDI-TOF-TOF MS/MS fragmentation (peaks marked with an 
asterisk*), previous publication (Haslam et al., 2000) and the knowledge of biosynthetic 
pathways.  
 
The PNGase-F released N-glycans from adult D. viviparus were analysed by MALDI-TOF 
MS to assess if any structures previously not detected by FAB-MS analysis (Haslam et al., 
2000) could be found. The MALDI-TOF MS spectrum can be seen in the Figure 75. The 
major glycan families seen are high mannose structures with the general composition of 
Man5-9 GlcNAc2, paucimannosidic Man1-4 GlcNAc2, truncated fucosylated Man2-
3FucGlcNAc2 and complex bi-, tri- and tetra-antennary structures with the general 
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composition of Hex3-7Fuc0-5 HexNAc3-6. All these glycan families seen in the MALDI-TOF 
MS spectrum have been observed earlier in the FAB-MS analysis (Haslam et al., 2000). 
 
4.2.2 MALDI-MS/MS analysis of permethylated PNGase F released N-glycans from 
adult D. viviparus  
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Figure76 MALDI-TOF-TOF MS/MS spectrum of permethylated PNGase F released m/z 
3215 N-glycan. The blue horizontal arrowed lines represent the loss of depicted fragments 
from the parental molecular ion. The proposed monosaccharide configurations is fully 
consistent with the previous publication of (Haslam et al., 2000) and knowledge of 
biosynthetic pathways in other organisms. 
 
In order to investigate the presence of new possible structural isomers not observed 
previously by the FAB-MS instrumentation (Haslam et al., 2000) the molecular ions at m/z 
1171, 1345, 1416, 1375, 1579, 1590, 1661, 1794, 1835, 1906, 2396, 3041, 3215 from the 
MALDI-TOF MS spectrum (see Figure 75) were further fragmented by MALDI-TOF-TOF. 
Exemplar data is shown for the molecular ion at m/z 3215 in Figure 76. The abundant 
fragment ions at m/z 2578 and 660 indicate the presence of the earlier observed (Haslam et 
al., 2000) Lewisx (Galβ1-4(Fucα1-3)GlcNAc) structure. The fragment ion at m/z 1941 
originates from the loss of two Lewisx structures. The fragment ions at m/z 474 and 2764 
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indicate the fucosylation of the reducing-end GlcNAc. Overall the fragment ions suggest a 
core-fucosylated complex N-glycan with three Lewisx antennae which was reported 
previously using FAB-MS instrumentation (Haslam et al., 2000). MALDI-TOF-TOF MS/MS 
analyses of the other molecular ion peaks (data not shown) are also consistent with the earlier 
reported FAB-MS derived structures (Haslam et al., 2000) and indicate no new N-glycan 
structures detected by ultrasensitive MALDI instrumentation.  
 
4.2.3 MALDI-MS analysis of permethylated PNGase A released N-glycans from adult 
D. viviparus  
Adult D. viviparus glycopeptided remaining after the PNGase F digestion were subjected to 
subsequent PNGase A digestion to test for the presence of N-glycans with 3-linked fucose on 
the reducing-end GlcNAc. The MALDI-TOF MS spectrum (data not shown) did not reveal 
any glycan peaks indicating the absence of this N-glycan population in adult D. viviparus. 
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4.3 Structural characterization of the O-glycome of adult D. 
viviparus 
4.3.1 MALDI-TOF MS analysis of reductively eliminated, permethylated O-glycans 
from adult D. viviparus  
To our knowledge no literature reports have been previously published for adult D. viviparus 
O-glycans. Therefore glycopeptides remaining after enzymatic removal of N-glycans were 
subject to reductive elimination with the resultant MALDI-TOF MS spectrum of the 
permethylated O-glycans shown in the Figure 77 and Table 17. The most abundant peak at 
m/z 534 compositionally corresponds to the Galβ1-3GalNAc Core 1 structure. From the 
MALDI-MS compositional analysis we can propose core 1, Schisto core and core 2 structures 
for the molecular ions at m/z 534, 738 and 779. However to provide more evidence and 
collect more structural information about the molecular ions at m/z 575, 983, 1157 all of the 
aforementioned peaks have been fragmented by MALDI-TOF-TOF with the exemplar data 
shown for the peaks at m/z 534, 575, 738, 779, 1157 as seen in the section 4.3.3. 
 
Figure77 MALDI-TOF MS spectrum of permethylated, 35% acetonitrile fraction O-glycans 
released from the adult D. viviparus adult stage whole worm extracts by reductive elimination 
(50% acetonitrile fraction is not shown as no new structures have been observed). The 
structures marked with asterisk* were later subject to MALDI-TOF-TOF analyses. It is 
important to note that MALDI-TOF-MS experiment provides compositional data only shown 
in Table 17 and the proposed structures are based on other experiments described further in 
the chapter. 
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m/z value composition RA s1 RA s2 
534 HexHexNAc 1 1 
575 HexNAc2 0.12 0.056 
738 Hex2HexNAc 0.20 0.029 
779 Hex HexNAc2 0.29 0.054 
983 Hex2HexNAc2 0.20 0.025 
1157 FucHex2HexNAc2 0.10 0.014 
Table 17 The assignment and relative quantification of molecular ions observed in MALDI-
TOF-MS spectrum (see Figure 77) of permethylated (35% acetonitrile fraction), reductively 
eliminated O-glycans of adult D. viviparus. The relative abundance (RA) was calculated by 
measuring the total ion count (TIC) of each peak and dividing the value by the TIC of the 
most abundant peak. RA-relative abundance, SD- standard deviation, SEM- standard error of 
the mean, N/D- not detected, N/A- non applicable, s- sample. For formulas and calculations 
of the mean, variance, SD and SEM see section ‘2.2.14’. 
 
4.3.2 GC-MS linkage analysis of adult D. viviparus O-glycans released by β-reductive 
elimination 
The GC-MS linkage data analyses for the reductively eliminated O-glycans are summarized 
in the Table 18. The presence of the terminal fucose, 3, 4-linked GlcNAc and terminal 
galactose are consistent with the Lewisx structure proposed for the molecular ion at m/z 1157. 
The 4-linked GlcNAc and earlier mentioned terminal galactose support the proposed LacNAc 
(Galβ1-4GlcNAc) structure seen in the molecular ion at m/z 983. The presence of the 
terminal GlcNAc may indicate that the molecular ion peak at m/z 779 is Core 2 O-glycan 
although the presence of the terminal GalNAc may indicate other configurational isomers. In 
the same way the molecular ion peak at m/z 575 may contain both terminal GlcNAc and 
terminal GalNAc. The linkage between two HexNAcs in the molecular ion at m/z 575 
remains unknown since the only mono-substituted GalNAc-itol is 3-linked although the 
biosynthetically likely 6-linked GalNAc-itol was possibly not detected due to the low 
abundance of the molecular ion at m/z 575. The presence of both 3-and 6-linked GalNAc-itol 
is supported by the MALDI-TOF-TOF fragmentation of the molecular ion at m/z 575 
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discussed earlier. The 3-linked GalNAc-itol is consistent with the proposed Core 1 structure 
and the 3, 6-linked GalNAc-itol complies with the Core 2 and Schisto Core structures. 
Interestingly the most abundant peak corresponds to GalNAc-itol which is a precursor for the 
biosynthesis of other O-glycans observed. This monosaccharide was not detected by MALDI-
MS due to the 500 m/z lower mass limit setting of the instrument, chosen because of high 
levels of contaminant matrix peaks in the lower mass region. 
 
Elution 
time 
Characteristic fragment ions Assignment Relative 
abundance 
16.93 115,118,131,162,175 Terminal fucose 0.19 
18.42 102,118,129,162,161, 205 Terminal glucose/ 
mannose (likely 
contaminant) 
0.37 
18.71 102,118,129,162,161, 205 Terminal galactose 0.64 
19.68 88,130,174,218,262 GalNAc-itol  1.00 
20.86 88,130,246,290 3-linked GalNAc-
itol 
0.59 
22.24 117, 159, 205 Terminal GlcNAc 0.17 
22.61 88,130,161,246,318 3,6-linked 
GalNAc-itol 
0.08 
22.69 117, 159, 205 Terminal GalNAc 0.12 
23.13 117,159, 233 4-linked GlcNAc 0.47 
23.98 117, 159, 244, 301 3,4-GlcNAc 0.13 
 
Table 18 GC-MS analysis of partially methylated alditol acetates obtained from adult D. 
viviparus O-glycans released by reductive elimination (35% acetonitrile fraction). The 
relative abundance was calculated by measuring the total ion count (TIC) of each peak and 
dividing the value by the TIC of the most abundant peak. 
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4.3.3 MALDI-TOF-TOF MS/MS analysis of reductively eliminated, permethylated O-
glycans from adult D. viviparus  
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Figure78 MALDI-TOF-TOF MS/MS spectrum of 35% acetonitrile permethylated 
reductively eliminated m/z 534 adult D. viviparus O-glycan. The blue arrowed horizontal line 
represents the loss of indicated structural fragment from the parental molecular ion. The 
proposed monosaccharide configurations are based on GC-MS data (see section 4.3.2) and 
knowledge of biosynthetic pathways in other organisms 
 
To confirm the presence of the Galβ1-3GalNAc core 1 structure, the molecular ion at m/z 534 
observed in the MALDI-MS spectrum (see Figure 77) was fragmented by MALDI-TOF-
TOF (see Figure 78). The most abundant fragment ion observed at m/z 298 corresponds to 
the reducing end ‘Z-type’ (Domon, Costello 1988) HexNAc ion suggesting it is 3-linked. The 
minor ‘Y’-type ion of the reducing-end HexNAc is observed at m/z 316. The fragment ion at 
m/z 259 corresponds to the non-reducing end hexose. Overall the spectrum is typical for core-
1 O-glycan fragmentation pathways and, together with the terminal galactose and 3-linked 
GalNAc-itol observed in GC-MS experiment (see section 4.3.2), confirms the presence of the 
core 1 O-glycan. 
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Figure 79. MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
575 adult D. viviparus O-glycan. The proposed monosaccharide configurations are based on 
GC-MS data (see section 3.3.2) and knowledge of biosynthetic pathways in other organisms. 
 
The MALDI-TOF-TOF fragmentation of the molecular ion at m/z 575 was performed (see 
Figure 79) to obtain some information on the linkage between the HexNAc residues. The 
presence of the Y-fragment ion (Domon, Costello 1988) at m/z 316 is consistent with the 
HexNAc attachment to the 6-position of GalNAc. On the other hand the presence of the most 
abundant Z-fragment ion (Domon, Costello 1988) at m/z 298 suggest the HexNAc is attached 
to the 3-position of the GalNAc. The fragment ions at m/z 282 and 300 correspond to B-type 
and C-type ions (Domon, Costello 1988) of the non-reducing end terminal HexNAc, 
respectively. This indicates the molecular ion at m/z 575 contains two isomers with the 
reducing end GalNAc beeing modified both at the 3- and 6- positions. 
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Figure 80 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
738 adult D. viviparus O-glycan. The proposed monosaccharide configurations are based on 
GC-MS data (see section 4.3.2) and knowledge of biosynthetic pathways in other organisms. 
 
To confirm the Galβ1-3(Gal β1-6)-GalNAc Schisto core (Khoo et al., 2001) the molecular 
ion at m/z 738 was fragmented by MALDI-TOF-TOF instrumentation. The resultant 
spectrum seen in the Figure 80 is characteristic of the proposed Shisto core structure (Khoo 
et al., 2001). The most abundant fragment ion at m/z 502 is the ‘Z’-type ion (Domon, Costello 
1988) of the reducing-end Hex-HexNAc suggesting HexNAc being 3-linked. The minor 
fragment ion at m/z 520 corresponds to the ‘Y’-type ion (Domon, Costello 1988) of reducing-
end Hex-HexNAc. The fragment ion at m/z 259 represents the non-reducing end hexose. 
Together with the 3,6-linked GalNAc-itol and terminal galactose observed in GC-MS 
experiment (see section 4.3.2) these results confirm the earlier proposed Galβ1-3(Gal β1-6)-
GalNAc Schisto core structure. 
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Figure 81 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
779 adult D. viviparus O-glycan. The proposed monosaccharide configurations are based on 
GC-MS data (see section 4.3.2) and knowledge of biosynthetic pathways in other organisms. 
 
To get more structural information the molecular ion at m/z 779 has been further fragmented 
by MALDI-TOF-TOF instrumentation (see Figure 81). The most abundant fragment ion at 
m/z 543 results by eliminating hexose from the molecular ion and the Z-type fragment nature 
(Domon, Costello 1988) indicates it is attached to the 3-position of the HexNAc. The 
fragment ion at m/z 520 results from the loss of the non-reducing end HexNAc and the Y-
type fragment nature (Domon, Costello 1988) suggests HexNAc is attached to the 6-position 
of the GalNAc. The fragment ions at m/z 259 and 282 correspond to terminal hexose and 
HexNAc, respectively. The fragment ion at m/z 284 corresponds to the internal reducing end 
GalNAc. Together with the terminal GlcNAc, terminal galactose and 3, 6-linked GalNAc-itol 
seen in GC-MS data (see section 4.3.2), the MALDI-TOF-TOF data are consistent with a 
GlcNAcβ1-6(Galβ1-3)GalANc Core 2 structure.  
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Figure 82 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
1157 adult D. viviparus O-glycan. The blue horizontal arrowed lines represent the loss of 
depicted fragments from the parental molecular ion. The proposed monosaccharide 
configurations are based on GC-MS data (see section 4.3.2) and knowledge of biosynthetic 
pathways in other organisms. 
 
The fragment ions at m/z 660 compositionally correspond to a Lewisx structure and the 
fragment ions at m/z 520 correspond to the loss of the Lewisx structure. The more abundant 
‘Z-type’ (Domon, Costello 1988) ions at m/z 951 in comparison to the ‘Y-type’ Domon, 
Costello 1988) ions at m/z 969 suggest more favoured elimination, not cleavage of the fucose 
residue indicating it being 3-linked. These results are consistent with the proposed Lewisx 
structure. The most abundant ‘Z-type’ (Domon, Costello 1988) fragment ion at m/z 921 
suggests the hexose is 3-linked which is consistent with the Core 2 structure having galactose 
attached to the 3-position of the reducing-end GalNAc. The eliminated galactose is seen as 
the fragment ion at m/z 259 although it can also originate from the Lewisx part of the 
molecular ion. Overall the fragment ions support the proposed modified Core 2 O-glycan 
where the GlcNAc branch forms the Lewisx structure which is supported by the 3,4-GlcNAc 
seen in GC-MS data (see section 4.3.2) and is also very abundant in the N-glycome of adult 
D. viviparus (see previous Figure 75). 
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4.3.4 The summary of reductively eliminated O-glycan structures from adult D. 
viviparus 
Putting all the data together acquired so far in the thesis about reductively eliminated O-
glycans from adult D. viviparus, the proposed structures with the corresponding m/z values 
can be seen below in Table 19.  
 
m/z value Proposed 
structurec 
534 
ß1-
3
 
575 
1-3
1-6
 
738 ß1-6
ß1-
3
 
779 
ß1-
3
ß1-6
 
983 ß1-6
ß1
-3
ß1-4
 
1157 
α1
-3
ß1-6
ß1
-3
ß1-4
 
Table 19 showing the proposed O-glycan structures released by reductive elimination from 
adult D. viviparus. 
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4.4 Structural characterization of the N-glycome of L3 stage D. 
viviparus 
4.4.1 MALDI-MS analysis of permethylated PNGase F released N-glycans from L3 
stage D. viviparus 
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Figure 83 MALDI-TOF MS spectrum of permethylated 50% acetonitrile N-glycans released 
from D. viviparus L3 stage whole worm extracts by PNGase F (35% acetonitrile fraction was 
not shown as no new structures were detected). The structures proposed are based on the 
further MALDI-TOF-TOF MS/MS fragmentation (peaks marked with an asterisk*), previous 
knowledge about the adult N-glycome (Haslam et al., 2000) and knowledge of biosynthetic 
pathways in other organisms.  
 
There are no literature reports on structural data of L3 D. viviparus N-glycans. The PNGase F 
released permethylated N-glycans were analysed by the MALDI-TOF MS analysis as seen in 
Figure 83. Abundant paucimannosidic structures with or without fucose and with the general 
composition of Man1-4Fuc0-1GlcNAc2 are observed. The other relatively abundant structures 
are high mannose Man5-9GlcNAc2 structures. In addition complex structures having the 
composition of Man3Fuc0-4GlcNAc3-5 are also relatively abundant in the L3 stage. In terms of 
the higher molecular weight complex structures in comparison with the adult parasite, these 
are more minor components suggesting stage specific differential expression in D. viviparus.  
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4.4.2 GC-MS linkage analysis of L3 D. viviparus N-glycans released by PNGase F 
Elution 
time 
Characteristic fragment ions Assignment Relative 
abundance 
16.96 115,118,131,162,175 Terminal fucose 0.12 
18.44 102,118,129,162,161, 205 Terminal mannose 1.00 
18.70 102,118,129,162,161, 205 Terminal galactose 0.09 
19.59 129, 130, 161, 190 2-linked mannose 0.84 
20.78 113, 129, 130, 190, 233 2,4-linked mannose 0.11 
21.17 129, 130, 189, 190 2,6-linked mannose 0.12 
21.33 118, 129, 189, 234 3,6-linked mannose 0.50 
22.26 117, 159, 205 Terminal GlcNAc 0.05 
23.12 117, 159, 233 4-linked GlcNAc 0.32 
23.98 117, 159 3,4-linked GlcNAc 0.03 
Table 20 GC-MS analysis of partially methylated alditol acetates obtained from L3 stage D. 
viviparus N-glycans released by PNGase F (35% acetonitrile fraction). The relative 
abundance was calculated by measuring the total ion count (TIC) of each peak and dividing 
the value by the TIC of the most abundant peak. 
 
The GC-MS linkage data analyses from the PNGase F released permethylated N-glycans are 
summarized in Table 20. The terminal, 2 and 3, 6-linked mannoses are consistent with the 
most abundant paucimannosidic and high mannose class of N-gycans in the L3 stage. The 
terminal GlcNAc is consistent with the initiation of antennae later becoming LacNAc and 
Lewisx structures. Terminal galactose and 4-linked GlcNAc are consistent with the LacNAc 
structure although the latter is also consistent with the distal GlcNAc of the chitobiose core. 
Low abundance of 3, 4-linked GlcNAc shows the Lewisx antennae as minor structures in the 
L3 stage in comparison to adult D. viviparus (see Figure 75). The terminal fucose is 
consistent with the proximal GlcNAc fucosylation and minor Lewisx structures in the sample. 
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4.4.3 MALDI-TOF-TOF MS/MS analysis of permethylated PNGase F released N-
glycans from L3 stage D. viviparus  
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Figure 84 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
2694 L3 stage D. viviparus N-glycan. The blue horizontal arrowed lines represent the loss of 
depicted fragments from the parental molecular ion. The proposed monosaccharide 
configurations are based on GC-MS data (see section 4.4.2), previous knowledge about adult 
N-glycome (Haslam et al., 2000) and knowledge of biosynthetic pathways in other 
organisms. 
 
To get more structural information the molecular ions at m/z 1345, 1416, 1590, 1661, 1783, 
1906, 2080, 2693 from the PNGase F released permethylated N-glycans were subjected to 
MALDI-TOF-TOF analyses and the exemplar spectrum of the ion at m/z 2694 is shown in 
the Figure 84. The fragment ions at m/z 486, 2231, 1767 suggest the presence of multiple 
LacNAc units in the N-glycan. The absence of the fragment ions corresponding to one 
antenna having more than one LacNAc unit strongly suggests the presence of three separate 
LacNAc units rather than elongated antennas. The fragment ions at m/z 474, 2243 indicate 
fucosylation of the reducing-end GlcNAc.  
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4.4.4 MALDI-MS analysis of permethylated PNGase A released N-glycans from L3 
stage D. viviparus  
The L3 stage D. viviparus glycopeptides remaining after PNGase F digestion were subjected 
to subsequent PNGase A digestion to test for the presence of any N-glycans with 3-linked 
fucose on the reducing-end GlcNAc. The MALDI-TOF MS spectrum (data not shown) did 
not reveal any glycan peaks indicating the absence of this N-glycan population in D. 
viviparus L3. 
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4.5 Structural characterization of the O-glycome of L3 stage D. 
viviparus 
4.5.1 MALDI-MS analysis of permethylated reductively eliminated O-glycans from L3 
stage D. viviparus 
The O-glycans remaining on D. viviparus L3 stage glycopeptides after PNGase F digestion 
were released by reductive elimination and the MALDI-TOF MS spectrum obtained can be 
seen in the Figure 85. In contrast to adult D. viviparus parasite where the O-glycans contain 
mostly Core 1, Core 2, and Schisto Core structures, the compositional MALDI-TOF MS O-
glycan profiling of the L3 stage parasite revealed the presence of a single potential Core 1 
structure at m/z 534 and a large family of hexose rich O-glycans bearing the likely Galβ1-3-
(Galβ1-6)-GalNAc Schisto Core structure. The O-glycans represented by the molecular ion 
peaks at m/z 912, 1116, 1321, 1525 also contain one fucose residue. The other O-glycans 
represented by the molecular ion peaks at m/z 738, 942, 1146, 1351, 1555, 1579, 1963, 2167 
have the molecular composition of HexNAc1Hex3-9.  
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Figure 85 MALDI-TOF MS spectrum of permethylated reductively eliminated 35% 
acetonitrile fraction O-glycans from D. viviparus L3 stage parasite (50% acetonitrile fraction 
is not shown as no new O-glycans were observed). The peaks marked with asterisk ‘*’ have 
been subjected to MALDI-TOF-TOF analyses at later stages. It is important to note that 
MALDI-TOF-MS experiment provides compositional data only shown in Table 21 and the 
proposed structures are based on other experiments described further in the chapter. 
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m/z 
value 
Composition RA s1 RA s2 RA s3 Mean Variance SD SEM 
534 HexHexNAc 0.55 0.40 0.53 0.49 0.0044 0.066 0.038 
738 Hex2HexNAc 1.0 1.0 1.0 1.0 0.0 0.0 0.0 
912 FucHex2HexNAc 0.059 0.026 0.018 0.034 0.00031 0.018 0.010 
942 Hex3HexNAc 0.36 0.14 0.10 0.20 0.013 0.11 0.066 
1116 FucHex3HexNAc 0.16 0.047 0.018 0.075 0.0038 0.061 0.035 
1146 Hex4HexNAc 0.11 0.032 0.019 0.054 0.0016 0.040 0.023 
1321 FucHex4HexNAc 0.0078 0.0035 N/D N/A N/A N/A N/A 
1351 Hex5HexNAc 0.048 0.0092 0.0016 0.020 0.00041 0.020 0.012 
1525 FucHex5HexNAc 0.0038 N/D N/D N/A N/A N/A N/A 
1555 Hex6HexNAc 0.018 N/D N/D N/A N/A N/A N/A 
1759 Hex7HexNAc 0.0067 N/D N/D N/A N/A N/A N/A 
1963 Hex8HexNAc 0.0031 N/D N/D N/A N/A N/A N/A 
2167 Hex9HexNAc 0.00090 N/D N/D N/A N/A N/A N/A 
Table 21. The assignment and relative quantification of molecular ions observed in MALDI-
TOF-MS spectrum (see Figure 85) of permethylated (35% acetonitrile fraction), reductively 
eliminated O-glycans of L3 stage D. viviparus. The relative abundance (RA) was calculated 
by measuring the total ion count (TIC) of each peak and dividing the value by the TIC of the 
most abundant peak. RA-relative abundance, SD- standard deviation, SEM- standard error of 
the mean, N/D- not detected, N/A- non applicable, s- sample. For formulas and calculations 
of the mean, variance, SD and SEM see section ‘2.2.14’. 
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4.5.2 GC-MS linkage analysis of partially permethylated alditol acetates of O-glycans 
released by reductive elimination from L3 stage D. viviparus 
The GC-MS linkage analysis was performed on partially methylated alditol acetates of the O-
glycans released by reductive elimination from L3 stage D. viviparus. The presence of the 3, 
6-linked GalNAc-itol is consistent with the earlier proposed Galβ1-3-(Galβ1-6)-GalNAc 
Schisto Core O-glycan structure. 3-linked GalNAc-itol is consistent with the Galβ1-3GalNAc 
Core 1 O-glycan structure proposed on the O-glycans MALDI-MS spectrum. The most 
abundant peak of terminal galactose together with the 2-linked, 3-linked, 6-linked, 2, 3-
linked, 3, 6-linked galactoses suggest the potential configurations of the hexoses.  
 
Elution 
time 
Characteristic fragment ions Assignment Relative abundance 
12.78 115,118,131,162,175 Terminal fucose 0.015 
14.53 102,118,129,162,161, 205 Terminal galactose 1.000 
15.30 88,89,130,174,218,262 GalNAc-itol  0.077 
15.61 129, 130, 161, 190 2-linked galactose  0.006 
15.66 118, 129, 161, 234 3-linked galactose 0.007 
16.15 102, 118, 129, 162, 189, 233 6-linked galactose 0.045 
16.42 88,130,133,246,290 3-linked GalNAc-itol 0.027 
16.47 129, 161, 262 2,3-linked galactose  trace 
17.26 118, 129, 189, 234 3,6-linked galactose 0.004  
18.18 118, 129, 189, 234 3,6-linked GalNAc-itol 0.050 
Table 22. GC-MS analysis of partially methylated alditol acetates obtained from L3 stage D. 
viviparus O-glycans released by reductive elimination (35% acetonitrile fraction). The 
relative abundance was calculated by measuring the total ion count (TIC) of each peak and 
dividing the value by the TIC of the most abundant peak. 
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4.5.3 MALDI-MS/MS analyses of permethylated reductively eliminated m/z 534 and 738 
O-glycans  
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Figure 86 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
534 L3 stage D. viviparus O-glycan. The blue horizontal arrowed line represents the loss of 
depicted fragment from the parental molecular ion. The proposed monosaccharide 
configurations are based on GC-MS data (see section 4.5.2) and knowledge of biosynthetic 
pathways in other organisms. 
 
To confirm the presence of the Galβ1-3GalNAc core 1 structure, the molecular ion at m/z 534 
observed in the MALDI-MS spectrum (see Figure 85) was fragmented by MALDI-TOF-
TOF as seen in the Figure 86. The spectrum shows the classical fragmentation of a core 1 O-
glycan. The most abundant fragment ion observed at m/z 298 corresponds to the reducing end 
‘Z-type’ (Domon, Costello 1988) HexNAc ion suggesting it is 3-linked. The minor ‘Y’-type 
ion of the reducing-end HexNAc is observed at m/z 316. The fragment ion at m/z 259 
corresponds to the non-reducing end hexose. Together with the terminal galactose and 3-
linked GalNAc-itol seen in the GC-MS experiment (see section 4.5.2), the data confirm the 
presence of the core 1 O-glycan. 
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Figure 87 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
738 L3 stage D. viviparus O-glycan. The proposed monosaccharide configurations are based 
on GC-MS data (see section 4.5.2) and knowledge of biosynthetic pathways in other 
organisms. 
 
To demonstrate the presence of the Galβ1-3(Gal β1-6)-GalNAc Schisto Core (Khoo et al., 
2001) the molecular ion at m/z 738 observed in the MALDI-MS spectrum (see Figure 85) 
has been fragmented by MALDI-TOF-TOF as seen in Figure 87. The most abundant 
fragment ion at m/z 502 corresponds to the ‘Z’-type ion (Domon, Costello 1988) of reducing-
end Hex-HexNAc suggesting HexNAc being 3-linked. The minor ‘Y’-type ion (Domon, 
Costello 1988) of reducing-end Hex-HexNAc is observed at m/z 520. The fragment ion at m/z 
259 corresponds to the non-reducing end hexose. Absence of a fragment ion at m/z 463 
corresponding to Hex-Hex, or fragment ions at m/z 298 and/or 316, corresponding to ‘Z’- and 
‘Y’-type ions (Domon, Costello 1988), excludes the possibility of two hexoses being linked. 
Together with the terminal galactose and 3, 6-linked GalNAc-itol observed in the GC-MS 
experiment (see section 4.5.2) these results confirm the earlier proposed Galβ1-3(Gal β1-6)-
GalNAc Schisto core structure. 
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4.5.4 MALDI-MSn analyses of permethylated reductively eliminated m/z 1116 O-glycan  
Figure 88  MALDI-QIT-TOF MS2 spectrum of permethylated reductively eliminated m/z 
1116 O-glycan from D. viviparus L3 stage. The proposed monosaccharide configurations are 
based on GC-MS data (see section 4.5.2) and knowledge of biosynthetic pathways in other 
organisms. 
 
 
 Additional levels of the structural information were obtained by selecting molecular ion 
peaks for a MALDI-QIT-TOF MSn fragmentation. The MS2 fragmentation of the molecular 
ion peak at m/z 1116 was performed (see Figure 88) to obtain information about the position 
of the fucose residue within the O-glycan. The major fragmentation peaks at m/z 502 and 637 
indicate two hexoses and a fucose moiety being 3-linked to the GalNAc. The 3-position was 
concluded based on the nature of the m/z 502 ion fragment which is Z-, rather than Y-ion 
(Domon, Costello 1988).  
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Figure 89 MALDI-QIT-TOF MS3 spectrum of m/z 637 fragment ions from permethylated 
reductively eliminated m/z 1116 O-glycan. Dashed arrowed lines on the proposed structure 
represent glycosidic bond cleavages and cross-ring fragments. The proposed monosaccharide 
configurations are based on GC-MS data (see section 4.5.2) and knowledge of biosynthetic 
pathways in other organisms. 
 
To provide additional structural confirmation the fragment ion at m/z 637 was subjected to 
MS3 analysis as seen in the Figure 89. The presence of the fragment ions at m/z 259 and 419 
corresponds to the non-reducing end hexose and its loss. Together with the absence of the 
Fuc-Hex fragment ion at m/z 433, this demonstrates that the fucose is attached to the 
innermost galactose rather than terminal galactose. The cross-ring fragment ions at m/z 271, 
389 and 359 could indicate fucose being 2-linked. The cross-ring fragment ions at m/z 315 
and 345 can be explained by the galactose being 3-linked to the other galactose. The cross-
ring fragments at m/z 489 and 519 are in accordance with the proposed Gal1-3(Fucα1-2)-Gal-
OH fragment ion which is also supported by the earlier presented GC-MS data (see section 
4.5.2) providing the evidence for the 2,3-linked galactose. It has to be noted that the GC-MS 
linkage data (see section 4.5.2) also provided evidence for the 3, 6- linked galactose. 
Nevertheless, the large combination of possible cross-ring fragments generated by the MSn 
analysis of the trisaccharide, in contrast to the disaccharide, makes these linkage assignments 
still tentative. In addition the cross-ring fragment ions at m/z 301, 359, 329 and 331 may 
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suggest a second structural isomer with the galactose being attached not to 3-, but 6-position. 
The absence of the 2, 6-linked galactose in the GC-MS experiment may be explained by the 
sensitivity limits of the instrument. 
 
4.5.5 MALDI-MS/MS analysis of permethylated reductively eliminated m/z 1146 O-
glycan  
 
Figure 90 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
1146 from L3 D. viviparus O-glycan. The proposed monosaccharide configurations are based 
on GC-MS data (see section 4.5.2) and knowledge of biosynthetic pathways in other 
organisms. 
 
To get more structural information about the poly-hexose family of O-glycans with the 
general composition of Hex3-9HexNAc1 one of its members giving the molecular ion at m/z 
1146, with a composition of Hex4HexNAc1, was subjected to MALDI-TOF-TOF MS/MS 
fragmentation as seen in the Figure 90. The fragment ion at m/z 910 corresponds to the Z-
type fragment ion (Domon, Costello 1988) which has lost a hexose from the 3-position of the 
GalNAc suggesting the structural isomer with three hexoses comprising the 6- linked branch 
and one galactose at the 3-position of the GalNAc. This structural isomer is also supported by 
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the fragment ion at m/z 520 resulting from the loss of three hexoses from the 6-linked branch. 
The fragment ion at m/z 259 can be explained by any non-reducing end terminal hexose. The 
fragment ions at m/z 706 and 463 can be explained by the structural isomer bearing two 
hexoses at both the 6-linked and the 3-linked branches of the Schisto Core O-glycan. It has to 
be noted that the fragment ion at m/z 463 can also originate from other structural isomers. 
Finally the fragment ions at m/z 502 and 667 correspond to the structural isomer bearing three 
hexoses on the 3-linked branch of the Shisto Core and one galactose on the 6-linked branch, 
although the fragment ion at m/z 667 can be generated from the structural isomer bearing 
three hexoses on the 6-linked branch. It needs to be emphasized that the linear or branched 
nature of the 3-linked and the 6-linked branches comprised of three hexoses at this stage 
remains ambiguous. The data therefore indicate the presence of several potential structural 
isomers. 
 
4.5.6 MALDI-MS/MS analyses of other permethylated reductively eliminated O-glycans 
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Figure 91 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
1524 O-glycan from the D. viviparus infective L3 stage parasite. ‘M’ denotes the major 
isomer and ‘m’ minor. The proposed monosaccharide configurations are based on GC-MS 
data (see section 4.5.2), previous results and knowledge of biosynthetic pathways in other 
organisms. 
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The molecular ion at m/z 1320 from MALDI-MS spectrum (see Figure 85) has been further 
fragmented by the MALDI-TOF-TOF MS/MS instrumentation as seen in the Figure 91. 
Major fragment ions at m/z 637 and 706 are observed corresponding to the Hex-Hex-Fuc 
fragment and its loss from the 3-position of the GalNAc. The fragment ions at m/z 259 
correspond to the terminal hexose ion. The fragment at m/z 415 corresponds to the internal 
Hex-Fuc structure. The fragment at m/z 463 corresponds to Hex-Hex structure. All these 
fragments originate from the major structural isomer present depicted in the Figure 91, left 
(denoted ‘M’). The fragment ions at m/z 841 and 502 correspond to a Hex3Fuc structure and 
its loss from the 3-position of the HexNAc and indicate the presence of the minor isomer 
which has three hexoses and fucose on the 3-branch of the GalNAc as seen in the Figure 91, 
right (denoted ‘m’). The MALDI-TOF-TOF fragmentation of another fucosylated molecular 
ion at m/z 1524 resulted in a spectrum of low quality (data not shown). Nonetheless two 
major fragment ions at m/z 637 and 910 suggested an analogous structure to that seen in 
Figure91, left (denoted ‘M’), but with a total of three, not two, hexoses on the 6-linked 
branch.  
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Figure 92 MALDI-TOF-TOF MS/MS spectrum of permethylated reductively eliminated m/z 
1759 O-glycan from the L3 stage D. viviparus. The proposed monosaccharide configurations 
are based on GC-MS data (see section 4.5.2), previous results and knowledge of biosynthetic 
pathways in other organisms. 
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The MALDI-TOF-TOF fragmentation of the molecular ion at m/z 1759 (see Figure 92) 
showed a similar fragmentation pattern to that observed for the molecular ion at m/z 1146 
(see Figure 90). Mixtures of isomers are likely to be present with both 3-and 6-linked 
branches of the Schisto Core containing up to six hexoses. The MS/MS fragmentation of the 
molecular ion at m/z 1963 with a composition Hex8HexNAc, although of low quality (data 
not shown), also suggested the similar pattern with seven potential structural isomers bearing 
from one to seven hexoses on both 3-and 6-linked branches. Due to its extremely low 
abundance, the MS/MS fragmentation of the highest molecular weight ion at m/z 2167 was 
not performed. 
4.5.7 MALDI-MS and MALDI-MS/MS analyses of permethylated reductively 
eliminated, broad specificity β-galactosidase digested O-glycans  
To try to assign a higher level of structural definition to the hexose rich O-glycans, the 
reductively eliminated O-glycans of D. viviparus L3 stage were subjected to bovine testes 
broad specificity β1-3,4,6-galactosidase digestion as seen in the Figure 93. It has to be noted 
for the rest of the chapter that enzymatic digestion experiments do not always go to 
completion and when digesting unusual glycan structures the removal of monosaccharides 
could be extremely difficult to accomplish (Paschinger et al., 2011). Also the Shisto core 
appears to be resistant to galactosidase digestion which is consistent with previous 
observations (Khoo et al., 2001). Despite these issues, changes in relative abundances can be 
very informative. The first observation when comparing the MALDI-TOF MS spectra before 
and after the digest is the decrease of the peak corresponding to the molecular ion at m/z 534 
confirming the earlier proposed Galβ1-3GalNAc Core 1 structure (see Figure 86). The 
appearance of the molecular ion peak at m/z 708, the appearance of the new structural isomer 
in the molecular ion peak at m/z 738, the disappearance of the old and appearance of the new 
structural isomer in the molecular ion peak at m/z 912, taken together is explained by the 
removal of the proposed β1-6 galactose from the GalNAc residue thus confirming the 
presence of the earlier proposed (see Figure 87) Galβ1-3-(Galβ1-6)-GalNAc Schisto Core. 
Another important observation is that the peaks above m/z 1146 corresponding to the higher 
molecular weight O-glycans with the general composition of Gal4-9Fuc0-1GalNAc1 have 
disappeared suggesting they carry β1-3/4/6-galactose(s). Finally, in contrast to the 6-linked 
branch hexoses, those attached to the 3-linked branch galactose of the Schisto Core seem to 
be resistant to the broad specificity β1-3, 4, 6-galactosidase enzyme.  
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Figure 93 MALDI-TOF MS spectrum (35% acetonitrile fraction) of permethylated O-
glycans released by reductive elimination and digested with bovine testes broad specificity 
β1-3, 4, 6 galactosidase. The MALDI-TOF-MS spectrum prior to the digest is given for 
reference purposes and has been shown earlier (Figure 85). The proposed structures are 
based on the MALDI-TOF-TOF MS/MS analyses (peaks marked with an asterisk*), previous 
results, GC-MS data (see section 4.5.2) and the knowledge of biosynthetic pathways. M’ and 
‘m’ represent major and minor structures, respectively.  
210 
 
To exemplify the broad specificity β1-3, 4, 6-galactosidase ability to remove the hexoses 
from the 6-linked branch compared to the hexoses attached to the 3-linked branch galactose 
the MALDI-TOF/TOF MS/MS spectra of the molecular ion peak at m/z 1146 before and after 
the enzymatic digest are shown in Figure 94. Prior to the enzymatic treatment the molecular 
ion at m/z 1146 was considered to potentially include three structural isomers having one and 
three, two and two, three and one hexoses on the 6-linked and 3-linked GalNAc branches, 
respectively. These structural isomers are supported by the similarly abundant ‘Z-type’ 
fragment ions (Domon, Costello 1988) at m/z 502, 706 and 910 resulting from the elimination 
of the hexose(s) from the 3-position of the GalNAc. Upon sample treatment with the broad 
specificity β1-3, 4, 6-galactosidase, the fragment ions at m/z 706 and 910 corresponding to 
the structural isomers with two and three hexoses respectively on the 6-linked GalNAc 
branch are significantly reduced. The only remaining structural isomer is with three hexoses 
on the 3-linked GalNAc branch as seen by the fragment ion at m/z 502. These results suggest 
that the hexoses on the 6-linked GalNAc branch are β1-3/4/6-linked galactoses. In addition, 
the presence of the fragment ion at m/z 667 containing three hexoses, and the absence of the 
fragment ion at m/z 463 containing two hexoses, suggest a branched, not linear arrangement 
of the three hexoses on the 3-position of GalNAc. 
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Figure 94 MALDI-TOF-TOF MS/MS spectra of permethylated reductively eliminated m/z 
1146 L3 D. viviparus O-glycans before and after the bovine testes broad specificity β1-3, 4, 6 
galactosidase digestion. The proposed monosaccharide configurations are based on GC-MS 
data (see section 4.5.2), previous results and knowledge of biosynthetic pathways in other 
organisms. 
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4.5.8 MALDI-TOF MS analyses of permethylated reductively eliminated O-glycans 
which were subjected to consecutive broad specificity β-galactosidase and broad 
specificity α-galactosidase treatment 
The reductively eliminated, broad specificity β1-3, 4, 6-galactosidase digested O-glycans 
from the D. viviparus L3 stage were subjected to green coffee bean broad specificity α-
galactosidase digestion. The MALDI-TOF MS spectrum is presented in the Figure 95, 
bottom. The disappearance of the peaks at m/z 1146 and 1116, the reduction in the relative 
abundance of the peaks at m/z 942 and 912, and the increase in the relative abundance of the 
peak at m/z 708 suggest the presence of α-linked galactoses in the sample. The reduction in 
the relative abundance of the peak at m/z 912 and the complete disappearance of the 
structural isomer having a second hexose attached to the β1-3-linked branch galactose, 
together with the increase in the relative abundance of the structural isomer in the molecular 
ion peak at m/z 708 provides strong evidence for this hexose being α-linked galactose. The 
appearance of the minor structural isomer at m/z 912 having galactose 6-linked to the 
GalNAc can be explained by the removal of the α-linked galactose from the molecular 
structure at m/z 1116. The disappearance of the structural isomer bearing a hexose attached to 
the 3-linked branch galactose at m/z 738 provides the proof for this hexose being α-linked 
galactose. Additional MALDI-TOF-TOF MS/MS structural evidence is discussed later (see 
section.4.5.9). Prior to the broad specificity α-galactosidase digestion, the O-glycans at m/z 
1146 and one of the structural isomers at m/z 942 have two hexoses attached to the 3-linked 
branch galactose and the question arises whether both of them are α-linked galactoses. If only 
one of them was α-linked galactose, after the broad specificity α-galactosidase digestion the 
molecular ion at m/z 738 would have had a structural isomer bearing two hexoses on the 3-
linked GalNAc branch. The fact that it has not been observed (see next section.4.5.9) 
suggests both hexoses attached to the 3-linked branch galactose are α-linked galactoses. 
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Figure 95  MALDI-TOF MS spectrum (35% acetonitrile fraction) of permethylated O-
glycans released by reductive elimination and digested with bovine testes broad specificity 
β1-3, 4, 6 galactosidase and broad specificity α-galactosidase enzymes. The MALDI-TOF-
MS spectrum of O-glycans digested by broad specificity β1-3, 4, 6 galactosidase is given for 
the reference purposes and has been shown earlier (Figure 93, bottom). The proposed 
structures are based on the MALDI-TOF-TOF MS/MS analyses (peaks marked with an 
asterisk*), GC-MS data (see section 4.5.2), previous results and the knowledge of 
biosynthetic pathways. M’ and ‘m’ represent major and minor structures, respectively.  
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4.5.9 MALDI-TOF-TOF MS/MS analyses of permethylated reductively eliminated O-
glycans which were subject to consecutive broad specificity β-galactosidase and broad 
specificity α-galactosidase treatment 
The MALDI-TOF-TOF MS/MS spectra of the molecular ion at m/z 738 both before and after 
the broad specificity β1-3, 4, 6-galactosidase digestion are shown in the Figure 96. After the 
broad specificity β1-3, 4, 6-galactosidase treatment the molecular ion at m/z 738 appears to 
contain two structural isomers. One is a Schisto Core O-glycan with the galactoses being 
attached to the 3- and 6-positions of the GalNAc and is represented by fragment ions at m/z 
502 and 259. The other structural isomer has a hexose attached to the 3-branch galactose and 
is represented by the fragment ions at m/z 463 and 298. Upon the subsequent sample 
treatment with the broad specificity α-galactosidase the structural isomer with two hexoses on 
the 3-linked branch disappears as is seen by the virtual disappearance of the fragment ions at 
m/z 463 and 298. The presence of the Shisto core structure in both samples is also supported 
by the presence of a low abundance internal reducing-end GalNAc fragment ion at m/z 284. 
Together these results provide evidence for the hexose attached to the 3-linked branch 
galactose being an α-linked galactose. 
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Figure 96 MALDI-TOF-TOF MS/MS spectra of permethylated reductively eliminated, β1-3, 
4, 6 galactosidase digested m/z 738 L3 D. viviparus O-glycans before and after the green 
coffee beans broad specificity α1-3, 4, 6 galactosidase digestion. The proposed 
monosaccharide configurations are based on GC-MS data (see section 4.5.2), previous results 
and knowledge of biosynthetic pathways in other organisms. 
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The molecular ion peaks at m/z 912 from the broad specificity β-galactosidase digested O-
glycans, and from broad specificity β-galactosidase and subsequently α-galactosidase digest 
O-glycans, were subjected to MALDI-TOF-TOF structural analyses. The resultant MS/MS 
spectra are shown in the Figure 97. The main structural isomer found in the molecular ion at 
m/z 912 from the broad specificity β-galactosidase digested O-glycans has a Hex-(Fuc)-Gal 
structure attached to the 3-position of the reducing-end GalNAc as seen by the most abundant 
fragment ions at m/z 637, the corresponding fragment ion at m/z 298 and the secondary 
fragment ions at m/z 415 and 449. The traces of another structural isomer having fucose 
attached to the 3-linked branch galactose and the 6-linked branch with one galactose are also 
present as seen by the low-abundance fragment ions at m/z 502 and 433. After the broad 
specificity α-galactosidase treatment, the previously most abundant structural isomer with the 
Hex-(Fuc)-Gal structure attached to the 3-position of the GalNAc almost completely 
disappears. This is consistent with the complete disappearance of the fragment ions at m/z 
298 and by the trace presence of the fragment ion at m/z 637. Instead, a previously low-
abundance Shisto Core fucosylated structural isomer becomes the most abundant as is seen 
by the most abundant fragment ions at m/z 502 and the corresponding fragment ions at m/z 
433. These results show the susceptibility of the Hex-(Fuc)-Gal containing structural isomer 
to the broad specificity α-galactosidase enzyme digestion and prove the non-reducing end 
terminal hexose of the ‘lower’ branch being an α-linked galactose. 
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Figure 97 MALDI-TOF-TOF MS/MS spectra of permethylated reductively eliminated, β1-3, 
4, 6 galactosidase digested m/z 912 L3 D. viviparus O-glycans before and after green coffee 
bean broad specificity α1-3, 4, 6 galactosidase digestion. The blue arrowed horizontal lines 
represent the loss of depicted structures. ‘M’ represents the major structure. The proposed 
monosaccharide configurations are based on GC-MS data (see section 4.5.2), previous results 
and knowledge of biosynthetic pathways in other organisms. 
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The Figure 98 shows the MALDI-TOF-TOF MS/MS spectra of the molecular ions at m/z 
942 of the broad specificity β-galactosidase digested O-glycans prior and after the broad 
specificity α-galactosidase digestion. In the broad specificity β-galactosidase digested O-
glycans the molecular ion at m/z 942 is made up of at least three structural isomers. O-glycan 
isomers having two and three hexoses on the 3-linked branch are represented by the fragment 
ions at m/z 502, 463 and 298, 667 respectively. There is also a trace of the third structural 
isomer having only one 3-linked galactose on the 3-linked branch and two on the 6-linked 
branch. This structural isomer is best represented by the fragment ions at m/z 706 since the 
corresponding fragment ions at m/z 259 can also result from fragmentation of the other 
structural isomers. After the broad specificity α-galactosidase digestion the molecular ion 
peak at m/z 942 as seen in MALDI-MS spectrum (see Figure 95) is greatly reduced in terms 
of relative abundance and upon MALDI-TOF-TOF MS/MS fragmentation only traces of the 
structural isomers with one and two hexoses on the 3-linked branch of the Schisto Core are 
observed as indicated by fragment ions at m/z 502 and 706 respectively. The structural isomer 
with three hexoses on the 3-linked branch virtually disappears as seen by the absence of the 
fragment ions at m/z 667 and 298. Together with the presence of only one Schisto Core 
structural isomer in the molecular ion at m/z 738 after broad specificity α-galactosidase 
digestion (see previous Figure 96) these results show the susceptibility to digestion of both 
hexoses on the 3-linked branch galactose establishing them as α-linked galactoses. 
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Figure 98 MALDI-TOF-TOF MS/MS spectra of permethylated reductively eliminated, β1-3, 
4, 6 galactosidase digested m/z 942 L3 D. viviparus O-glycans before and after the green 
coffee bean broad specificity α1-3, 4, 6 galactosidase digestion. Blue arrowed horizontal lines 
represent the loss of depicted structure. The peak at m/z 538 most likely represents the 
contaminant. The proposed monosaccharide configurations are based on GC-MS data (see 
section 4.5.2), previous results and knowledge of biosynthetic pathways in other organisms. 
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4.5.10 MALDI-MSn analysis of permethylated reductively eliminated m/z 708 O-glycan 
after consecutive broad specificity β-galactosidase and broad specificity α-galactosidase 
treatment 
Figure 99 MALDI-QIT-TOF MS2 spectrum of permethylated reductively eliminated, bovine 
testes β1-3, 4, 6 galactosidase and green coffee bean α1-3, 4, 6 galactosidase digested m/z 708 
O-glycan from the D. viviparus L3 stage. The proposed monosaccharide configurations are 
based on GC-MS data (see section 4.5.2), previous results and knowledge of biosynthetic 
pathways in other organisms. 
 
Although the potential α1-2 linkage between the fucose and galactose residues has been 
suggested earlier (see Figure 89), to provide additional evidence the molecular ion at m/z 708 
from the reductively eliminated, broad specificity β-galactosidase and broad specificity α-
galactosidase digested and permethylated O-glycans (see Figure 95), were subjected to MS2 
analysis on the MALDI-QIT-TOF instrument as seen in the Figure 99. The most abundant 
fragment ions at m/z 433 was subjected to MS3 analysis as seen in the Figure 100, top. The 
most abundant fragment ions at m/z 245 together with the fragment ions at m/z 229, 227 and 
211 confirm a linked galactose and a terminal fucose. Cross-ring fragment ions at m/z 271, 
315 and 329 suggest the fucose is 2-linked to the galactose. To get even stronger evidence a 
glycan standard containing the Fucα1-2Gal structure was also subjected to MSn analysis. The 
MS3 spectrum of the Fuc-Gal fragment ions at m/z 433 is shown in the Figure 100, bottom. 
Together with the 2-linked galactose seen in the GC-MS data (see section 4.5.2) the almost 
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identical spectra provide an additional evidence for the fucose being 2-linked to the galactose 
in the D. viviparus L3 stage O-glycan. 
 
Figure 100 MALDI-QIT-TOF MS3 spectrum of m/z 433 fragment ion from permethylated 
reductively eliminated, bovine testes β1-3,4,6 galactosidase and green coffee bean α1-3,4,6 
galactosidase digested m/z 708 O-glycan from D. viviparus L3 stage. The MALDI-QIT-TOF 
MS3 spectrum of m/z 433 Fucα1-2Gal fragment is shown for the reference. Dashed arrowed 
lines on the proposed/known structures represent glycosidic bond cleavages and cross-ring 
fragments. The proposed monosaccharide configurations for the top figure are based on GC-
MS data (see section 4.5.2), previous results and knowledge of biosynthetic pathways in 
other organisms. 
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4.5.11 MALDI-MS analysis of permethylated reductively eliminated, X. manihotis β-
galactosidase digested O-glycans  
The reductively eliminated D. viviparus L3 stage O-glycans were also subjected to β-
galactosidase from X. manihotis. Although this enzyme has been marketed as β1-3,6 
galactosidase, in fact the enzyme 100 times prefers β1-3 over β1-6 linked galactose and 500 
times β1-3 over β1-4 linked galactose (Wong-Madden and Landry, 1995) (unpublished 
observations obtained from New England Biolabs (NEB) website). The resultant MALDI-
TOF MS spectrum can be seen in Figure 101 where all the molecular ion peaks have also 
been subjected to the MALDI-TOF-TOF MS/MS analyses. As with the bovine testes broad 
specificity β1-3, 4, 6 galactosidase digestion, the molecular ion peaks corresponding to O-
glycans above m/z 1146 disappear suggesting the presence of the β-linked galactoses in the 
sample. On the other hand, due to the not strict specificity of the enzyme used, the specific 
linkages of the galactoses cannot be determined from the MALDI-TOF MS and MALDI-
TOF-TOF MS/MS experiments alone.  
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Figure 101 MALDI-TOF MS spectrum (35% acetonitrile fraction) of permethylated O-
glycans released by reductive elimination and digested with X. manihotis β-galactosidase. 
The MALDI-TOF-MS spectrum prior to the digest is given for the reference purposes and 
has been shown earlier (Figure 85). The proposed structures are based on the MALDI-TOF-
TOF MS/MS analyses (peaks marked with an asterisk*), GC-MS data (see section 4.5.2), 
previous results and the knowledge of biosynthetic pathways.  
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4.5.12 MALDI-MSn analyses of permethylated reductively eliminated, X. manihotis β-
galactosidase digested O-glycan at m/z 942  
Figure 102 MALDI-QIT-TOF MS2 spectrum of permethylated reductively eliminated, X. 
manihotis β-galactosidase digested m/z 942 O-glycan from the D. viviparus L3 stage. The 
blue arrowed horizontal line represents the loss of depicted fragment. The proposed 
monosaccharide configurations are based on GC-MS data (see section 4.5.2), previous results 
and knowledge of biosynthetic pathways in other organisms. 
 
The molecular ion at m/z 942 from the X. manihotis β-galactosidase digested, permethylated 
O-glycans (see previous Figure 101, bottom) was further fragmented by the MALDI-QIT -
TOF MS2 instrumentation. In contrast to the bovine testes broad specificity β-galactosidase 
digestion experiment (see Figure 98, top) where three structural isomers were present, the X. 
manihotis β-galactosidase digestion resulted in only one structural isomer as seen in Figure 
102. The two most abundant fragment ions at m/z 502 and 463 suggest the presence of the 
structural isomer where two galactoses comprise the 3-linked branch of the Schisto Core and 
one galactose comprises the 6-linked branch. No fragment ion at m/z 706 indicates the 
absence of the structural isomer with two galactoses on the 6-linked branch and no fragment 
ions at m/z 298 and 667 indicate the absence of the structural isomer with three galactoses on 
the 3-linked Schisto Core branch. 
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Figure 103 MALDI-QIT-TOF MS3 spectrum of m/z 463 fragment ions from permethylated 
reductively eliminated, X. manihotis β-galactosidase digested m/z 942 O-glycan. Dashed 
arrowed lines on the proposed structure represent glycosidic bond cleavages and cross-ring 
fragments. The proposed monosaccharide configurations are based on GC-MS data (see 
section 4.5.2), previous results and knowledge of biosynthetic pathways in other organisms. 
 
In order to obtain linkage information, the presence of only one structural isomer makes the 
fragment ion at m/z 463 a good target for MALDI-QIT-TOF MS3 structural analysis. In this 
way we know that the two galactoses are originating only from the 3-linked branch of the 
Schisto Core. The MALDI-QIT-TOF MS3 spectrum of the fragment ion at m/z 463 is shown 
in Figure 103. When determining the linkage the most informative cross-ring fragments in 
the spectrum are at m/z 345, 141, 315, 171 and 389 suggesting presence of Gal1-3Gal 
structure attached to the 3-position of the reducing-end GalNAc. 
To support this suggestion we can consider the following. The GC-MS data of the D. 
viviparus L3 Stage O-glycans (see section 4.5.2) showed the presence of 2-linked, 3-linked 
and 6-linked galactoses. The Gal-Gal structure attached to the 3-position of the GalNAc has 
been proved to be prone to the green coffee bean broad specificity α1-3,4,6 galactosidase. 
Putting these facts together we can assume Galα1-3Gal or Galα1-6Gal structures on the 3-
linked branch of the Schisto Core. 
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In order to get more information about the fragmentation of the 6-linked and 3-linked 
hexoses, the fragment ions at m/z 463 corresponding to Glcβ1-3Glc and Manα1-6Man 
structures from the laminaritriose and the oligomannose standards were subjected to MALDI-
QIT-TOF MS3 analyses (see Figure 104). Although the relative abundance of cross-ring 
fragment ions upon the fragmentation of various hexoses can be different (Ashline et al., 
2005), the actual m/z values of the cross-ring fragments are expected to be the same (Ashline 
et al., 2005). When comparing the MS3 spectrum of the fragment ions at m/z 463 from the 
molecular ion at m/z 942 (see Figure 103) to the MS3 spectrum of the Glcβ1-3Glc fragment 
ion (see Figure 104, top), there is the presence of the common cross-ring fragment ions at 
m/z 171, 315, 345, 359 and 389. The MS3 spectrum of the fragment ions derived from the D. 
viviparus L3 O-glycan lacks characteristic fragments for the 6-linked hexose such as ions at 
m/z 301 and 329 seen in the MS3 spectrum of the Manα1-6Man structure (see Figure 104, 
bottom). All these data put together strongly suggest the Galα1-3Gal structure forming the 3-
linked branch of the Shisto Core. 
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Figure 104 MALDI-QIT-TOF MS3 spectra are showing m/z 463 Glcα1-3Glc and Manα1-
6Man fragment ions from permethylated known standard compounds. Dashed arrowed lines 
on the known structures represent glycosidic bond cleavages and cross-ring fragments. The 
spectrum above has the zoomed in the m/z 300-460 region of the spectrum inserted.  
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4.5.13 MALDI-MSn analyses of permethylated reductively eliminated, X. manihotis β-
galactosidase digested O-glycan at m/z 1146  
 
Figure 105 MALDI-QIT-TOF MS2 spectrum of permethylated reductively eliminated, X. 
manihotis β-galactosidase digested m/z 1146 O-glycan from the D. viviparus L3 stage. The 
proposed monosaccharide configurations are based on GC-MS data (see section 4.5.2), 
previous results and knowledge of biosynthetic pathways in other organisms. 
 
The molecular ions at m/z 1146 from the X. manihotis β-galactosidase digested, 
permethylated O-glycans (see previous Figure 101, bottom) were further fragmented by the 
MALDI-QIT-TOF MS2 instrument as seen in the Figure 105. The most abundant fragment 
ions at m/z 667 and 502 indicate the structural isomer with the three galactoses on the 3-
linked branch and one galactose on the 6-linked branch of the Schisto Core. In addition very 
small amounts of another structural isomer having two galactoses on both Schisto Core 
branches are also present as indicated by the fragment ions at m/z 706 and 463.  
229 
 
 
Figure 106 MALDI-QIT-TOF MS3 spectrum of m/z 667 fragment ions from permethylated 
reductively eliminated, X.manihotis β-galactosidase digested m/z 1146 O-glycan. Dashed 
arrowed lines on the proposed structure represent glycosidic bond cleavages and cross-ring 
fragments. The proposed monosaccharide configurations are based on GC-MS data (see 
section 4.5.2), previous results and knowledge of biosynthetic pathways in other organisms. 
 
To obtain linkage information, the fragment ion at m/z 667 was subjected to MALDI-QIT-
TOF MS3 fragmentation as seen in the Figure 106. The absence of the fragment ions at m/z 
463 corresponding to the Gal-Gal structure confirms the branched nature of these three 
galactoses as proposed earlier (see Figure 94, bottom). Instead the fragment ions at m/z 449 
and 259 corresponding to the cleavage of one hexose are observed. The presence of the 
characteristic 6-linked hexose cross-ring fragment ions at m/z 301 and 329 (see Figure 104) 
strongly suggests the presence of the 6-linked galactose. The presence of the cross-ring 
fragment ions at m/z 315, 345, 375 (see Figure 104) also suggests the presence of the 3-
linked galactose. The cross ring fragments at m/z 593 and 563 suggest that the reducing end 
galactose is not 2-linked. 
Out of both 2, 3- and 3, 6-linked galactoses seen in the GC-MS data (see section 4.5.2) the 
linkage between the three galactoses on the -3 branch of the Schisto Core is consistent with 
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the latter. These results are also consistent with the fact that both galactoses attached to the 
galactose of the 3-linked branch of the Schisto Core are sensitive to green coffee bean broad 
specificity α1-3, 4, 6 galactosidase (see Figures 96 and 98) which does not cleave 2-linked 
galactose. Put together the results from the MS3, the GC-MS and the α1-3,4,6 galactosidase 
digestion experiments provide strong evidence for the Galα1-3-(Galα1-6)Gal structure 
attached to the 3-position of the reducing-end GalNAc. 
 
4.5.14 MALDI-MS analysis of permethylated reductively eliminated, α-galactosidase 
digested O-glycans 
 
From the green coffee beans broad specificity α1-3,4,6 galactosidase digestion of reductively 
eliminated, bovine testes broad specificity β-galactosidase digested O-glycans (see previous 
Figure 95) we already know that the broad specificity α1-3,4,6 galactosidase removes 
hexoses from the 3-linked branch of the Schisto Core. Nevertheless the same broad 
specificity α1-3,4,6 galactosidase digestion was performed on reductively eliminated O-
glycans in order to obtain good targets for the MALDI-QIT-TOF MSn analyses. The resultant 
MALDI-TOF MS spectrum can be seen in the Figure 107. The increase in the relative 
abundance of the molecular ion peak at m/z 738, the decrease in the relative abundance of the 
molecular ion peak at m/z 1116 in comparison to molecular ion peak at m/z 912, and the 
disappearance of the glycan molecular ions above the m/z 1350, are all consistent with the 
already described enzymatic removal of α-linked galactose(s) on the 3-linked branch of the 
Schisto Core (see sections 4.5.8 and 4.5.9). 
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Figure 107 MALDI-TOF MS spectrum (35% acetonitrile fraction) of permethylated O-
glycans released by reductive elimination and digested with green coffee bean broad 
specificity α1-3, 4, 6 galactosidase. The MALDI-TOF-MS spectrum prior to the digest is 
given for the reference purposes and has been shown earlier (see Figure 85). The proposed 
structures are based on the MALDI-TOF-TOF MS/MS analyses (peaks marked with an 
asterisk*), previous results and the knowledge of biosynthetic pathways. ‘M’ and ‘m’ 
corresponds to major and minor structures, respectively.  
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4.5.15 MALDI-MSn analyses of permethylated reductively eliminated, α-galactosidase 
digested O-glycan at m/z 942 
Figure 108 MALDI-QIT-TOF MS2 spectrum of permethylated reductively eliminated, green 
coffee bean α-galactosidase digested m/z 942 O-glycan from the D. viviparus L3 stage 
parasite. The proposed monosaccharide configurations are based on GC-MS data (see section 
4.5.2), previous results and knowledge of biosynthetic pathways in other organisms. 
 
In order to obtain the linkage information between the galactoses on the 6-linked branch of 
the Schisto Core O-glycans the molecular ion at m/z 942 after the broad specificity α-
galactosidase digestion was subjected to the MALDI-QIT-TOF MSn analyses. Initially it was 
subjected to the MS2 structural analysis (see Figure 108) where fragment ions at m/z 502, 
463 indicate the structural isomer with two galactoses on the 3-linked and one galactose on 
the 6-linked branch of the Schisto Core. In addition the abundant fragment ion at m/z 706 
indicates another structural isomer with two galactoses on the 6-linked, and one galactose on 
the 3-linked, branch of the Schisto Core. The expected fragment ion at m/z 259 corresponding 
to one hexose is not seen due to the low sensitivity in the lower molecular weight region of 
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the MALDI-QIT-TOF instrument. It has to be noted that although the majority of the 
fragment ion at m/z 463 is expected to originate from the more favourable Gal-Gal structure 
elimination from the GalNAc 3-position, it could also potentially be generated from the 
cleavage of the Gal-Gal structure from the GalNAc 6-position. 
Figure 109 MALDI-QIT-TOF MS3 spectrum of m/z 706 fragment ion from permethylated 
reductively eliminated, green coffee bean α-galactosidase digested m/z 1942 O-glycan. The 
proposed monosaccharide configurations are based on GC-MS data (see section 4.5.2), 
previous results and knowledge of biosynthetic pathways in other organisms. 
 
To obtain the fragment ion at m/z 463 generated from the 6-linked branch of the Schisto 
Core, the MALDI-QIT-TOF MS3 structural analysis of the fragment ion at m/z 706 was 
performed as seen in the Figure 109. Although with MSn analyses the sensitivity decreases 
with each consecutive ‘n’ experiment, in this case the most abundant generated fragment ion 
was the desired m/z 463 thus enabling us to perform the MS4 analysis on it. Other fragment 
ions at m/z 227, 245, 259, 284, 488 confirmed the proposed structure for the fragment ion at 
m/z 706. 
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Figure 110 MALDI-QIT-TOF MS4 spectrum of m/z 463 fragment ion from m/z 706 ion 
precursor which in turn originated from permethylated reductively eliminated, green coffee 
bean α-galactosidase digested m/z 1146 O-glycan. Dashed arrowed lines on the proposed 
structure represent glycosidic bond cleavages and cross-ring fragments. The proposed 
monosaccharide configurations are based on GC-MS data (see section 4.5.2), previous results 
and knowledge of biosynthetic pathways in other organisms. 
 
The MALDI-QIT-TOF MS4 spectrum of the fragment ion at m/z 463 is shown in the Figure 
110. The fragment ions at m/z 227, 245, 241 and 259 originate from the glycosidic bond 
cleavage and, together with fragment ion at m/z 431 resulting from the loss of methanol, do 
not yield any information about the linkage. However, the cross-ring fragment ions at m/z 
301, 329 are characteristic for 6-linked hexose (see Figure 104, bottom). In addition the 
cross-ring fragment ions at m/z 345 and 389 are also consistent with 6-linked hexose. The 
most abundant fragment ion at mz 359 .could originate from the analogous to m/z 389 
fragmentation but with an extra loss of methanal coming from the methyl group . Overall the 
MS4 spectrum of the fragment ion at m/z 463 from the O-glycan at m/z 942 (see Figure 110) 
looks remarkably similar to the MS3 spectrum of the Manα1-6Man fragment as seen in 
Figure 104, bottom providing strong evidence for the Galβ1-6Gal structure comprising the 
6-linked branch of the Schisto Core. The proposed Galβ1-6Gal structure on the 6-linked 
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branch is also supported by the presence of the 6-linked galatcose in the GC-MS data shown 
earlier (see section 4.5.2).  
 
4.5.16 MALDI-MSn analyses of permethylated reductively eliminated, α-galactosidase 
digested m/z 1146 O-glycan 
 
Figure 111 MALDI-QIT-TOF MS2 spectrum of permethylated reductively eliminated, green 
coffee bean α-galactosidase digested m/z 1146 O-glycan from the D. viviparus infective L3 
stage parasite. The proposed monosaccharide configurations are based on GC-MS data (see 
section 4.5.2), previous results and knowledge of biosynthetic pathways in other organisms. 
 
In order to get the linkage information between the second and the third galactoses of the 6-
linked branch of the Schisto Core MALDI-QIT-TOF MSn analyses was performed on the 
permethylated reductively eliminated, broad specificity α-galactosidase digested molecular 
ions at m/z 1146. The MALDI-QIT-TOF MS2 analysis revealed three structural isomers 
present as seen in the Figure 111. The fragment ions at m/z 502 and 667 correspond to the 
structural isomer with three galactoses on the 3-linked branch and one galactose on the 6-
linked branch of the Schisto Core. It has to be noted that the fragment ion at m/z 667 can also 
originate from another structural isomer with three galactoses on the 6-linked branch and one 
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galactose on the 3-linked branch of the Schisto Core. The best evidence for this second 
structural isomer is the fragment ion at m/z 910. The expected additional fragment ion at m/z 
259 corresponding to one hexose is not seen, possibly due to the low sensitivity of the 
instrument in the low molecular weight region. The third structural isomer has two galactoses 
on both branches of the Schisto Core and is represented by the fragment ions at m/z 706 and 
463 although the latter fragment ion can be generated from other structural isomers as well. 
Figure 112 MALDI-QIT-TOF MS3 spectrum of m/z 910 fragment ion from permethylated 
reductively eliminated, green coffee bean α-galactosidase digested m/z 1146 O-glycan. The 
proposed monosaccharide configurations are based on GC-MS data (see section 4.5.2), 
previous results and knowledge of biosynthetic pathways in other organisms. 
 
To be confident that the galactoses we fragment are originating from the 6-linked branch of 
the Schisto Core, the fragment ion at m/z 910 was selected for further MALDI-QIT-TOF MS3 
analysis as seen in the Figure 112. The fragment ions at m/z 463 and 488 indicate that three 
galactoses on the 6-linked branch are arranged in a linear, not branched form. Other fragment 
ions at m/z 259, 284, 449, 667 692 support the proposed structure. The abundance of the 
fragment ions at m/z 667 and 463 corresponding to three and two galactoses encouraged us to 
perform MALDI-QIT-TOF MS4 analyses on them. 
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Figure 113 MALDI-QIT-TOF MS4 spectrum of m/z 667 fragment ions from m/z 910 ion 
precursor which in turn originated from permethylated reductively eliminated, green coffee 
bean α-galactosidase digested m/z 1146 O-glycan. Dashed arrowed lines on the proposed 
structure represent glycosidic bond cleavages and cross-ring fragments. The proposed 
monosaccharide configurations are based on GC-MS data (see section 4.5.2), previous results 
and knowledge of biosynthetic pathways in other organisms. 
 
The MALDI-QIT-TOF MS4 analysis of the fragment ion at m/z 667 was carried out as seen in 
the Figure 113. The presence of the fragment ion at m/z 463 confirms the earlier proposed 
linear, not branched, structure for the three 6-linked branch galactoses. Fragment ions at m/z 
259 and 449 correspond to a hexose and two hexoses with two hydroxyl groups. although 
they are not as informative since these fragment ions can be generated from both linear and 
branched structures. The cross-ring fragment ions at m/z 533 and 505 confirm the earlier 
proposed β1-6 glycosidic bond between the first two galactoses of the 6-linked branch. The 
fragment ions at m/z 329 may suggest a 1-6 glycosidic bond between the second and third 
galactoses. MALDI-QIT-TOF MS4 of the fragment ion at m/z 463 was carried out. 
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Figure 114 MALDI-QIT-TOF MS4 spectrum of m/z 463 fragment ion from m/z 910 ion 
precursor which in turn originated from permethylated reductively eliminated, green coffee 
bean α-galactosidase digested m/z 1146 O-glycan. Dashed arrowed lines on the proposed 
structure represent glycosidic bond cleavages and cross-ring fragments. The proposed 
monosaccharide configurations are based on GC-MS data (see section 4.5.2) and previous 
results. 
 
The MALDI-QIT-TOF MS4 analysis of the fragment ion at m/z 463 corresponding to the 
second and third galactoses from the 6-linked branch of the Schisto Core was carried out as 
seen in the Figure 114. The fragment ions at m/z 245 and 259 correspond to reducing and 
non-reducing end hexoses confirming the hexose-hexose structure although, together with the 
fragment ion at m/z 431 generated by the loss of a methanol, they are not linkage-informative. 
However, characteristic for 6-linked hexose, the cross-ring fragment ions at m/z 329 and 301 
suggest the Galβ1-6Gal structure for the second and third galactoses in the 6-linked branch of 
the Schisto Core. The cross-ring fragment ion at m/z 345 supports the Galβ1-6Gal structure. 
Although not assigned, the cross-ring fragments at m/z 359 and 375 are also present in the 
MS3 spectrum of the Manα1-6Man structure (see previous Figure 104, bottom). Overall the 
spectrum profile, although of lower quality due to the MS4 nature of the experiment looks 
very similar to the MS3 spectrum of the Manα1-6Man fragment ion (previous Figure 104, 
bottom). Together with the presence of the 6-linked galactose in the GC-MS results (see 
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section 4.5.2) this data provides a strong evidence for the Galβ1-6Gal structure for the 
second and third galactoses on the 6-linked linear branch of the Schisto Core. 
 
4.5.17 MALDI-MS analysis of permethylated reductively eliminated, broad specificity 
α-galactosidase and subsequently broad specificity β1-3, 4, 6 galactosidase digested O-
glycans  
The reductively eliminated and broad specificity α-galactosidase digested D. viviparus L3 
stage O-glycans described in the Figure 107, bottom have also been subjected to consecutive 
bovine testes broad specificity β1-3, 4, 6 galactosidase digestion. The resultant MALDI-TOF 
MS spectrum can be seen in the Figure 115where the structures presented are based on the 
MALDI-TOF-TOF MS/MS fragmentation and previous results. The appearance of the new 
structural isomer in the molecular ion at m/z 534 having galactose on the 6-position of the 
GalNAc, the decrease of the molecular ion peak at m/z 942, the disappearance of the 
molecular ion peaks at m/z 1116 and 1146, are all consistent with the removal of up to three 
already-proven β1-6 galactoses from the 6-linked branch of the Schisto Core. The key result 
of this experiment is the disappearance of the molecular ion peak at m/z 1350. As shown in 
the MALDI-TOF| MS spectrum in Figure 115, top and proven later by the MALDI-QIT-
TOF MS2 results in the Figures 116, the most abundant structural isomer comprising this 
molecular ion is the one having four hexoses on the 6-linked branch of the Schisto Core. 
Although the initial molecular ion peak at m/z 1350 in the Figure 115, top has relatively low 
abundance, considering that it completely disappears after the broad specificity β1-3, 4, 6 
galactosidase digestion (see Figure 115, bottom), and that the most abundant structural 
isomer has four hexoses on the 6-linked branch, all this data points to the fourth hexose on 
the 6-linked branch of the Schisto Core being β-galactose. 
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Figure 115 MALDI-TOF MS spectrum (35% acetonitrile fraction) of permethylated O-
glycans released by reductive elimination and digested with broad specificity α-galactosidase 
and bovine testes broad specificity β1-3, 4, 6 galactosidase enzymes. The MALDI-TOF-MS 
spectrum of O-glycans digested by broad specificity α1-3, 4, 6 galactosidase is given for the 
reference purposes and has been shown earlier (Figure 107, bottom). The proposed 
structures are based on the MALDI-TOF-TOF MS/MS analyses (peaks marked with an 
asterisk*), previous results and the knowledge of biosynthetic pathways.  ‘M’ and ‘m’ 
represent major and minor structures, respectively. 
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4.5.18 MALDI-MSn analyses of permethylated reductively eliminated, α-galactosidase 
digested m/z 1350 O-glycan 
Figure 116 MALDI-QIT-TOF MS2 spectrum of permethylated reductively eliminated, green 
coffee bean α-galactosidase digested m/z 1350 O-glycan from D. viviparus L3 stage parasite. 
The proposed monosaccharide configurations are based on GC-MS data (see section 4.5.2), 
previous results and knowledge of biosynthetic pathways in other organisms. 
 
In a similar way to the molecular ion at m/z 1146 (see section 4.5.16), the permethylated 
reductively eliminated, broad specificity α-galactosidase digested molecular ion at m/z 1350 
was further analysed by MALDI-QIT-TOF MSn approach in order to get information about 
the linkage between the third and fourth galactoses. The MALDI-QIT-TOF MS2 spectrum of 
the molecular ions at m/z 1350 is shown in the Figure 116 and reveals four structural isomers 
are present. The fragment ions at m/z 1114 represent the structural isomer with four 
galactoses on the 6-linked branch of the Schisto Core. The corresponding fragment ion at m/z 
259 is not observed due to the MALDI-QIT-TOF instrument sensitivity limitations in the 
lower molecular mass region. The fragment ions at m/z 910 with corresponding fragment ions 
at m/z 463 indicate the presence of the structural isomer with three galactoses on the 6-linked 
branch and two on the 3-linked branch of the Schisto Core. The fragment ions at m/z 706, 667 
originate from the structural isomer with two galactoses on the 6-linked branch and three on 
the 3-linked branch branches of the Schisto Core. Finally the fragment ions at m/z 502 and 
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871 indicate the presence of the structural isomer with one galactose on the 6-linked branch 
and four galactoses on the 3-linked branch of the Schisto Core. It has to be noted that the 
fragment ions at m/z 463, 667, 871 corresponding to two, three and four galactoses are not 
unique to the structural isomers assigned and can originate from other structural isomers as 
well. 
Figure 117 MALDI-QIT-TOF MS3 spectrum of m/z 1114 fragment ion from permethylated 
reductively eliminated, green coffee bean α-galactosidase digested m/z 1350 O-glycan. The 
proposed monosaccharide configurations are based on GC-MS data (see section 4.5.2), 
previous results and knowledge of biosynthetic pathways in other organisms. 
 
To be confident that the galactoses originate from the 6-linked branch of the Schisto Core, the 
fragment ion at m/z 1114 were further fragmented in the MALDI-QIT-TOF MS3 experiment 
and the resultant spectrum is shown in the Figure 117. The presence of the fragment ions at 
m/z 463 and 667 prove the linear, not branched arrangement of the four galactoses on the 6-
linked branch of the Schisto Core. This arrangement is supported by the series of fragment 
ions at m/z 488, 692 and 896. The fragment ions at m/z 871 comprised of four galactoses 
support the proposed structure of the parental fragment ion. 
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Figure 118 MALDI-QIT-TOF MS4 spectrum of m/z 463 fragment ion from m/z 1114 ion 
precursor which in turn originated from permethylated reductively eliminated, green coffee 
bean α-galactosidase digested m/z 1350 O-glycan. Dashed arrowed lines on the proposed 
structure represent glycosidic bond cleavages and cross-ring fragments. The proposed 
monosaccharide configurations are based on GC-MS data (see section 4.5.2) and previous 
results. 
 
In order to determine the linkage between the third and fourth galactoses of the 6-linked 
branch of the Schisto Core, the fragment ion at m/z 463 was selected for MALDI-QIT-TOF 
MS4 analysis as seen in Figure 118. Due to the initial relatively low abundance of the 
molecular ions at m/z 1350 in the MS spectrum and the nature of the MSn experiment, the 
resultant MS4 spectrum is not of the highest quality. Nevertheless the cross-ring fragments at 
m/z 329 and 345 indicate 6- or 4-linked galactose. Although with some missing peaks, the 
resemblance of this spectrum to the standard MS3 spectrum of the Manα1-6Man fragment 
(see previous Figure 104, bottom), the proven β1-6 linkage between the first-second and 
second- third and the presence of 6-linked, not 4-linked galactose in the GC-MS data (see 
section 4.5.2) makes the β1-6, not β1-4 linkage most probable between the third and the 
fourth galactoses of the 6-linked branch of the Schisto Core. 
 
244 
 
4.5.19 The summary of reductively eliminated O-glycan structures from L3 stage D. 
viviparus 
Putting all the data together acquired so far in the thesis about reductively eliminated O-
glycans from L3 stage D. viviparus, the proposed structures with the corresponding m/z 
values can be seen below in the Table 23. Considering that O-glycans from D. viviparus have 
not been reported previously, the proposed linkages for most of the structures have been 
included as well. 
 
m/z 
 
Structure 
534 
ß1-3 
738 
ß1-3
ß1-6
 
912 
α1-2
ß1-3
ß1-6
 
942 
ß1-3
ß1-6
α1-3      ß1-3
ß1-6
ß1-6
 
1116 
ß1-3
ß1-6
α1-2
α1-3/6
 
1146 
ß1-3
ß1-6
α1-3
α1-6
       
ß1-3
ß1-6
α1-3
ß1-6
…… ß1-3
ß1-6
ß1-6ß1-6
 
1321 
ß1-3
ß1-6
α1-2
α1-3/6
ß1-6
ß1-3
ß1-6
α1-2
α1-3/6
{
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1351 
{ ß1-3
ß1-6
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α1-6
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α1-6
ß1-6
      
α1-3
ß1-6 ß1-6
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ß1-3      
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1525 
ß1-3
ß1-6
α1-2
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1555 
4X
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ß1-6
 
1759 
5X
ß1-3
ß1-6
 
1963 
6X
ß1-3
ß1-6
 
2167 
7X
ß1-3
ß1-6
 
Table 23 showing the proposed O-glycan structures released by reductive elimination from 
L3 stage D. viviparus. 
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4.6 Structural conclusions of D. viviparus parasite glycomes 
4.6.1. Structural conclusions of adult N and O-glycans 
The MALDI analysis of adult Dictyocaulus viviparus N-glycans showed the presence of high 
mannose, paucimannodic, truncated fucosylated and complex bi-, tri- and tetra-antennary 
structures with the latter carrying terminal GlcNAc(s), LacNAc(s) and Lewisx structures. All 
these N-glycans have been reported earlier using FAB-MS techniques (Haslam et al., 2000). 
For the first time the D. viviparus O-glycan data have been described and the evidence for 
Galβ1-3GalNAc Core 1, Galβ1-3(Gal β1-6)GalNAc Schisto Core and Galβ1-3(GlcNAc β1-
6)GalNAc Core 2 structures has been presented. Interestingly the GlcNAc of latter O-glycans 
can be modified into terminal LacNAc and Lewisx structures, the same terminal antennae 
seen in N-glycans. The abundant Lewisx containing structures have been proposed to interact 
with host lectins such as DC-SIGN (van Die et al., 2003) and skew immune response towards 
inflammatory CD4 + Th2 immune response (van Die and Cummings, 2010). Newly reported 
adult O-glycans are summarized in the Figure 119. 
   
 
 
Figure 119 proposed structural conclusions of O-glycan structures discovered in D. viviparus 
adult and L3 stages.  
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4.6.2. Structural conclusions of L3 stage N- and O-glycans  
For the first time N-glycan data form D. viviparus L3 stage has been presented. Overall most 
of the N-glycan structures are also seen in the adult stage, although complex bi- and tri- 
antennary structures carrying terminal GlcNAc(s), LacNAc(s) and Lewisx structures were 
less abundant. No tetra-antennary complex structures have been observed suggesting the 
wider transcriptomics profile in adult D. viviparus as also seen for H. contortus (Laing et al., 
2013; Schwarz et al., 2013). 
 
Surprisingly the analysis of the L3 stage D. viviparus O-glycans revealed not a more simple, 
but rather a substantially different O-glycome when compared to the adult stage as 
summarized in Figure 119. None of the Core 2 structures were observed and instead 
extended families of Schisto Core structures were detected. The first has poly-β1-6 galactoses 
on the ‘upper’ 6-linked branch of the Schisto Core arranged linearly. Up to four β1-6 
galactoses have been demonstrated although longer, up to 8 hexoses, most likely all 
galactoses comprising ‘upper branch’ antennae are likely to be present. Interestingly Galβ1-
6Gal structure has been detected in free bovine milk oligosaccharides which are not attached 
to any proteins or lipids (Aldredge et al., 2013). The 3-linked ‘lower branch of the Schisto 
Core has been demonstrated to contain α-linked galactoses arranged in a branched manner. 
Initially α-galactose is attached to the 3-position of the ‘lower branch’ galactose, then another 
α-galactose is attached to the 6-position of the same β1-3-linked galactose. More hexoses, 
most likely galactoses can be added to the ‘lower branch’ of the Schisto Core. The Galβ1-
3(Gal β1-6)GalNAc Schisto Core was originally discovered in Shistosoma mansoni 
trematode however both ‘upper’ and ‘lower’ branches have Lewisx rather than poly-galactose 
antennae (Khoo et al., 2001). Interestingly Galα1-3Gal structure has been detected in bovine 
milk oligosaccharides (Aldredge et al., 2013). 
 
The second family of L3 stage D. viviparus O-glycans is also based on the Schisto Core 
however the ‘lower branch’ galactose is 2-linked to the fucose forming the ‘blood group H’ 
structure. In addition the same galactose can be further modified at the 3-position with an α-
galactose forming the blood group B antigen. No further addition of galactoses to the lower 
branch has been observed. Up to three galactoses have been observed on the ‘upper branch’, 
most likely arranged in a linear fashion forming β1-6 linkages based on another non-
fucosylated O-glycan family. The Fucα1-2Galβ1-3GalNAc blood group H structure has also 
248 
 
been observed in P. tenuis nematode however no further extensions of this structure were 
reported (Duffy et al., 2006).  
 
The presence of terminal galactoses in D. viviparus L3 stage O-glycans suggest possible 
interactions with host lectins such as galectins thus modulating host immune responses (van 
Die and Cummings, 2010). The Galα1-3(Fuc α1-2)Gal blood group B antigen found in E. 
coli 086 strain was shown to interact with human galectins 3, 4 and 8 with galectins 4 and 8 
being able to eliminate bacteria (Stowell et al., 2010). Later the same blood group B antigen 
was shown to interact with the subset of human dendritic cells found in mucus and skin, 
Langerhans cells via the C-type lectin langerin (Feinberg et al., 2011). To our knowledge no 
parasite-derived Fucα1-2Gal blood group H antigen-host lectin interactions have been 
reported, however the presence of this blood group antigen in cows (Aldredge et al., 2013) 
may suggest the molecular mimicry approach of the parasite to evade the host immune 
system. It is not known whether poly-β1-6-galactoses would interact with galectins or other 
host lectins. 
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Future perspectives 
In my thesis I have reported the detailed structural characterizations of a range of novel N- 
and O-glycans from Haemonchus contortus and Dictyocaulus viviparus. Obtaining the 
structural information about the glycans, such as monosaccharide conformation, linkage and 
anomericity, is a pre-requisite before chemical synthesis and an investigation of their effects 
as potential vaccine candidates. Although synthesis of glycans still remains a daunting task, 
the progress in the field is obvious. In 2015 the first commercial automated carbohydrate 
synthesizer Glyconeer® appeared on the market. Although it is unlikely that at this stage it 
would be able to synthesize the unusual parasite glycans reported in my thesis. 
An alternative solution could be the utilization of enzymatic synthesis which has been proven 
to be successful for the synthesis of some of the glycans. The Galβ1-4(Fucα1-3)GlcNAc 
(Lewisx), GalNAcβ1-4GlcNAc (LacdiNAc), LDNF (GalNAcβ1-4(Fucα1-3)GlcNAc), 
LDNDF (GalNAcβ1-4(Fucα1-2Fucα1-3)GlcNAc) structures found in schistosomes were 
successfully synthesised in micromolar amounts using recombinant β1-4GalT 
galactosyltranserase, α1-3FucT fucosyltransferase, β1-4GalNAcT N-
acetylgalactosyltransferase, α1-2FucT fucosyltransferase enzymes (van Remoortere et al., 
2000). In another study the Globo-H glycolipid-derived hexasaccharide Fucα1-2Galβ1-
3GalNAcβ1-3Galα1-4Galα1-4Glc has been synthesised which is one of the most promising 
glycan-based anticancer vaccine candidates (Su et al., 2008). Three recombinant 
glycosyltransferases, namely an α1-4 galactosyltransferase LgtC, a bifunctional β1-3 
galactosyl/ β1-3 N-acetylgalactosaminyltransferase and an α1-2 fucosyltransferase WbsJ 
together with two recombinant epimerases GalE and WbgU for conversion of less expensive 
UDP-Glc, UDP-GlcNAc to more expensive UDP-Gal, UDP-GalNAc have been employed to 
achieve milimolar (grams) quantitities of the hexasaccharide product (Su et al., 2008). Very 
recently commercially available recombinant β1-4 galactosyltransferase (B4GALT1) and α1-
6 fucosyltransferase (FUT8) as well as recombinant α2-3 sialyltransferase (PmST1m), α2-6 
sialyltransferase (Pd2,6ST), CMP-sialic acid synthetase (NmCSS) enzymes have been used to 
create sialylated Lewisx and sialylated LacNAc antennae and fucosylate the proximal 
GlcNAc of the chitobiose core on various N-glycans in an attempt to create a large libray of 
N-glycans in milligram quantities (Li et al., 2015). Speaking about enzymatic O-glycan 
synthesis recombinant commercially available β1-4 galactosyltranserase (β4-GalT1), α2-3 
sialyltransferase (ST3Gal3), α1-3 fucosyltransferase (α3-FucT3) enzymes together with 
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recombinantly expressed polypeptide N-acetylgalactosaminyltransferase 3 (GalNAcT3) and 
core-2 β6-N-acetylglucosaminyltrasnsferase (C2GnT) have been used to synthesise core-2 
sialyl Lewisx O-glycans in milligram quantities (Gutierrez Gallego et al., 2003). 
Although many of the glycosyltransferases and glycosidases involved in glycan synthesis of 
the novel species specific nematode structures are not available commercially, a number of 
them have been cloned and characterized. Considering adult H. contortus N-glycans with 
Gal-Fuc modifications the range of glycan biosynthetic enzymes characterized in C. elegans 
organism immediately suggests the idea of using these enzymes for H. contortus N-glycans 
synthesis. The three fucosyltransferases FUT-1, FUT-6, FUT-8 generating the trifucosylated 
chitobiose core have been cloned and characterized (Paschinger et al., 2005; Titz et al., 2009; 
Yan et al., 2013). The galactosyltransferase GALT-1 involved in the generation of Galβ1-
4Fuc structure attached to the 6-position of the proximal GlcNAc has also been cloned and 
characterized (Titz et al., 2009; Yan et al., 2013). No α1-2 galactosyltransferase(s) acting on 
the fucose attached to the 3-position of the distal GlcNAc has been cloned and characterized 
yet. However, over twenty potential α-galactosyltransferases have been identified in C. 
elegans (Yan et al., 2013; Zheng et al., 2002). It is likely that the required α1-2 
galactosyltransferase is one of them. In contrast to C. elegans the N-glycans from H. 
contortus also contain the proposed GalNAcβ1-4(Galα1-2Fucα1-3)GlcNAc non-reducing end 
antennae. The GLY-13 protein transferring the GlcNAc onto 2-position of mannose (Chen et 
al., 2002), the β4GalNAc-T3 and β4GalNAc-T4 enzymes forming GalNAcβ1-4GlcNAc 
(Gotoh et al., 2004; Sato et al., 2003) and the FUT-6 enzyme being able to form GalNAcβ1-
4(Fucα1-3)GlcNAc (LDNF) (Yan et al., 2013) have been cloned and characterized. The 
earlier discussed putative α1-2 galactosyltransferase generating the proposed Galα1-2Fuc on 
the 3-position of the distal GlcNAc could also add galactose to the LDNF structure. The 
summary of the strategies for enzymatic biosynthesis of adult H. contortus N-glycans is 
shown in Figure 120. 
Considering the adult H. contortus O-glycans as potential vaccine candidates I will discuss 
the potential enzymatic synthesis of the highest molecular weight O-glycan observed, see 
Figure 120. The core 1 O-glycan T-synthase which adds β-galactose to the 3-position of 
GalNAc has been cloned and characterized (Ju et al., 2006). The β1-6 GlcNAc transferase 
responsible for the formation of GlcNAcβ1-6(Galβ1-3)GalNAc core 2 structure has also been 
cloned and characterized (Bierhuizen and Fukuda, 1992). The formation of the galactosylated 
LDNF structure has been described earlier for N-glycans. Although no α1-3 
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galactosyltransferase(s) acting on the terminal GalNAc have been cloned or characterized, a 
H. contortus worm extract has been shown to contain such an activity (van Stijn et al., 
2010b). When discussing O-glycans from L3 stage it would be worth considering the 
synthesis of the Galβ1-3(Galβ1-6)GalNAc Schisto Core structure. Unfortunately to my 
knowledge no β1-6 galactosyltransferase(s) acting on Galβ1-3GalNAc core 1 structure have 
been reported. However the sequencing of the H. contortus genome (Laing et al., 2013; 
Schwarz et al., 2013) allows the expectation that soon this enzyme will be discovered. 
Both N- and O-glycans from D. viviparus contain Galβ1-4(Fucα1-3)GlcNAc (Lewisx) 
structures or their precursors. Considering the fact that the Lewisx structure is abundant in 
cows (Siciliano et al., 1993) it makes it less likely to consider these glycans as successful 
vaccine candidates. Although the analysis of L3 stage D. viviparus glycans revealed 
previously unseen O-glycan structures, most of their separate features such as Fucα1-2Gal 
Blood group H, Galα1-3Gal, Galβ1-6Gal have been detected in bovine milk oligosaccharides 
(Aldredge et al., 2013). On the other hand Galβ1-3(Galβ1-6)GalNAc Schisto Core could be 
an attractive vaccine candidate especially because it is found both in L3 stage and adult 
parasites. Its potential enzymatic synthesis has been described above as this structure is also 
seen in H. contortus parasite. Although the Galβ1-6Gal structure has been observed in cows 
(Aldredge et al., 2013) the poly-(Galβ1-6) structure, to my knowledge was not been observed 
in any mammals. For this reason this structure can also be considered as a potential vaccine 
candidate. Unfortunately no β1-6- galactosyltransferase(s) have been identified. However the 
generated transcriptomics data (Cantacessi et al., 2011; Ranganathan et al., 2007; Strube et 
al., 2012) and ongoing research on the genome sequencing of D. viviparus (Martin et al., 
2015) allows the expectation that soon these β1-6- galactosyltransferase(s) and other enzymes 
involved in biosynthesis of L3stage O-glycans will be identified, cloned and characterized. In 
addition the fact that certain glycan structures are present in the host does not eliminate those 
structures as potential vaccine candidates. The similar rational is used for the development of 
carbohydrate-based vaccines against cancer (Astronomo and Burton, 2010) where tumour-
associated carbohydrate antigens (TACA) are present on cancer and other parts of the body 
not necessarily accessible to antibodies against TACA. Finally, the synthesis of these unusual 
H. contortus and D. viviparus N- and O-glycans as well as testing of their immunological 
properties may not only reveal the potential vaccine candidates but also immune-modulators 
with unexpected properties and a range of different applications in treating immune disorders. 
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Figure 120 The overview of the strategies for enzymatic synthesis of adult H.contortus N- 
and O-glycans 
Alternatively cell lines or organisms can be glycoengineered to produce proteins with the 
parasite glycan structures. The major advantage of this approach is that once engineered the 
expression of the desired glycoprotein can be achieved in large quantities. If whole cells are 
used for vaccination as shown for glycoengineered Lec 8 Chinese Hamster Ovary (CHO) 
cells expressing poly- GalNAcβ1-4GlcNAc (poly-LDN) and poly- GalNAcβ1-4(Fucα1-
3)GlcNAc (poly-LDNF) (Prasanphanich et al., 2014) there is no need for protein purification 
and immunization material can be obtained even easier. On the other hand the major 
drawback for this approach when compared to enzymatic in vitro synthesis is that cell 
engineering provides an extra layer of complexity as not only expression of desired glycan-
modifying enzymes in the ER or Golgi has to be considered, but also the availabaility of 
corresponding sugar donors as well as the deletion of undesired 
glycosyltransferases/glycosidases.For the creation of the cell line which would produce adult 
H. contortus N-glycans the C.elegans organism as an expression system would be the logical 
candidate. Since both C. elegans and H. contortus seem to share the same chitobiose core 
modifications, only non-reducing end antennae have to be changed. The C. elegans non-
reducing antennae are known to contain single GlcNAc residue as well as mannose and 
galactose residues which can be modified with fucose (see section 1.2.2.5). To create 
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GalNAcβ1-4(Galα1-2Fucα1-3)GlcNAc structures which have been suggested to be present in 
H. contortus, GalNAc transferase has to be introduced into the Golgi of C. elegans. Since no 
GalNAc antennae have been observed in C. elegans N- or O-glycans, it is likely that the 
GalNAc-UDP transporter would have to be inserted into the Golgi as well. If needed the 
levels of the GalNAc-UDP could be enhanced by the insertion of the GlcNAc-UDP 
epimerase WbgU (Su et al., 2008). Likely α1-3 fucosyltransferase FUT-6 and putative α1-2 
fucosyltransferase forming the Galα1-2Fuc structure on the 3-position of the distal chitobiose 
core GlcNAc would also be able to modify the GalNAcβ1-4GlcNAc antennae. If not, the 
insertion of additional putative fucosyltransferase and galactosyltransferase has to be 
performed as well. Since both fucose and galactose are found on the chitobiose core of C. 
elegans there would be no need to insert GDP-Fuc and UDP-Gal transporters. If 
homogenious N-glycosylation is needed the putative fucosyltransferase(s) and 
galactosyltransferase enzymes modifying C.elegans non-reducing end N-glycans would have 
to be deleted. These glycoengineered C. elegans could be used to make recombinant proteins 
with H. contortus N-glycans as vaccine candidates or whole worms could be tried as well 
assuming that other molecules present in C. elegans would not interfere with immunization. 
In attempt to glycoengineer the cell line which would express unusual L3 stage D. viviparus 
O-glycans, already existing CHO mutant cell lines can be considered. For example Lec2 
CHO cell line has been demonstrated to contain only core 1 Galβ1-3GalNAc O-glycans 
without any structures containing sialic acid (North et al., 2010a). Putative β1-6 
galactosyltransferase(s) would have to be inserted into Golgi to form the poly- β1-6-galactose 
branch. Putative α-galactosyltransferases as well as α1-2 fucosyltransferase enzymes would 
have to be inserted into Golgi as well. Since galactose is present in both N- and O-glycans of 
this cell line as well as fucose is present in N-glycans (North et al., 2010a) no additional 
sugar donor transporters would be required. The proteins with O-glycosylation site(s) could 
be expressed using that system and used as potential vaccine candidates. Alternatively if 
human N-glycans present on cell surface would not interfere with cow immunization studies, 
whole cells could be used as vaccination material as shown for immunization studies with 
glycoengineered CHO cells expressing schisto parasite anatigens (Prasanphanich et al., 
2014). 
The discovered unusual glycans can also be used to raise antibodies against them. These 
antibodies could be used in a range of scientific applications such as staining the worm to 
find the exact position of the antigens within the worm as well as antibody-based antigen 
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purification. Similarly the antibodies raised against parasite-specific glycans can be used in 
the development of tests to diagnose the worm infection. Currently apart from general 
symptoms and faecal examination the H. contortus parasite infection is detected by two tests. 
The Dipstick Test was developed in Australia and is based on blood detection in dung 
(Colditz and Le Jambre, 2008). Second test was developed later by University of Georgia, 
Athenes and is based on staining parsite eggs with fluoresccein-labeled peanut agglutinin and 
examination of faeces under the microscope in the presence of ultraviolet light (Jurasek et al., 
2010). Although the second test is less expensive and less labour intensive it still takes two 
days to perform. Having an antibody against glycans found, for example, on excretory-
secretory proteins of adult H. contortus would potentially enable us to perform the sandwich-
ELISA experiment to detect the excretory-secretory antigens in the blood. Alertnatively the 
synthesized glycan antigens from L3 and/ or adult parasite would enable us to detect 
antibodies elicited against them in the host blood. In combination with new tecnnologies such 
as microfluidics these tests could be performed within minutes as shown for ELISA-based 
detection of HIV antigen (Chin et al., 2011). 
In terms of D. viviparus parasite, two tests based on ELISA (Cornelissen et al., 1997) and 
dipstick immunoasay (Schnieder, 1993) are available to detect the infection. However both of 
them are based on adult Major Sperm Protein antigen which binds antibodies circulating in 
cow’s blood or milk. Two current problems are associated with these tests. The first problem 
is that it takes a couple of weeks needed for the development of antibodies against adult 
antigen. The second problem is that these tests do not show the ‘reinfection’ phenomenon 
where L3 stage parasites accumulate in bronchi, cause strong immune response and 
eventually are cleared out of bronchi (Sekiya et al., 2013). The discovered unusual O-glycans 
of L3 stage D. viviparus parasite could act as potential antigens to raise antibodies against 
them for the alternative ELISA-based diagnostics.  
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